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Vibrational spectroscopic methods are minimally invasive, and are appropriate for use in 
clinical contexts. Methods were developed in this dissertation for evaluating joint damage 
and disease using Raman spectroscopy. Subtle changes in the molecular structure of joint 
tissue and synovial fluid precede morphological changes in the joint. The goal of this 
research is to develop Raman spectroscopic methods for the examination of joint tissue 
and biological fluids, for monitoring and detecting molecular alterations associated with 
osteoarthritis. We identified Raman spectroscopic markers of altered molecular structure 
in subchondral bone and relevant biological fluids. Using Raman spectroscopy the 
molecular structure of joint tissues was measured, and the results were compared to the 
results from micro-computed tomographic and histopathologic analysis. Raman spectra 
of subchondral bone collected from Del1 (+/-) transgenic mice, a mouse model for early-
onset osteoarthritis, indicated lower bone mineralization in transgenic mice (5.73 ± 0.28 
vs. 6.87 ± 0.225 in wild-type mice, p=0.003). A fiber-optic Raman probe for arthroscopic 
measurements was developed to demonstrate the feasibility of measuring the molecular 
structure of joint tissue with clinically-relevant instrumentation. The carbonate-to-
phosphate ratio, a Raman spectroscopic measurement of bone mineral composition, was 
measured from subchondral bone under an intact layer of cartilage. Our initial work on a 
human proximal radius specimen indicated that an arthroscope configuration is capable 
of providing similar carbonate-to-phosphate values as spectra collected on a Raman 
microscope (0.25 vs. 0.24).  In addition to cartilage and subchondral bone, the chemical 
structure of synovial fluid molecules is a key factor in maintaining healthy joint function. 
Synovial fluid from normal and diseased joints was examined using a novel drop 
deposition/Raman spectroscopic method. Raman spectra of synovial fluid from patients 
with radiographic evidence of osteoarthritis showed evidence of altered protein structure, 
as shown by increased Raman band intensity ratios at 1080 cm-1/1002 cm-1 (0.054 ± 0.07 
xiv 
 
vs. 0.038 ± 0.003, p<0.01) and 1670 cm-1/1655 cm-1 (0.68 ± 0.06 vs. 0.51 ± 0.05, 
p<0.01). These studies show that Raman spectroscopic measurements of joint tissue and 
synovial fluid correlate with established techniques for osteoarthritis detection and 




Chapter 1  
Introduction 
Overview of Thesis Research 
The goal of this thesis research is to examine the chemical composition and molecular 
structure of various components in joint tissues and synovial fluid. Early-stage 
osteoarthritis is characterized by chemical structure changes to extracellular matrix 
macromolecules, many of which have not been reliably measured by current histology, 
imaging or clinical methods. These subtle, inherent changes that occur in joint tissues 
and/or synovial fluid will provide the markers for diagnosis of knee joint damage. We 
propose to develop Raman spectroscopy techniques to examine molecular structure and 
chemical composition of cartilage, subchondral bone or relevant biological fluids. We 
further propose that Raman spectroscopy will complement current strategies to repair 
cartilage or subchondral bone by providing insight into the chemistry of joint 
degeneration.  
 
Chapter 2 provides an overview of the analytical techniques, instrumentation, and data 
processing techniques used. Chapters 3 and 4 present two studies of Raman spectroscopic 
examination of tissue specimens from Del1 (+/-) transgenic mice. Eye tissue and femora 
obtained from wild-type and Del1 (+/-) transgenic mice provided an opportunity to 
evaluate the ability of Raman spectroscopy to identify chemical structure differences 
from natural aging and defective type II collagen formation. Type II collagen is a major 
component of articular cartilage and the vitreous humor of the eye. Known mutations of 
the type II collagen gene, COL2A1, in humans causes disorders that affect both the eye 
and skeletal systems.[1-3] Del1 (+/-) mice have defective type II collagen formation. 
These transgenic mice exhibit altered skeletal development and are a model of early-
onset osteoarthritis. Additionally, the Del1 (+/-) mouse can be used to systematically 
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examine the ultrastructure in ocular tissue because of the role of type II collagen in the 
development of eye tissue and the limited availability of eye tissue from human patients 
of arthro-ophthalmopathies.[4] Because abnormal type II collagen is also expressed in 
vitreous, cornea and sclera of Del1 (+/-) mice they exhibit ocular damage including early-
onset liquefaction of the vitreous humor and reduction in vitreous fibrils.  
 
Chapter 5 discusses development of an arthroscope coupled with Raman spectroscopy 
Fiber optic arthroscopy is a technique used by clinicians to visualize areas of eroded 
cartilage, remove loose cartilage fragments or repair ligament injury. Identification of 
damaged cartilage during arthroscopy is reliant upon application of visual grading scales 
that have limited sensitivity and specificity. However, vibrational spectroscopy studies of 
cartilage surfaces have shown that alterations to cartilage extracellular matrix molecules 
occur before damage is visually apparent. Instrument response, accuracy and efficiency 
were tested using cadaveric specimens obtained from the University of Michigan 
anatomical donations program.  
 
Chapter 6 presents a study of the fluid dynamics of biofluid drop deposition. We explored 
the effects of fluid viscosity and substrate surface chemistry on drop deposition of plasma 
and synovial fluid. Simple physical measurements, such as contact angle and viscosity, 
incorporated into a drop deposition study can aid in interpreting the dried drop and 
provide insight into the complex drop deposition process. Raman spectra collected from 
dried plasma drops suggest that the chemistry of the protein-rich outer edge in the dried 
drop was consistent when dried on different substrates. We concluded that the choice of 
substrate affects the final deposition pattern and the efficiency of the coarse separation. 
Dilution had a moderate effect on the optical properties and residual free water in the 
dried drop. However, Raman markers of protein secondary structure remain unaffected 
during the evaporation process.  
 
Chapter 7 introduces drop deposition coupled with Raman spectroscopy for 
characterizing synovial fluid and spectroscopic identification of osteoarthritis biomarkers. 
For many years, viscosity has been the primary method used by researchers in 
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rheumatology to assess the physiochemical properties of synovial fluid in both normal 
and osteoarthritic patients. However, progress has been limited by the lack of methods 
that provide multiple layers of information, use small sample volumes, and are rapid. In 
this study, Raman spectroscopy was used to assess the biochemical composition of 
synovial fluid collected from forty patients with clinical evidence of knee osteoarthritis at 
the time of elective surgical treatment. Severity of knee osteoarthritis was assessed by a 
radiologist using Kellgren/Lawrence (K/L) scores from knee joint x-rays, while light 
microscopy and Raman spectroscopy were used to examine synovial fluid aspirates (2-10 
µL), deposited on fused silica slides. We showed that Raman bands used to describe 
protein secondary structure and content can be used to detect changes in synovial fluid 
from osteoarthritic patients. Several Raman band intensity ratios increased significantly 
in spectra collected from synovial fluid in patients with radiological evidence of 
moderate-to-severe osteoarthritis damage. These ratios can be used to provide a “yes/no” 
damage assessment. These studies provide evidence that Raman spectroscopy would be a 
suitable candidate in the evaluation of joint damage in knee osteoarthritis patients.  
 
Chapter 8 presents research into developing surface-enhanced Raman spectroscopy 
(SERS) for in-vitro osteoarthritis (OA) biomarker detection. Hyaluronic acid (HA) is a 
potential OA biomarker and synovial fluid levels of HA have been correlated with 
progression of joint space narrowing. However, current immunoassay and 
chromatographic methods used to identify HA in synovial fluid specimens are 
cumbersome and often require sophisticated instrumentation. Raman spectroscopy may 
be an alternative to these analytical methods, providing rapid identification of HA using 
characteristic Raman biomarker bands. Yet, previous reports of normal (unenhanced) 
Raman spectroscopy for HA are in aqueous solutions exceed 1000X in-vivo 
concentrations because HA is a weakly scattering polysaccharide. In contrast, SERS 
could improve the detection limits of HA to below the clinical range and we present, to 
our best knowledge, the first surface-enhanced Raman spectra of HA. The recent 
commercial availability of gold-coated SERS substrates has enabled rapid the SERS 
detection of this biomarker at physiological concentrations. Preliminary results showed 
that HA was observed at low concentrations in aqueous solutions and in synthetic models 
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of biofluids, such as artificial synovial fluid, that contain HA at low concentrations. 
Complex biofluids, such as synovial fluid or serum, often contain proteins that will 
compete with HA for the SERS-active sites, and the resulting spectra are dominated by 
protein Raman bands. To overcome this problem, we used a simple and validated protein 
precipitation protocol to artificial synovial fluid prior to deposition onto the SERS 
substrate.  
 
Chapter 9 presents our study of the effects of solution properties on hyaluronic acid drop 
deposition were also explored. Nanoliter volumes of HA solutions were dried onto a 
patterned SERS substrate and spectra were collected from the dried hyaluronic acid drops 
with a near-infrared Raman microscope. Viscosity measurements were incorporated into 
models of drop deposition of suspended particles to account for the effect of inter-chain 
attraction on drop formation. Entanglement behavior was described using scaling theory 
principles. Microscope images were used to evaluate shape of the dried drop. Relative 
drop thickness was estimated from concentric rings found at drop edges using established 
models of light interference by thin films. Characteristic hyaluronic acid SERS bands 
were examined. We found SERS spectra were sensitive not only to polymer 
conformation, but also to type of deposition (ring versus uniform), and the thickness of 
the resulting deposition. These data suggest an approach to elucidate the effects of 
biopolymers on SERS analysis.  
 
Conclusions and future directions are discussed in Chapter 10.  
 
Joint Composition, Chemical Structure and Function 
The knee joint is a complex biological system comprised of non-mineralized cartilage, 
mineralized cartilage, bone, synovial fluid and a synovial membrane (also known as 
synovium). A schematic of knee joint anatomy is shown in Figure 1.1. Within the 
synovium, cartilage is attached to the joint surface of the patella, femur and tibia, and the 
cavity between and around the joint is filled with synovial fluid.[5] Synovium 
encapsulates the joint. Additional fibrous and ligament layers outside the synovium 
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further contain the entire joint and help to stabilize the joint during motion. The knee 
joint is avascular and delivery of nutrients is controlled by diffusion through the 
synovium. Intricate biological, chemical and mechanical properties of cartilage, synovial 
fluid and subchondral bone within the knee joint underscore its complexity in health and 
disease.  
 
Cartilage is a connective tissue located throughout the body and varies in physiological 
function, chemical composition and mechanical properties. There are three types of 
cartilage: hyaline, elastic and fibrocartilage. Hyaline cartilage is the focus of many 
studies because it is the cartilage type that covers the ends of bones at joints (as articular 
cartilage), and comprises epiphyseal plates where bones grow.[6] Articular cartilage 
provides a lubricated surface for joint movement and resists compressive forces. 
Chondrocytes, the cells which are responsible for the maintenance and repair of cartilage, 
are primarily found in the superficial layer near the articular surface and are surrounded 
by an extracellular matrix consisting primarily of water, type II collagen, proteoglycans, 
and glycoproteins, Water is a major component in cartilage, comprising between 60-80% 
of its total weight.  
 
The extracellular matrix of cartilage regulates nutrient diffusion, provides resistance to 
compressive forces, and adds tensile strength to cartilage. Type II collagen, 
glycoproteins, and proteoglycans intertwine to form the extracellular matrix. Articular 
cartilage is heterogeneous in the axial direction in both the relative abundance of 
chondrocytes and type II collagen orientation. A cross-sectional view of articular 
cartilage is shown in Figure 1.2. The three zones of articular cartilage are defined 
primarily by type II collagen orientation. The superficial zone, located at the articular 
surface, contains the highest density of chondrocytes in cartilage tissue and type II 
collagen fibers are oriented parallel to the joint surface. In the tangential, or mid, zone 
collagen fibers are not preferentially oriented. Type II collagen is ubiquitous in the deep 




Glycoproteins bound to type II collagen provide structural integrity and influence type II 
collagen fibrillogenesis.[7] Proteoglycans consist of a hyaluronic acid backbone with 
core protein side chains. Sulfated glycosaminoglycans, chondroitin sulfate and keratin 
sulfate, are attached to the core protein. At physiological pH glycosaminoglycans are 
negatively charged and are highly hydrated. The unique viscoelastic properties of 
glycosaminoglycans, in addition to the high degree of hydration, renders to proteoglycans 
a sponge-like quality that provides compression resistance properties to cartilage. 
Aggrecan is the most abundant proteoglycan in cartilage.  
 
Articular cartilage is unmineralized in the surface layers, but contains a layer of calcified 
tissue adjacent to subchondral bone. Calcified cartilage intertwines with subchondral 
bone to form a mineralized plate beneath cartilage and serves as the source of cartilage 
attachment to bone. Calcified cartilage provides additional structural integrity to the joint 
and limits diffusion across the bone/cartilage interface. The organic matrix of calcified 
cartilage is similar to non-mineralized cartilage and the mineral composition of the 
calcified layer closely resembles hydroxyapatite. The chemical composition of calcified 
cartilage resembles both cartilage and bone. Because the mineral in calcified cartilage is 
similar to the carbonated apatite in bone, it exhibits unique mechanical properties.[8, 9] 
The cortical bone that directly underlies cartilage is called subchondral bone and it is 
composed primarily of type I collagen and a carbonated apatite mineral.  
 
Synovial fluid, a dialysate of plasma, fills the joint cavity space in diarthrodial joints and 
is essential to maintaining joint health and function. Synovial fluid is primarily composed 
of water, proteins, glycosaminoglycans, lipids, small inorganic salts, and metabolites 
such as amino acids or sugars. Synovial fluid functions include resistance to compression, 
nutrient diffusion, molecular signaling, and lubrication of cartilage surfaces.[10, 11] 
Synovial fluid molecules often have multiple functions and exhibit a large degree of 
interaction with other synovial fluid and cartilage molecules. For example, hyaluronic 
acid is responsible for the complex viscoelastic properties of synovial fluid but has also 
recently been found to regulate the biological activity of advanced glycation endproducts 
and cytokines and enzymes associated with late-stage osteoarthritis.[12-14]  
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Knee Osteoarthritis  
Arthritis is a disease that is marked by the degradation of components in the synovial 
joint leading to an increase in fluid shear and hydrostatic pressure between two adjacent 
bones. The main form of arthritis, osteoarthritis (OA), is a degenerative joint disease that 
is prevalent (rate >30%) among Americans over 65.[15] Primary osteoarthritis occurs 
without an obvious cause or because of the accumulation of mechanical damage that 
accompanies aging. Secondary OA occurs as a response to trauma, previous injury, 
obesity, or metabolic disease. The percentage of adults afflicted with OA increases with 
age, and causes an important economic burden in lost wages and early retirement.[16] 
Because of its prevalence in an aging society, OA is one of the most common causes of 
disability in the elderly.[17] To date, there are no treatments to reverse the cartilage 
damage characterized by osteoarthritis or induce cartilage regeneration. Identification of 
osteoarthritis in its early stages is critical to disease management because minimally 
invasive therapies such as diet, exercise, non-steroidal anti-inflammatory medicines, or 
intra-articular injections can be effective in delaying disease progression and ameliorating 
pain. However, by the time patients present with symptoms or when radiographs are able 
to diagnose OA reliably, then OA is typically in an advanced stage. More challenging to 
physicians is to estimate OA progression, especially for sub-clinical patients. 
 
The pathogenesis of osteoarthritis (OA) is exceedingly complex, involving genetic and 
environmental factors as well as local biomechanical factors. Osteoarthritis was 
historically defined pathologically as focal and progressive loss of hyaline cartilage with 
concomitant changes in underlying bone. More recent studies have shown that 
osteoarthritis may be considered a whole joint disease. Biological, chemical and 
viscoelastic changes affect cartilage, synovium, subchondral bone, synovial fluid, and 
surrounding muscles and ligaments.[18-21] Degradation of extracellular matrix 
molecules, such as cleavage of glycosaminoglycans or a loss of collagen cross-linking, is 
implicated in a complex series of biological, mechanical and chemical events that lead to 
loss of articular cartilage function. At the level of the articular chondrocyte, an altered 
composition of matrix, a pathological response to mechanical stress and programmed cell 
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death contribute to the pathologic syndrome, with alterations in cartilage extracellular 
matrix proteins likely occurring early.   
 
The role of subchondral bone has been examined in current models of osteoarthritis 
because a common indication of osteoarthritis is thickening of the subchondral bone 
plate, increased bone mineral density and increased bone stiffness.[22-24] Also, there is a 
positive correlation between mineral deposits in synovial fluid with advanced stage 
osteoarthritis. Radiography and other imaging studies have shown alterations in bone 
architecture and chemistry in addition to plate thickening. [20, 21, 25-28] Material 
properties in subchondral bone are also compromised, as observed by a less mineralized 
tissue and altered architecture in the cancellous and cortical bone regions.[23, 29]  These 
studies support the idea that osteoarthritis is a disease that affects the entire joint. 
Moreover, studies have not been able to show if subchondral bone damage is 
arthritogenic in nature. 
 
Clinical symptoms, such as pain, swelling or loss of function, are observed in most 
patients with osteoarthritis. However, these symptoms vary across patient populations, do 
not adequately correlate with disease stage and are non-specific to osteoarthritis. In 2004, 
Webb and colleagues reported the results of a population-based cross-sectional survey of 
knee pain [30].  The survey population included approximately 4,500 people living in the 
urban area of Manchester, England, divided into eight groups defined by age and gender.  
Symptomatically, OA is defined as pain with joint use, however, the cause of joint pain in 
OA has yet to be elucidated.  
Assessment of Knee Joint Damage 
Identifying osteoarthritis damage, either through clinical observation or laboratory 
measurements, remains a challenge because of the complex nature of the disease. There 
is a large body of research in not only identifying suitable biomarkers, but also in 
developing corresponding analytical methodologies. A variety of clinical imaging, 
histology, biochemical assay, and analytical chemistry tools have been proposed for 
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diagnosing osteoarthritis. We focus on non-invasive and minimally invasive 
measurements of joint morphology and synovial fluid biomarkers. 
Joint Morphology Measurements 
Clinical assessment of osteoarthritis is typically made from a combination of laboratory 
tests and a patient history for osteoarthritis symptoms such as pain, swelling, stiffness, or 
loss of function. The gold standard in osteoarthritis laboratory tests is to collect an 
examination of an x-ray of the affected joint for morphological features that indicate 
osteoarthritis. The most commonly-used grading system of x-ray features is based on the 
work of Kellgren and Lawrence.[31, 32] Table 1.1 shows the Kellgren/Lawrence (K/L) 
grade system for interpreting radiological images of joints. A diagnosis is made based on 
features in the radiograph, such as osteophytes, narrowing of joint space, and subchondral 
bone sclerosis. X-ray images representative of K/L scores 1-4 are shown in Figure 1.3. 
Patients with K/L grades 0-1 are typically considered negative for radiological evidence 
of osteoarthritis. Patients with K/L grades 2-4 are considered positive for radiological 
evidence of osteoarthritis. Other imaging modalities, such as magnetic resonance imaging 
(MRI), are sensitive to morphological alterations in cartilage and may be a promising 
technique for non-invasive joint tissue imaging of early-stage osteoarthritis damage.[33-
35] Ultrasound and computer tomography imaging are also promising techniques for 
non-invasive visualization of cartilage damage.[36]  
Synovial Fluid Biomarkers 
Current literature in the field of osteoarthritis biomarkers has largely focused on studying 
synovial fluid because it is the primary location for secretion of chemical markers related 
to cartilage damage.[37-44] One approach is to examine the entire chemical profile of 
synovial fluid. Proteomic analysis, using 2-D electrophoresis or mass spectrometry, has 
been demonstrated for synovial fluid.[45] A recent SF proteomic analysis found changes 
in abundant proteins in synovial fluid from arthritic joints, but these changes in protein 
profile were not dependent on the stage of OA.[46]  
 
Another approach is to examine biomarkers, expressed in the synovial fluid, cartilage 
matrix, or surrounding bone.[38] However, there is no clear consensus on suitable 
biomarkers to estimate OA progression or a standardized method to examine synovial 
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fluid. Several bone and cartilage biomarkers only correlate strongly with severe 
degradation (Outerbridge classification 4 or Noyes classification 0-20%).[47] Other 
markers, such as proteoglycan fragments, white blood cells, calcium phosphate crystals 
and collagen fibrils, are correlated with disease progression.[37, 39, 42] Recent studies of 
cartilage oligomeric matrix protein (COMP) levels in synovial fluid are promising.[48] 
Arthritic SF may contain higher levels of cartilage fragments, low molecular weight 
hyaluronic acid molecules, and basic calcium phosphate crystals.[47, 49, 50]  
 
The most prevalent glycosaminoglycan, hyaluronic acid (also called hyaluronan), has 
been shown to be a critical macromolecule in both healthy and pathological joints, and is 
currently used to treat pain associated with osteoarthritis. As the primary molecule in 
intra-articular viscoelastic supplements, hyaluronic acid has been shown to alleviate pain 
associated with osteoarthritis and may also reduce cartilage damage.[51-53] The 
secretion of glycosaminoglycans into serum as a response to cartilage damage is an active 
field of research and the detection of glycosaminoglycan molecules in both serum and 
synovial fluid has potential to serve as a marker for osteoarthritis diagnosis. Serum levels 
of hyaluronic acid (HA) have been shown to be a predictor of a positive osteoarthritis 
diagnosis within 2 years.[54]  
Vibrational Spectroscopy of Joint Tissues 
The addition of vibrational spectroscopy as a method for analyzing bone tissue has been 
instrumental in advancing the understanding of bone structure/function relations.[55] 
Infrared or Raman spectra can reflect perturbations to bone tissue that result from 
chemical damage, mechanical stress, or genetic defects. The high spatial resolution (1-20 
µm) of infrared and Raman spectroscopies facilitates the collection of information on 
chemical processes, such as re-mineralization of bone or collagen matrix degeneration 
that would otherwise go unnoticed if using other spectroscopic and biochemical analyses. 
Vibrational spectroscopy, Fourier-transform infrared (FT-IR) and Raman, are used to 
complement current histological and biochemical methods of bone (and, by extension, 
cartilage) analysis. Vibrational spectroscopy and imaging for the analysis of bone serves 
as a basis for analysis of cartilage. As indicated by increasing number of reports in 
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literature since 2000, using FT-IR and Raman to study articular cartilage is an exciting 
and valuable field of research, and either method has potential as a diagnostic tool. 
Raman and FT-IR studies to characterize components such as collagen or hyaluronic acid 
provide a framework for assessing pathological changes in articular cartilage or the 
surrounding synovial fluid. Vibrational spectra of cartilage, subchondral bone, 
extracellular matrix molecules, and cartilage matrix vesicles provided detailed chemical 
composition which can be used to complement histological or optical microscopy 
findings. Raman spectroscopy has been used to examine subchondral bone and monitor 
mineralization of cartilage in-vitro, but has not yet been used to examine articular 
cartilage. FT-IR images and spectra of damaged cartilage correlated to standard 
histological measures of cartilage tissue quality. 
 
To date, infrared spectroscopy (commonly used in the Fourier-transform mode) has been 
the predominant vibrational spectroscopy method for studying cartilage.[56-59] FT-IR 
has proven useful in applications ranging from tissue engineering to articular cartilage 
damage assessment. Detailed analysis of collagen and proteoglycan content in bovine 
cartilage using a variety of FT-IR microscopy and imaging techniques indicate that FT-IR 
is a feasible method for in-vivo identification of cartilage components and collagen fiber 
orientation. Yet, there is a major impediment to using FT-IR. FT-IR spectra are obscured 
by water, cartilage specimens need to be dehydrated prior to examination by FT-IR or the 
FT-IR probe needs to directly contact the tissue of analysis. Due to the high water content 
(60-80% of the total weight of cartilage), spectroscopic methods that require specimen 
dehydration and/or direct contact of the probe alters the chemical structure of cartilage or 
cause artifacts to arise in the spectra.  
 
Raman spectra provide similar information as FT-IR spectra, but Raman spectroscopy 
may be better suited to tissue spectroscopy. Raman spectra are not obscured by water and 
measurement does not require direct contact with tissue. The visible or near-infrared 
optics that are used by Raman instruments are compatible with fiber-optic probes used in 
clinical instruments such as arthroscopes. A Raman spectroscopic probe for alterations in 
protein structure is especially useful to distinguish normal and pathological tissues since 
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subtle molecular changes often cause detectable vibrational changes. Properties of Raman 
that make it an attractive method for direct analysis of biological tissues include high 
spatial resolution (0.25-0.5 µm for a 532 nm system, 0.5 -1.0 µm for a 785 nm system) 
and limited spectral interference from water. Because of these advantages, the use of 
Raman for tissue analysis has been widely reported.[60, 61] Yet examination of cartilage 
by Raman has not been widely published, possibly due to the focus throughout both the 
FT-IR and Raman communities on identifying cancerous cells and quantifying glucose. 
Cartilage Raman spectra have an inherently low signal and require either long integration 
times or high laser power to obtain spectra that can be used as a diagnostic. Historically, 
these requirements may have restricted Raman spectroscopy from rapidly studying 
cartilage in-situ because it does not contain a strongly scattering mineral moiety, such as 
hydroxyapatite, that is ubiquitous throughout hard tissues. 
Cartilage Extracellular Matrix Molecules 
Early vibrational spectroscopy studies of cartilage extracellular matrix molecules focused 
on assigning bands and determining factors that affect secondary structure. These early 
studies provided a foundation for studying cartilage tissue. Glycosaminoglycans, sodium 
hyaluronate, chondroitin 6-sulfate, and chondroitin 4-sulfate, have been studied using 
infrared and Raman spectroscopy.[62-67] Table 1.2 shows Raman band assignments for 
type II collagen and glycosaminoglycans hyaluronic acid and chondroitin-6-sulfate based 
on our Raman spectra of these molecules and literature reports.[62-64, 68, 69] Polarized 
infrared spectroscopy was used to characterize dichroic properties of hyaluronic acid 
functional groups and assign bands using deuterium exchange. [65, 66, 70] Hydration 
properties of hyaluronic acid and chondroitin sulfate, were studied by infrared 
spectroscopy. [71-74] Enzymatically-digested hyaluronic acid was examined by nuclear 
magnetic resonance, infrared, Raman, and visible spectroscopy.[75] Examination of 
proteoglycans and glycosaminoglycans extracted from cartilage in a case of Langer-
Saldino achondrogenesis by infrared spectroscopy revealed low sulfation of proteoglycan 
and reduced  chondroitin 4-sulfate relative to chondroitin 6-sulfate.[76] Vibrational 
spectroscopy methods to examine collagen structure in tissue, identify pathologic tissue, 
and monitor fiber tension can be applied to either type I or type II collagen. [69, 77-83] 
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Type I collagen has been studied extensively, and these studies can also be applied to the 
examination of type II collagen.[68, 84-88]  
Normal Unmineralized Cartilage  
Although Raman spectroscopy of non-mineralized articular cartilage has not yet been 
reported, FT-IR spectroscopy of cartilage was first reported in 2001.[89, 90] The first 
reports discussed the impact of spectral standards on quantitative spectroscopic 
measurements, and proposed spectroscopic markers useful for identifying cartilage tissue 
damage. Camacho reported FT-IR microscopy and imaging on bovine articular cartilage 
using polarized and unpolarized light.[90] FT-IR images showed agreement with 
histological data for the distribution of type II collagen and aggrecan, which indicate that 
FT-IR is a feasible method for identification of cartilage components and determining 
collagen fiber orientation. Full-depth cartilage sections were dehydrated and embedded. 6 
µm thick cross-sections were examined for collagen and proteoglycan content using an 
FT-IR microscope. FT-IR spectra of aggrecan and type II collagen mixtures were used as 
a reference for relative amounts of proteoglycan and type II collagen. Differences of 
proteoglycan and type II collagen content in each of the three layers of the cartilage 
(superficial, middle and deep zones) were reflected in relative intensity variations. 
Spectral markers for collagen orientation, proteoglycan content and type II collagen 
content were reported. Polarized images showed varying type II collagen orientation in 
each layer of cartilage, as expected. Average fiber orientation, observed as changes in the 
peak area ratio of collagen amide I: amide II peaks, showed that the collagen orientation 
became more parallel to the adjacent bone surface in zones closer to the bone. These 
polarized images were especially indicative of collagen orientation in the superficial 
zone, and collagen defibrillation in the superficial zone may be an early indication of 
osteoarthritis. As noted by the authors, cartilage tissue was dehydrated prior to 
examination by FT-IR. Moreover, spectra were not very specific between type I or type II 
collagen or between different glycosaminoglycans.  
 
Imaging of type II collagen and proteoglycan in cartilage sections using FT-IR 
microscopy was reported by Potter et al in 2001.[89] FT-IR images normal bovine nasal 
cartilage, trypsin-treated bovine nasal cartilage and engineered cartilage in a hollow fiber 
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bioreactor (HFBR) were compared to histological staining of cartilage for sulfated 
glycosaminoglycan content. FT-IR spectra of type II collagen and chondroitin sulfate 
were used as pure-component references in least-squares estimations of protein and 
glycosaminoglycan content.  Spectral bands of cartilage were assigned to either type II 
collagen or chondroitin sulfate using difference spectra between normal and trypsin-
digested cartilage. This study found the pure-component spectra do not adequately 
describe cartilage matrix, because interactions between cartilage matrix molecules were 
not reflected in the pure component spectra. FT-IR images showed spatial heterogeneity 
in chondroitin sulfate distribution and confirmed the loss of chondroitin sulfate in 
trypsin-digested cartilage. FT-IR spectra of engineered cartilage showed penetration of 
type II collagen into the hollow fiber bioreactor. Least-square estimations of chondroitin 
sulfate and type II collagen content from FT-IR data showed that the collagen content 
was overestimated but properly estimated chondroitin sulfate content. The authors found 
that FT-IR protein bands were not specific to type II collagen and may contain 
contributions from noncollagenous proteins.   
 
Collagen orientation was quantified in histology sections of equine and human articular 
cartilage by Bi et al using polarized FT-IR imaging spectroscopy (FT-IRIS).[91] 
Cartilage specimens were collected from: normal equine articular cartilage, repair equine 
articular cartilage after a microfracture procedure, human articular cartilage from a 
normal patient and articular cartilage from a late-stage osteoarthritis patient. Polarized 
FT-IR images were compared to histological damage scoring and polarized light 
microscopy of cartilage. FT-IRIS spectra of equine tendon were used as a reference for 
collagen orientation. Intensity changes in the amide I, amide II and amide III envelopes 
were observed in FT-IRIS spectra collected from tendon using light polarized parallel or 
perpendicular to collagen fibers. The ratio of amide I/II areas was sensitive to collagen 
orientation, confirming the previous study by Camacho. FT-IRIS imaging quantified 
collagen orientation in each cartilage zone using the ratio of amide I/II areas. FT-IRIS 
images improved visualization of subtle differences in collagen orientation that were not 
observed using polarized light microscopy. Because collagen defibrillation in the 
superficial zone often precedes osteoarthritis onset, the studies by Bi and Camacho 
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demonstrated that vibrational spectroscopy is a useful tool for potentially identifying 
early-stage articular cartilage damage.  
Damaged Unmineralized Cartilage  
Use of a fiber-optic based probe for examination of cartilage by FT-IR was demonstrated 
in 2004 by West et al.[92] Spectral results from IFOP were validated against FT-IR 
microscopy of the cartilage specimens and Collins visual grading of cartilage damage.  
There were subtle but significant differences in established infrared markers of collagen 
damage between mildly and severely degraded cartilages. In another study, FT-IRIS was 
used to measure collagen structure after exposure to high levels of collagenase to verify 
the IFOP method. Collagenase breaks down type II collagen, and high levels of this 
enzyme in the synovial fluid were related to cartilage damage.[43] FT-IRIS, with 
polarized or unpolarized light, was used to examine full-depth sections of bovine articular 
cartilage.[58] Exposure time of cartilage to collagenase varied to model mild and severe 
cartilage damage. Staining of collagenase-treated cartilage showed that damage to type II 
collagen remained in the superficial zone and the stained specimens were used to verify 
results from FT-IRIS. Polarized FT-IRIS was used to measure collagen orientation using 
the AmideI/AmideII area ratio. FT-IRIS using unpolarized light was used to measure 
chemical structure of collagen using the Amide II/1338-1 band area ratio and the 1238 
cm-1/1227 cm-1 band intensity ratio. Models for mild and severe cartilage damage had 
shown significant differences in collagen damage. Damage was localized to the 
superficial zone. FT-IRIS showed that type II collagen had lost parallel alignment normal 
to the cartilage surface, and the collagen helix had lost structural integrity. This study 
confirmed the utility of FT-IRIS as a method to examine collagen orientation changes in 
histology samples. A review of FT-IR imaging and spectroscopy of cartilage reiterates 
the utility of the method for assessing collagen orientation and proteoglycan content in 
normal and pathological cartilage.[93]   
 
Least-squares estimations of collagen or proteoglycan content did not adequately account 
for the extensive interaction between cartilage matrix molecules. A chemometric model 
was developed by Li et al to optimize the spectral region for diagnosis of cartilage 
damage.[94] Tibia plateau cartilage specimens collected from 61 arthritic human patients 
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and 3 normal human patients were examined with the fiber-optic FT-IR probe. Tibiae 
were also examined using the Collins scale to visually identify surface damage. Selected 
cartilage sections were stained for modified Mankin histological scoring of cartilage 
damage. A 15-factor partial least-square (PLS) model with leave-one-out validation of 
spectra data was optimized for spectra region and preprocessing steps. The spectral 
region of 984-1733 cm-1, with a straight-line subtraction preprocessing step, was found to 
correlate with early stages of cartilage damage. Prediction of cartilage damage based on 
IFOP spectra was achieved for over 90% of the specimens, and was within ± 0.5 of the 
actual Collins grade. When IFOP results were compared with Mankin scoring, the PLS 
model slightly improved.  
 
FT-IR imaging of chondroitin sulfate and type II collagen content in arthritis focal lesions 
was shown by David-Vaudey et al.[95] Knee and hip cartilage sections from human 
patients exhibiting severe osteoarthritis, as evidenced by pre-operative 
Kellgren/Lawrence score, was examined by FT-IR imaging and Mankin histological 
scoring. FT-IR images were collected in the superficial, intermediate and deep cartilage 
zones. Distribution of chondroitin sulfate was calculated using the partial least squares 
and Euclidean distance method also used by Potter et al in their study. [89] FT-IR images 
revealed heterogeneous chondroitin sulfate distribution not only between cartilage zones 
but also within the territorial and inter-territorial matrices. FT-IR images suggest a 
significant decrease in superficial layer chondroitin sulfate content for severely 
osteoarthritic cartilage, and variability in intermediate zone collagen content. At arthritic 
focal lesions, there was significantly less chondroitin sulfate. These FT-IR results were 
well correlated with Mankin scoring. 
 
Collagen-induced arthritis (CIA) is an experimental model of rheumatoid arthritis where 
an autoimmune response occurs after administering type II collagen to cartilage tissue. 
Expression of type II collagen antibodies in serum and synovial fluid is common to 
collagen-induced arthritis and rheumatoid arthritis. Type II collagen antibodies may 
contribute to RA pathology or may be expressed as a reaction to cartilage degradation. 
Crombie et al used histology, FT-IR imaging, and immunofluorescence to determine if 
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monoclonal antibodies (mAbs) to type II collagen penetrate into cartilage and are 
arthritogenic in nature.[96] Cartilage explants were cultured in two separate arthritogenic 
mAbs or two control mAbs. Thin sections of cartilage were collected after 14 days and 
examined using FT-IR imaging, immunofluorescence, and histomorphometry. FT-IR 
cartilage spectra of treated cartilage sections were compared against a composite 
spectrum of type II collagen, hyaluronan, and proteoglycan. FT-IR images showed 
significant loss of proteoglycan content and toluidine blue-stained cartilage samples 
showed a loss of chondrocytes associated with penetration of arthritogenic mAbs into 
cartilage. FT-IR spectra also showed collagen degradation associated with mAb 
penetration into cartilage, as indicated by a shift of Amide I band from 1666 cm-1 in 
control mAb samples to ~1639-1655 cm-1 in arthritogenic mAb samples. The authors 
showed that penetration of mAbs into cartilage tissue is associated with loss of 
proteoglycan content and denaturation of type II collagen observed in a collagenase-
induced model of cartilage degradation.[58]   
Subchondral Bone and Mineralized Cartilage  
Subchondral bone and calcified articular cartilage structure and architecture have been 
examined using microscopy, staining and mechanical loading models.[8, 20, 22, 24, 29] 
But these methods do not provide chemical composition information that can be obtained 
using vibrational spectroscopy. Pathological mineralization of subchondral bone, 
cartilage matrix vesicles and cartilage has also been examined using Raman and 
synchrotron infrared spectroscopy. These studies support current research into the role of 
subchondral bone and pathological mineralization in the development of osteoarthritis.   
 
Infrared microscopy of subchondral bone was first reported in 1998 by Miller et al.[97] 
Use of a synchrotron light source improved spatial resolution to 5 µm. Chemical 
composition from sections of cancellous, cortical and subchondral bone harvested from 
monkey was measured by two spectra collection methods. In one approach, several line 
scans (also called transects) were collected radially from an osteon. In another approach, 
five line scans were collected in a single line from the cartilage to cancellous bone. Band 
area ratios used to describe bone chemistry, such as carbonate to phosphate ratio and 
mineral to matrix ratio, were applied. Infrared spectra collected closer to an osteon 
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showed a greater protein content reflecting newly formed bone. Spectra collected further 
from an osteon with an increased mineral content reflected more mature and mineralized 
bone tissue. The carbonate to phosphate band area ratio increased in thicker subchondral 
bone, and these results suggest a potential spectroscopic marker of osteoarthritis in 
subchondral bone.  
 
Altered mineralization in sclerotic bone and osteophytes were found in an osteoarthritic 
tibia plateau.[98] Specimens were taken from sclerotic areas of subchondral bone, 
attached osteophyte, detached osteophyte and cancellous bone underlying subchondral 
bone of an osteoarthritis patient. Specimens from normal cortical and cancellous bone 
were also collected. FT-IR spectra were collected from KBr pellets of dried and 
pulverized bone and compared to hydroxyapatite and type I collagen. The mineral to 
matrix ratio (MTMR) was calculated using the amide I intensity at ~1650 cm-1 and 
hydroxyapatite intensity at ~1030 cm-1. Generally, pathologic bone specimens were less 
mineralized than normal cortical or cancellous bone. Sclerotic areas were more 
mineralized than detached or attached osteophytes. The authors proposed two 
mechanisms to account for the observed differences in mineralization: 1) subchondral 
bone remineralization was induced by an acidic synovial fluid environment or 2) 
remineralization as based on deposition of mineral ions by the vascular system. To date, 
these interesting hypotheses have not yet been confirmed.  
 
Mineralization in cartilage occurs under a variety of biological, chemical and mechanical 
environments. Mechanisms of pathologic mineral deposits in osteoarthritis matrix 
vesicles of articular cartilage were examined in-vitro using enzyme assays, radiometric 
assay of 45Ca, FT-IR spectroscopy and polarized light microscopy by Derfus et al.[99] 
FT-IR spectra identified calcium pyrophosphate dihydrate (CPPD) and apatite mineral 
crystals that were being produced in osteoarthritis matrix vesicles, which are relevant in 
osteoarthritis progression.  
 
Heger et al proposed a mechanism that laser-induced mineralization of treated cartilage is 
responsible for long-term structural stability and the mechanism may be extrapolated to 
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biological mineralization. [100] Intracellular and extracellular laser-induced cartilage 
mineralization was monitored using Raman spectroscopy of laser reshaped rabbit 
auricular (ear) cartilage. Calcium sulfate and calcium carbonate crystals were found 
intracellularly and calcium phosphate crystals were found in extracellular spaces. The 
authors proposed that, in addition to a stress relaxation of cartilage tissue, laser treatment 
caused apoptotic cells to release matrix vesicles and the released matrix vesicles mediated 
mineralization. 
Cartilage and Bone Tissue Engineering 
Spectroscopy and data handling techniques used to examine cartilage in health or disease 
can be applied toward engineered bone and cartilage. Boskey and Camacho reviewed 
FT-IR imaging and microspectroscopy methods used to analyze bone and cartilage.[101] 
To date, all of the reports to examine tissue engineered cartilage have been using FT-IR. 
Camacho et al studied genetically modified bovine chondrocytes using FT-IR 
imaging.[56] Previously identified markers for collagen orientation and proteoglycan 
content in cartilage were used to examine integration of engineered cartilage-like tissue 
into defect sites and evaluate the native cartilage’s organization. Chondrocytes were 
treated with an adenovirus vector encoding bone morphogenetic protein-7 (AdBMP-7) to 
stimulate matrix production. FT-IR images showed an increase in proteoglycan 
production and a decrease in collagen II output. FT-IR images could distinguish between 
neo-tissue and host tissue. Results showed an incomplete integration of neo-tissue and 
could not conclusively indicate an active role of surrounding tissues in neo-tissue 
integration. Based on FT-IR images, the authors suggested that cell-based repairs could 
not be achieved by simply placing engineered tissue atop of defective tissue.  
 
FT-IR images to obtain quantitative proteoglycan content of nasal cartilage grown in a 
hollow fiber bioreactor (HFBR) was shown by Potter et al in 2001.[89]  In that study, the 
authors demonstrated that immature cartilage had grown after a 3 week incubation 
period, and incorporation of type II collagen into the HFBR. Lower chondroitin sulfate 
content was found in bioengineered cartilage, relative to native cartilage. In a separate 
study, FT-IR imaging spectroscopy (FT-IRIS) was used by Kim et al to monitor the 
growth of articular cartilage in a HFBR. [102] The authors used the integrated area of the 
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amide I envelope (1590-1720 cm-1) to measure type II collagen distribution and 
conformation and the integrated area of 985-1140 cm-1 to measure proteoglycan content 
of cartilage at the inflow and outflow sections of the HFBR. Results from FT-IRIS 
showed a significant increase of proteoglycan content at the center area and surface area 
of inflow tissue. However, FT-IRIS estimation of proteoglycan content was not 
well-correlated with biochemical assays of sulfated glycosaminoglycans because of the 
small number of samples.  
Synovial Fluid 
Near-infrared (NIR) and Fourier-transform infrared spectroscopy have both been used to 
analyze the chemical composition of SF from osteoarthritis, rheumatoid arthritis, or 
spondyloarthropathy patients.[103-106] NIR or FTIR spectra of dried SF films allowed 
automated identification of arthritis with a classification rate greater than 95%. Individual 
components in SF could not be identified using NIR or FTIR spectra. However, the 
overall chemical composition did correlate with spectral patterns. These early studies 
provided evidence that vibrational spectra of SF could be used to discriminate between 


















Figure 1.3:  X-rays of knees from patients with various Kellgren/Lawrence 
scores. Reproduced from original article, Ann.Rheum.Dis, 1957, 16(4) 





Kellgren/Lawrence Grade Description 
Grade 0 Normal,  no radiological evidence of osteoarthritis 
Grade 1 Doubtful; possible osteophytes and joint space 
narrowing 
Grade 2 Mild; definite osteophytes and joint space narrowing, 
possible sclerosis 
Grade 3 Moderate; slight osteophytes, pronounced joint space 
narrowing, some sclerosis, and deformation to 
condyle shape 
Grade 4 Severe; joint space is extensively narrowed, sclerosis 
and cysts, deformed condyle shape, large osteophytes 
 




Band Position (cm-1) Assignment Extracellular Matrix Molecule 
850 (s) Proline Type II collagen 
899 (ms-s) C1-H deformation, β-linkage Glycosaminoglycans 
920 (s) Proline Type II collagen 
937-945 (ms-s) C-O-C linkage Glycosaminoglycans 
937 (sh) C-C stretch, α-helix  Type II collagen 
995 (s)  Chondroitin-6-sulfate 
1002 (s) Phenylalanine ring breathing Type II collagen 
~1045 (s) C-O, C-C stretch Hyaluronic acid 
1065 (s) SO3
- symmetric stretch Chondroitin-6-sulfate 
~1090 (ms) C-OH bend, acetyl group Hyaluronic acid 
~1130 (s) C4-OH bend and C4-H bend Hyaluronic acid 
~1150 (sh) C-O, C-C, oxygen bridge Hyaluronic acid 
1205 (m) CH2 twist 
Hypro, Tyr, Phe 
Hyaluronic acid 
Type II collagen 
1220-1280 (ms) Amide III envelope Type II collagen 
1330-1340 (s) C-H bend, Amide III Glycosaminoglycans 
1375 (s) COO- symmetric stretch 
CH3 deformation 
Glycosaminoglycans 







Type II collagen 
Glycosaminoglycans 
1640-1700 (ms) Amide I envelope Type II collagen 
Table 1.2:  Raman band assignments for extracellular matrix molecules. Letters next to 
the band position indicate relative intensity (s=strong, ms=moderately strong, 
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Chapter 2  
Review of Analytical Techniques 
Raman Spectroscopy 
Raman spectroscopy is a vibrational spectroscopic and imaging technique based on the 
Raman effect. This effect is observed when electromagnetic radiation is inelastically 
scattered, which is caused by rotational or vibrational transitions in molecules, and is 
characterized by a change in net energy between the incident beam and scattered beam. 
Light that is scattered at lower frequency than the incident light is called a Stokes line 
whereas light scattered at a higher energy yields an anti-Stokes line. Monochromatic light 
(usually a laser) is scattered by chemical components in a sample. Raman scatter occurs 
when light is scattered at a slightly longer wavelength than the illuminating laser 
wavelength. The wavelength differences correspond to molecular vibrations and provide 
a unique “chemical fingerprint” of the sample.   
 
The classical treatment of the Raman effect focuses on the interaction between a 
molecule’s electron cloud and the electromagnetic radiation that drives inelastic 
scattering of light. The Raman effect is observed when a change in polarizability occurs, 
where polarizability is defined as the ability of a molecule’s electron cloud to interact 
with electromagnetic radiation and produce an induced dipole. Normal modes of 
vibration that are accompanied by a change in polarizability are Raman active. While the 
classical treatment of the Raman effect is effective in describing the basic mechanism for 
inelastic scattering, it does not explain the intensity differences seen in anti-Stokes and 
Stokes scattering. Quantum mechanics allows a clearer understanding of these intensity 
variations in terms of simple energy level diagrams. Molecules in the ground vibrational 
state (ν=0) will absorb energy, and upon relaxation, scatter light at a loss of energy 
yielding a Stokes line or return to its original energy state to yield the Rayleigh line. 
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Molecules in an excited vibrational state (ν=1) will absorb energy, transition to the 
virtual state, and relax to the ground vibrational state. Intensity variations exist because of 
relative population differences in the upper and lower states. At thermal equilibrium, 
populations follow a Boltzman distribution and there is a higher population in the ground 
(v=0) state, indicating a higher Stokes intensity. Since there are statistically more 
absorbers able to make the transition to the virtual state from the (v=0) state than there 
are from the (v=1) state, the Stokes line is examined in Raman spectroscopy.  
Raman Spectroscopy Microscope 
Although instrumentation to study the Raman effect may vary in the details, components 
such as the laser, notch filter and low-noise detector are standard in all dispersive Raman 
instruments. For dispersive Raman systems, a monochromatic light source in the visible 
or near-infrared (λ=480-1100 nm) wavelength range is focused on to a sample using 
conventional refractive optics. The most commonly used excitation wavelengths are: 488 
nm, 514 nm, 532 nm, 633 nm, 785 nm, and 830 nm. Raman scatter is collected either at a 
180° or 90° angle with respect to the incident beam and then directed through a filter to 
eliminate the Rayleigh line.  
 
Raman microscopy is most often used for high spatial resolution spectroscopy and 
imaging, typically using low laser power (<20mW) to minimize sample degradation or 
sample heating. For biological tissue analysis, a Raman microscope coupled to a low 
noise charge-coupled device detector is an ideal tool for producing highly resolved 
spectra or images. A microscope adapted for Raman spectroscopy in the near-infrared 
(λ=785 nm) was used in many of the experiments described in this thesis. Some 
modifications to the instruments were made, which will be discussed in Chapters 3-9, but 
the basic apparatus remained consistent.  
 
Near-infrared Laser 
Vibrational spectroscopy of biological specimens is typically performed in the 
“therapeutic window” of the electromagnetic spectrum between 600-1100 nm because 
water and hemoglobin absorption are at a minimum, enabling the examination of minor 
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tissue or fluid components. Also, optical penetration is relatively efficient (~3-10 mm), 
and optical sources and detectors are commercially available. For Raman spectroscopy, 
the use of near-infrared wavelengths also minimizes endogenous fluorescence signal 
which may otherwise obscure weak Raman signals. The experiments described in this 
thesis were performed in the near-infrared region at either 785 nm or 830 nm. For 
experiments on the Raman microscope, presented in Chapters 3, 4, 6-9, a line-shaped  
beam from a 785 nm Kaiser Invictus laser (Kaiser Optical Systems, Inc., Ann Arbor, MI, 
USA) was used. Depending on the experiment, neutral density filters (0.3-1.0 ND) were 
used to maintain laser intensity between 10-100 mW at the objective. For experiments 
using the Raman arthroscope, as presented in Chapter 5, a 785 nm or 830 nm Kaiser 
Invictus laser was used. The laser intensity at the end of the arthroscope was 4-20 mW.  
 
Optical Microscope 
A schematic of the Raman microscope is shown in Figure 2.1. Briefly, it consists of a 
standard upright optical microscope with two optical paths (excitation, collection) for 
Raman spectroscopy. The excitation optical path consists of lenses to sharpen the line-
shaped laser beam and a dichroic mirror to direct the laser into the microscope. The laser 
is focused onto the specimen using an objective optimized for near-infrared wavelengths. 
The epi-illumination configuration of the microscope system enables collection of Raman 
scatter from the same objective at 180° from the sample. Raman scatter is passed through 
the dichroic mirror, focused by a 30 mm lens, and directed through a dispersive HoloSpec 
f/1.8 spectrograph (Kaiser Optical Systems Inc., Ann Arbor, MI, USA). Holographic 
notch filters are commonly used because they provide high attenuation of the Rayleigh 
line and also have good transmission for both Stokes and anti-Stokes scatter. The notch 
filter in the HoloSpec has a narrow rejection band, typically 12 nm, which enables 
detection of low wavenumber shifts (~50 cm-1). The spectral resolution of the 
spectrograph was 4 cm-1. A thermoelectrically cooled, back-thinned, charge-coupled 
device (CCD) was used as the detector. In earlier experiments, a 1024x256 chip was used 
and in latter experiments, a 1024x128 chip was used. The 1024 pixels corresponded to 
the wavelength axis and the 128, or 256 pixels, corresponded to the number of spectra 
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recorded on the chip. Raman transects, consisting of 128 or 256 spectra spaced evenly 
along the line-shaped laser, enabled rapid collection of multiple spectra.  
 
Fiber-Optic Instrumentation 
Fused silica fiber-optics for delivering laser light and collecting Raman spectra has 
generated much interest in process analytical, remote sensing, and biomedical 
communities as an instrument capable of minimally-invasive or non-invasive 
measurements.[1-4] Two types of fiber-optic Raman probes were examined as potential 
add-ons to arthroscopic instrumentation. In the first configuration, a 785 nm laser was 
coupled into a commercially-available arthroscope and a fiber-optic Raman collection 
probe. In another configuration, 830 nm laser was focused onto a bundle of optical fibers 
surrounded by 10 collection fibers. The fiber-optic bundle was coupled through a 
stainless steel tube with dimensions similar to an arthroscope.   
 
Raman Data Processing 
Preprocessing 
Raman data were preprocessed in Matlab (The Math Works, Natick MA, USA) using 
software routines developed in-house. Data were imported into Matlab using software 
developed in-house where they were corrected for cosmic ray spikes, dark current and 
variations in the CCD camera efficiency. A new approach to Raman data preprocessing 
was introduced in October 2008.[5] This new approach corrected for a horizontal offset 
of the CCD relative to the spectrograph, provided more efficient cosmic ray corrections, 
and completely automated the generation of a regression curve used to convert the x-axis 
from pixels to Raman shift measured in wavenumbers (cm-1).  
 
Univariate Analysis 
If transects were used, a mean spectrum was calculated. Mean spectra were imported into 
GRAMS/AI software (ThermoGalactic, Salem, NH, USA). Spectra were corrected for 
broadband fluorescence using a user-defined baseline correction routine. Baseline-
corrected spectra were intensity normalized to a well-resolved Raman band, either at the 
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phosphate ν1 at ~ 958 cm
-1 or the aromatic ring breathing mode at ~ 1002 cm-1. Raman 
bands in normalized, baseline-corrected spectra were fitted to mixed Lorentzian/Gaussian 
peaks to obtain band width, height and area parameters.  The resulting fit was accepted if 
the R2>0.99 and no negative bands were generated. Figure 2.2 shows deconvolution of 
the amide I envelope using the peak fitting function in GRAMS/AI. Band parameters, 
height or area, generated by curve fitting were used to calculate ratios that served as 
markers of chemical content or structure. Band area or band intensity ratios specific to 
the tissue or fluid are presented in Chapters 3-9.   
 
Multivariate Analysis 
Chemometrics has broadened the applicability of Raman spectroscopy for monitoring of 
complex biological systems. In simple mixtures, univariate methods such as measuring 
peak height or area are sufficient for qualitative identification based on unique peaks. 
Multivariate techniques, such as principal components analysis (PCA) or singular value 
decomposition (SVD), can separate out broadband noise, thus acting as sophisticated 
signal-to-noise enhancement tools with potential for automated data handling. 
Exploratory factor analysis and PCA have been successfully applied to Raman 
spectroscopy and imaging of bone specimens.[6-9] A recently developed method, band-
target entropy minimization (BTEM) uses principal components generated by SVD, then 
examines noisy low order factors for signal associated with a known Raman band such as 
phosphate ν1 at ~ 958 cm
-1. BTEM was first applied to recovering minor components 
with low signal in Fourier-transform infrared spectra with overlapping peaks from several 
components.[10] BTEM has been applied to Raman imaging of musculoskeletal tissue 
and was an important tool for identifying transient mineral species in mineralizing cranial 
bone tissue.[11, 12] In this thesis, SVD, PCA and BTEM are used as exploratory 


















Figure 2.2: Deconvolution of the amide I envelope (1640-1720 cm-1) in a 




1. Hayward IP, Kirkbride TE, Batchelder DN, Lacey RJ: Use of a Fiber Optic 
Probe for the Detection and Identification of Explosive Materials by Raman 
Spectroscopy. J Forensic Sci 1995, 40(5):883-884. 
2. Clegg IM, Everall NJ, King B, Melvin H, Norton C: On-Line Analysis Using 
Raman Spectroscopy for Process Control during the Manufacture of 
Titanium Dioxide. Appl Spectrosc 2001, 55(9):1138-1150. 
3. Matousek P, Clark IP, Draper ERC, Morris MD, Goodship AE, Everall N, Towrie 
M, Finney WF, Parker AW: Subsurface Probing in Diffusely Scattering Media 
Using Spatially Offset Raman Spectroscopy. Applied Spectroscopy 2005, 
59(4):393-400. 
4. Schulmerich MV, Dooley KA, Vanasse TM, Goldstein SA, Morris MD: 
Subsurface and Transcutaneous Raman Spectroscopy and Mapping Using 
Concentric Illumination Rings and Collection with a Circular Fiber-Optic 
Array. Applied Spectroscopy 2007, 61:671-678. 
5. Esmonde-White FWL, Schulmerich MV, Esmonde-White KA, Morris MD: 
Automated Raman spectral preprocessing of bone and other musculoskeletal 
tissues. In: Optics in Bone Biology and Diagnostics: 2009; San Jose, CA, USA: 
SPIE; 2009. 
6. Timlin JA, Carden A, Morris MD, Rajachar RM, Kohn D: Raman spectroscopic 
imaging markers for fatigue-related microdamage in bovine bone. Anal Chem 
2000, 72:2229-2236. 
7. Goodyear SR, Gibson IR, Skakle JMS, Wells RPK, Aspden RM: A comparison 
of cortical and trabecular bone from C57 Black 6 mice using Raman 
spectroscopy. Bone 2009, 44(5):899-907. 
8. Carden A, Rajachar RM, Morris MD, Kohn D: Ultrastructural changes 
accompanying the mechanical deformation of bone tissue: a Raman imaging 
study. Calcified Tissue International 2003, 72:166-172. 
9. Tarnowski CP, Ignelzi MA, Morris MD: Mineralization of Developing Mouse 
Calvaria as Revealed by Raman Microspectroscopy. Journal of Bone and 
Mineral Research 2002, 17(6):1118-1126. 
10. Widjaja E, Li C, Chew W, Garland M: Band-Target Entropy Minimization. A 
Robust Algorithm for Pure Component Spectral Recovery. Application to 
Complex Randomized Mixtures of Six Components. Anal Chem 2003, 
75:4499-4507. 
11. Widjaja E, Crane N, Chen T, Morris MD, Ignelzi Jr. MA, McCreadie B: Band-
Target Entropy Minimization (BTEM) Applied to Hyperspectral Raman 
Image Data. Applied Spectroscopy 2003, 57(11):1353-1362. 
12. Crane NJ, Popescu V, Morris MD, Steenhuis P, Ignelzi JMA: Raman 
spectroscopic evidence for octacalcium phosphate and other transient 





Chapter 3  
Chemical Alterations in Subchondral Bone 
Introduction 
Vibrational spectroscopy is a proven analytical tool to understand chemical changes that 
are associated with pathological conditions in tissue.[1, 2] In particular, infrared (IR) and 
Raman spectroscopy of mineralized tissue can provide detailed chemical information on 
the mineral and collagen matrix components of these complex tissues. Infrared and 
Raman spectroscopy have been applied to intact tissue samples, and both are 
well-established methods for the analysis of bone.[3-6] Both methods can provide insight 
into the interactions between the mineral and matrix or the chemical properties of a 
specific component by spectral imaging or point spectroscopy.[7]  
 
Fourier-transform infrared spectroscopy (FT-IR) of cartilage has been described in 
detail.[8-11] Infrared spectra of non-mineralized cartilage are dominated by protein 
signatures and do not contain mineral bands. Recent studies using FT-IR have correlated 
tissue damage with changes in the amide III and amide II envelopes and in the ~ 1340 
cm-1 band. Spectral features from proteoglycans and collagen have been mapped using 
infrared imaging with a spatial resolution approaching 10 micrometers.[8, 11] Recently, 
West and colleagues have demonstrated that infrared (IR) spectroscopy can detect 
collagen degradation in arthritic human knee explants and that spectra can be obtained 
through 1 meter of infrared-transmitting optical fiber.[12] Moreover, alterations in the 
collagen fibril orientation in articular cartilage, the result of collagenase treatment, are 
evident in polarized FT-IR images.[13]  
 
Raman spectroscopy has been used in transgenic mice to study the effects of genetic 
defects on the structure-function relationships in bone matrix.[14] There are no reports of 
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Raman spectroscopy applied through articular cartilage to the underlying intact 
subchondral bone plate. Currently, there is renewed interest in the role of subchondral 
bone in the progression of osteoarthritis (OA).[15] In traditional models of osteoarthritis, 
changes to subchondral bone are secondary to cartilage damage. A current postulate is 
that the subchondral bone is damaged early and this damage coincides with articular 
cartilage damage.[16] Moreover, it is unclear if damage to subchondral bone is 
arthrogenic or occurs as a response to damage in cartilage. As characterization of 
pathological and normal states in bone shaft specimens has already been demonstrated by 
Raman spectroscopy, we hypothesized that Raman spectroscopy would identify changes 
in subchondral bone components at the molecular level.  
 
Using a Raman microprobe, we obtained spectral signatures that are attributed to 
subchondral bone and protein features that are predominately attributed to type I collagen 
in bone. Articular cartilage is approximately 250 micrometers thick in healthy murine 
specimens. As a result of the relative Raman scattering efficiencies, and tissue 
thicknesses sampled from the cartilage and bone, mineral bands from apatite phosphate at 
~958 cm-1 and carbonate at ~1070 cm-1 are expected to dominate Raman spectra taken 
from murine femoral or tibial condyles. We demonstrate that the Raman microprobe can 
be used to obtain spectral data directly from subchondral bone using two sets of mice 
populations. The experimental methodology established in this study serves as a basis to 
expand Raman spectroscopic analysis to articular cartilage.  
 
The Del1 (+/-) mouse has an articular phenotype that has been well characterized for 
early-onset cartilage damage.[17] Heterozygous Del1 (+/-) transgenic mice contain 6 
copies of this 39 kb transgene; the type II collagen chain is truncated and affects the 
articular cartilage. Previous studies have shown Del1 (+/-) mice to develop age-
dependent histological features of osteoarthritis, with superficial fibrillation observed as 
early as 3-4 months of age on tibial cartilage. By age 3 months, Del1 (+/-) mice showed 
articular cartilage changes similar to 9-month-old wild-type (wt) mice and all male Del1 
(+/-) mice showed severe degeneration of femoral articular cartilage by age 9 
months.[17]  Polarized light microscopy showed greatly reduced birefringence of the 
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uncalcified articular cartilage in Del1 (+/-) mice, indicating decreased and/or 
disorganized collagen fibers. Other progressive changes included sclerosis of underlying 
bone, abnormal chondrocytes (pyknotic chondrocyte nuclei with clusters of reactive 
chondrocytes), and increased matrix staining with Safranin O. We hypothesize that 
Raman spectra taken from femoral condyles of Del1 (+/-) mice will reflect chemical 
changes in the mineral of the subchondral bone that result from osteoarthritis-like 
damage. Raman data obtained were compared to the widely accepted histologic scoring 
system for OA, the modified Mankin score, by two blinded observers.  
 
Materials and Methods 
Raman microprobe 
A near-infrared Raman microprobe was constructed in-house. The near-IR excitation 
laser, 785 nm (Kaiser Optical Systems Invictus), was line-focused through an Olympus 
BH-2 microscope. A 20×/0.75 NA Zeiss Fluar objective, with a working distance of 
approximately 0.66 mm, was used throughout the studies. Incident power on the 
specimen was dimmed to approximately 80 mW with a 0.25 O.D. neutral density filter to 
minimize the effect of specimen burning. The light was focused to a line approximately 
100 micrometers long and 1 micrometer wide. Raman-scattered light was collected 
through the objective and dispersed by an axial transmissive spectrograph (Kaiser Optical 
Systems Holospec f/1.8i) operated at 4 cm-1 resolution. The scattered light was integrated 
for 5 minutes on a 1024 x 256 back-illuminated deep depletion CCD camera (Andor 
Technology DU 420-BR-DD), which is sensitive in the near-infrared. Because 
line-focusing was used, transects consisting of 254 Raman spectra each, spaced at 
intervals of 0.5 micrometers along the line, were taken at each sampling area on the 
femur.  
 
Raman spectroscopic analysis of tissue 
Femurs were examined from 46 mouse specimens, 20 Del1 (+/-) transgenic and 26 
wild-type mice. One or both femurs from each animal were examined by Raman 
spectroscopy. The femurs, with the articular cartilage of the knee joints intact, were 
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isolated en bloc and stored in 70% (v/v) ethanol at 4ºC until Raman analysis. Femurs 
were removed from the ethanol storing solution and Raman spectra were taken under 
ambient temperature and relative humidity conditions. Prior to spectroscopic 
examination, the femurs were allowed to sit under an unfocused 785 nm laser for 5 
minutes to evaporate surface ethanol and to slightly photobleach the femurs to minimize 
the risk of burning the specimen. Femoral condyles were examined directly by the Raman 
microprobe, without pre- processing such as fixation or staining. Three to 10 transects 
were taken across the entire condyle surface, with a majority of transects taken along the 
interior edges of the medial and lateral condyles. Transects taken from the posterior or 
anterior cruciate ligaments, located between the femoral condyles, were easily 
distinguishable from the condyles in both light microscope images and Raman spectra 
(data not shown), and were not used in band area calculations.  
 
Raman data processing 
From each transect, a normalized mean spectrum was generated to offset the effect of a 
single spectrum on the arithmetic mean. Three to ten transects were obtained from each 
femur. Transects were imported in Matlab (v 6, Release 12.1, The Math Works), where 
spectra were corrected for dark signal and averaged into a normalized spectrum. 
Background signal from normalized spectra was removed using a user-defined multi-
point baseline routine, and Raman bands were fit using the curve-fit routine in 
GRAMS/AI© (ThermoGalatic) software. Band envelopes in the baseline-corrected 
spectra were fitted to mixed Gaussian/Lorentzian bands. Results from the curve-fitting 
routine were used if all band intensities were non-negative and the fit yielded an R2 value 
of 0.99 or greater. The curve-fitting procedure generally yielded bands that were readily 
identified based on Raman band assignments from previous experiments on bone matrix 
as summarized in Table 3.1.[5] Band areas calculated from the curve-fit routine were 
used to measure carbonate-to-phosphate ratios (carbonate 1070 cm-1: phosphate 958 cm-1 
and 945 cm-1), and the mineral-to-matrix ratio using the CH2 band vibration at ~1450 
cm-1 as a marker for matrix content. Microcomputed tomography (Micro CT) images 
were collected from femurs of aged (23-28 months) mice. Bone quality parameters were 





Three to ten Raman transects were taken on each femur, and a normalized mean spectrum 
from each transect was used to calculate band areas. Band areas were normalized against 
the sum of the bands to minimize the effect of varying signal-to-noise ratios. Raman data 
from mice in the Del1 (+/-) study were grouped into age subcategories (1-3, 4-6, 7-9, 
10-12, 12-18 and 23-28 months) for each genotype (wild-type or transgenic). Band area 
ratios were calculated for each spectrum, and were sorted by age group and genotype. 
P-values were determined using two-tailed Student’s T-test and used to compare band 
area ratios from wild-type and transgenic mice at each single time point. N-way ANOVA 
was used to determine longitudinal effects of age, transgenic status, and combined effects 
on Raman band area rations. A six-by-two experimental design was used in the study of 
Del1 (+/-) transgenic and wild-type mouse femurs by Raman spectroscopy. The null 
hypothesis was that Raman band area ratios were independent of age or transgenic status. 
Raman data were sorted into six age groups (1-3, 4-6, 7-9, 10-12, 12-18, and 23-28 
months) and two transgenic status groups (wild-type or Del1(+/-) transgenic). Outcome 
measures were the mineral-to-matrix ratio and the carbonate-to-phosphate ratio. Results 
from ANOVA tests are shown in Table 3.3. A post-hoc power analysis was performed to 
determine the power of an ANOVA, repeated measures, analysis within the main effects 
and interaction of the main effects. The post-hoc power analysis indicated 93% power to 
examine the transgenic status effect, 67% power to examine the age effect, and 43% 
power to examine a combined age and transgenic status effects.  
 
Animal models 
Del1 (+/-) transgenic mice were provided by Drs. E.I. Vuorio and A.-M. Säämänen at the 
University of Turku, Finland. Del1 (+/-) and wild-type mice were kept 1-5 per cage, 
allowed to ambulate ad lib and were given water and standard chow ad lib. Del1 (+/-) and 
wild-type mice were housed together under the same conditions. Del1 (+/-) transgenic 
and wild-type mice were sacrificed at 10 ages: 2, 2.5, 3, 5, 7, 9, 10, 12, 13, 16, 23, 26, 
and 28 months, using anesthesia overdose. Wild-type mice were sacrificed at additional 
time points of 4, 6 and 20 months. All ages were represented by at least two pairs of 
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sacrificed mice except for the 16-month group, for which only one pair was sacrificed. 
Each mouse had at least one femur examined by Raman spectroscopy. The femurs and 
stifle joints were isolated using an Olympus SZ30 dissecting microscope under 10X 
power. Genotyping was performed on tail snips using the REDExtract-N-Amp™ Tissue 
PCR Kit from Sigma. The DNA was then expanded with PCR using the following 
primers: 5’-GCT CCC TTA CTA TCT TCT TGT CCC TC-3’ (labeled exon6) and 5’-
CAG ACG GTA GCT TGG GTA GAA GAT-3’ (labeled exon8).  The PCR products 
were run on a 1% agarose gel using TAE buffer, and stained with ethidium bromide.  A 
218 bp band was identified in the transgenic mice, while a 368 bp band was seen in the 
wild-type mice. The difference in the size of the PCR products was easily resolved using 
agarose gel electrophoresis and ethidium bromide staining. Genotyping of tail snips from 
Del1 (+/-) transgenic mice confirmed the presence of the COL1A2 transgene when 
compared to wild-type mice. 
 
Histology 
The whole stifle joints were stored in 10% formalin, decalcified over 1-2 days in a 
solution containing sodium citrate and formic acid.  The samples were then embedded in 
paraffin, and cut into serial coronal sections 5 µm thick.  The sections containing the 
femur-tibia articulation were stained with both hematoxylin-eosin and safranin-O for 
determination of a modified Mankin score, as per Turner et al.[18]  The samples were not 
labeled for age or transgene status, and were read by 2 independent observers.  Total 
Mankin scores were compared for 6 different ages (2, 3, 5, 10, 12, and 13 months).  
 
Results 
As shown in Figure 3.1, Raman spectra of subchondral bone are comprised primarily of 
contributions from type I collagen and carbonated apatite mineral. The apatite phosphate 
ν1 band at 958 cm
-1 is strong in the raw spectrum but less intense peaks are difficult to 
clearly visualize. Raman bands corresponding to phosphate and carbonate groups in the 
apatite lattice (958 cm-1 and 1070 cm-1 respectively) were readily observed in baseline 
corrected spectra. Raman spectra of solid samples of type I collagen, type II collagen, 
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proteoglycan and chondroitin-6-sulfate were obtained in order to understand spectra 
contributions from polysaccharides and collagen found in cartilage (not shown here). 
Additionally, we examined articular cartilage surfaces from canine patella and were able 
to confirm that polysaccharide components do not make a significant contribution to the 
Raman spectrum of subchondral bone. Because bone mineral is a strong Raman scatterer, 
and murine cartilage is very thin (~250 µm), we were not surprised to observe that the 
articular cartilage layer has a minimal spectral contribution.  
 
A previous report had grouped Del1 transgenic and wild-type mice according to 
progression of damage to articular cartilage [17]. Age intervals, 1-3, 4-6, 7-9, 10-12, 
12-18 months, corresponding to maturation, young adult, adult, older adult and aged 
stages of mouse development were used to group Raman data. An additional age group of 
23-28 months was included in this study. We focused primarily on the mineral 
components of the Raman spectrum because type II collagen found in cartilage has bands 
in the amide III and amide I envelopes, and CH2 wag region that are similar to type I 
collagen found in bone. Thus the Raman spectra obtained during these studies contain 
matrix bands that arise from the cartilage and bone. The contribution of cartilage to the 
calculation of band area ratios that describe collagen secondary structure, such as the 
amide I or amide III band area ratio, is unclear.  
 
Figures 3.2 and 3.3 illustrate longitudinal effects in the mineral component of wild-type 
and Del1 (+/-) transgenic mice; the y-axis error bars indicate the standard deviation. The 
mineral-to-matrix ratio (1450 cm-1:958 cm-1) provides an indication of bone 
mineralization, and the carbonate-to-phosphate (1070 cm-1:958 cm-1) ratio was used to 
describe the degree of carbonate substitution in the apatite crystal lattice. Table 3.2 shows 
bone quality parameters obtained from microcomputer tomography of older Del1 (+/-) 
transgenic and wild-type mice.  
 
The modified Mankin score was used to evaluate histopathologic changes of OA on the 
femoral articular cartilage of Del1 (+/-) and wild-type mice. Pooled Mankin scores are 
shown in Figure 3.4. In contrast to other studies using the Del1 (+/-) transgenic model, 
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the scores did not consistently increase as a function of age.  The only statistically 
significant differences over age were an increase in Mankin score between the 5 and 12 
month old wild-type mice (p=0.045) and a decrease in Mankin score between the 2 and 3 
month old Del1 (+/-) mice (p=0.020). Mankin scores were not consistent between 
observers.  
Discussion 
In humans, mutations in COL2A1 gene have been linked to familial OA, as well as mild 
chondrodysplasia, Stickler and Wagner syndromes, to more lethal syndromes such as 
type II achondrogenesis (Langer-Saldino syndrome).[19] Similarly, the Del1 (+/-) 
transgenic mouse exhibits retarded skeletal development and is susceptible to early-onset 
progressive articular degeneration. Matrix metalloproteinase-13 mRNA and its inhibitor 
TIMP-1 are also expressed during early cartilage degeneration in this OA model, and are 
localized in the synovial tissue, deep calcified cartilage, and subchondral bone.[20]  
These may be involved in tissue remodeling in response to cartilage damage. 
 
Most of the previous characterization of the Del1 (+/-) phenotype has relied on the use of 
histologic parameters, including the use of the modified Mankin score. Within the 
Mankin system scores are given for surface integrity, hyper- and hypo-cellularity, and 
matrix quality using hematoxylin/eosin and Safranin-O staining.  The final score ranges 
from 0 (no osteoarthritis) to 20 (severe osteoarthritis). The modified Mankin score has 
been validated as an adequate measure of histological damage in at least one animal 
model of OA.[21] The authors of this validation study examined rabbit articular cartilage, 
comparing wild-type to experimental OA (either medial meniscectomy or plaster 
immobilization extension), with each sample being evaluated by two blinded observers.  
They found that most scores were less than 6, with reasonable intra-observer agreement 
(standard deviation varying between 1.5 and 2.6 points). Other researchers, however, 
have questioned the validity of the scoring system and have identified inherent problems 
associated with both inter- and intra-observer variation.[22]  In our study we observed 
significant inter-observer variation and the mean score did not consistently increase as a 
function of age or transgenic status. Statistical analyses showed no significant differences 
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between Del1 (+/-) and wild-type mice in total scores at ages 2, 3, 10, or 13 months of 
age. While the data are not statistically significant, histology data suggests that the 
phenotype expression for OA damage is maximized by the time the Del1 (+/-) transgenic 
mice reach age 5 months instead of demonstrating a progressive degeneration of cartilage 
that is expected in OA. It is possible that, after 5 months of age, other joint tissues in 
Del1 (+/-) transgenic mice compensate for loss of cartilage integrity. An experiment to 
further test this hypothesis would include examination of a non-load bearing joint in the 
Del1 (+/-) transgenic mice to test for possible mechanical-induced compensation.  
 
By contrast to variability observed in histology scoring, Raman spectral features were 
consistent across femur specimens. A comparison of the femur tissue spectra with 
reference collagen spectra indicated that mineral components and the collagen protein 
make the major contributions in spectra taken from subchondral bone. However, due to 
the similarities seen in reference collagen spectra, it is unclear if the collagen spectral 
contributions are from type I collagen, type II collagen, or a mixture of both collagen 
types. Because our microscope system operates in a non-confocal configuration, it is 
likely that spectra collected from the mouse femur specimens arose primarily from 
subchondral bone with minor contributions from articular cartilage.  
 
Common spectral features from hydroxyproline, aromatic ring breathing, amide III and 
amide I (880 cm-1, 1001 cm-1, 1220-1280 cm-1 and 1600-1720 cm-1) were observed from 
both types I and II collagen. Raman spectra of type II collagen have a low signal-to-noise 
ratio, even after a 10 minute signal integration time (data not shown). Because the 
differences in band position between types I and II collagen were generally 2-3 cm-1 and 
were within the spectral resolution of the instrument (4 cm-1). Band positions in the 
amide I and amide III envelopes could not be used to distinguish between types I and II 
collagen. The only possible exception is the band maximum in the amide I envelope, for 
type II collagen it is ~1671 cm-1 and for type I collagen it is ~1655 cm-1. However, in 
spectra collected from subchondral bone, the amide I envelope was sufficiently broad to 
incorporate the two bands, and band fitting routinely found more than two bands under 




We found that the changes in Raman band area ratios from Del1 (+/-) transgenic mice 
were subtle and, in most age groups, the band area ratios were statistically 
indistinguishable from those of wild-type mice. One possible explanation for these 
observations is the small number of wild-type and Del1 (+/-) animals that were examined 
in each age group due to the limited availability of mouse specimens. The effect of a 
cartilage depth that varies with genotype and age may complicate collection of light 
scattered from subchondral bone. Calculation of matrix-related band areas, such as the 
amide III, amide I envelopes and 1450 cm-1 band, may have been affected by a variable 
intra-and inter-specimen cartilage depth. Moreover, the similarities in Raman spectra 
from types I and II collagen complicate identification of individual contributions from 
cartilage and bone. Regardless, these preliminary studies are encouraging because of the 
apparent trends observed in the mineral-to-matrix and carbonate-to-phosphate ratios.  
 
The mineral-to-matrix ratio (MTMR) was used in previous bone Raman studies to 
examine the extent of mineralization. Markers of organic matrix included the amide I 
band at ~1667 cm-1, the area under the amide I envelope (1600-1720 cm-1), and the CH2 
wag at 1450 cm-1. [5, 23, 24] In this study, the 1450 cm-1 band was used as a marker for 
the organic matrix because it is less susceptible to conformation changes and thus, a more 
robust measurement of matrix content. The 1450 cm-1 band may include contributions 
from either the type I collagen in bone, the type II collagen in cartilage or a mixture of 
both. Despite contributions from both the cartilage and bone matrix in the 1450 cm-1 
band, we postulate that chemical changes in the mineral, rather than a variable cartilage 
depth, is the underlying reason why we observe a difference in the MTMR. We 
hypothesized that, even if the 1450 cm-1 band contains contributions from both cartilage 
and bone, then the MTMR would increase as the cartilage becomes thinner with age or 
surface erosion. Histopathology scoring of cartilage in wild-type and Del1 (+/-) mice 
were inconclusive and Mankin scores did not indicate age-related or transgene-related 
cartilage damage. Thus, we are confident that cartilage erosion was minimal and did not 




Figure 3.2 presents MTMR data for wild-type and Del1 (+/-) mice. In both types of mice, 
this ratio changes to show that the tissue becomes less mineralized as mice age. Raman 
data shows a trend that bone in Del1 (+/-) transgenic mice is less mineralized than bone 
from wild-type mice. These results support previous histology findings in Del1 (+/-) 
transgenic mice which found that Del1 (+/-) transgenic mice exhibit retarded long bone 
growth, reduced long bone dimensions and reduced mineralization in bone.[25]  
 
Micro CT was used to examine subchondral bone in older Del1 (+/-) transgenic and wild-
type mice (23-28 months old) and confirm the underlying reason why Raman studies 
indicated a lower MTMR in Del1 (+/-) mice. Table 3.2 shows that femurs from Del1 (+/-) 
transgenic mice have less mineralized bone tissue, as indicated by bone mineral content 
and bone mineral density. Trabecular architecture in cancellous bone was also affected by 
the Del1 (+/-) transgene, and we observed fewer trabeculae and increased spacing 
between trabeculae in the transgenic mice. The micro CT data suggest that cancellous 
bone tissue in Del1 (+/-) mice is less mineralized resulting in a diminished quality in 
bone architecture. Similar results have been previously reported.[26] Micro CT data also 
support Raman spectroscopy results showing that subchondral bone in Del1 (+/-) 
transgenic mice is less mineralized.  
 
The MTMR was not significantly different in transects from Del1 (+/-) transgenic mice in 
the aged mice, yet micro CT data suggests large bone mineral density differences 
between wild-type and Del1 (+/-) transgenic mice (0.74 vs. 0.26). We suspect that the 
discrepancy arises because of differences in the tissues examined. Raman spectra 
collected for this study did not contain signatures unique to bone marrow lipids, which 
indicate that the Raman microscope is sampling primarily subchondral bone with 
possible contributions from non-calcified and calcified cartilage. By contrast, the micro 
CT analyzed both cortical and cancellous bone. We hypothesize that the differences 
observed in the microCT measurements of bone mineral density arose because of 
differences in the cancellous bone. It is possible that cancellous bone remodeling was 
also affected by a truncated type II collagen chain. A future study would be to use Raman 
spectroscopy and micro CT to examine cancellous bone in OA models. Examination of 
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cancellous bone by Raman spectroscopy may reveal pathological alterations in trabeculae 
architecture or cancellous bone remodeling as response to OA.   
 
As seen in Figure 3.3, the carbonate-to-phosphate ratio in Del1 (+/-) femurs follows the 
same general trend as the data from age-matched wild-type femurs. But, after 2-4 months, 
the band area ratio value is consistently higher in Del1 (+/-) transgenic mice. The 
carbonate (CO3): phosphate (PO4) band area ratio, 1070 cm
-1: (958 cm-1 + 945 cm-1), is 
an indication of carbonate substitution into the mineral. The carbonate-to-phosphate ratio 
data indicates that the extent of carbonate ion substitution into the apatite mineral is 
greater in bone from Del1 (+/-) mice. Previous bone Raman studies have shown that 
increases in the carbonate-to-phosphate ratio is associated with increased bone 
stiffness.[27, 28] Previous research showed that osteoarthritic subchondral bone is stiffer 
than normal subchondral bone, which support our observations in the 
carbonate-to-phosphate Raman data.[29, 30]  
 
Alterations to the molecular composition of murine subchondral bone as response to age 
and defective type II collagen formation were observed using Raman spectroscopy. 
Subchondral bone was less mineralized, concurrent with slightly elevated carbonate 
content in bone mineral, in Del1 (+/-) transgenic mice. It is possible that the increased 
carbonate substitution occurred in response to deficient mineralization. Because no 
statistically significant changes in cartilage morphological or ultrastructural features were 
observed in histology specimens from wild-type or Del1 (+/-) transgenic mice, we think 
that chemical composition changes in subchondral bone occurred independent from 
changes to cartilage tissue. However, we cannot conclude that alterations to subchondral 
bone chemical composition are arthritogenic in nature.      
 
ANOVA tests revealed that MTMR and carbonate-to-phosphate ratios were dependent on 
age and transgenic status, as shown in Table 3.3. The carbonate-to-phosphate ratio 
provided the most compelling results for the effect of the both the Del1 (+/-) transgene 
and age. Longitudinal trends in the carbonate-to-phosphate ratio was significantly 
different when comparing wild-type and Del1(+/-) transgenic mice. Other Raman 
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spectroscopy studies of altered bone chemistry showed that the carbonate-to-phosphate 
ratio is altered at damaged sites.[27, 31] It is possible that future studies will show 
statistically significant elevated carbonate-to-phosphate ratio values in damaged areas of 
subchondral bone. The MTMR did not have a significantly different longitudinal trend 
between wild-type mice and Del1 (+/-) transgenic mice. ANOVA tests suggest a trend 
toward statistical significance of MTMR in future studies that may be revealed in an 
expanded test with more mouse specimens, especially when comparing mice in the young 
adult vs. adult developmental stages (4-6 months vs. 7-9 months).  
 
Conclusions 
To date, it is unclear if the primary tissue of origin in osteoarthritis is the articular 
cartilage or subchondral bone. Raman spectroscopy may provide new insights into the 
structure-function relationships that determine the properties of the complex bone-
cartilage interface. Raman spectra collected from subchondral bone under a layer of 
intact articular cartilage were used to identify chemical changes to the bone mineral that 
may result from genetic mutation of extracellular matrix molecules or with aging. 
Variations in cartilage depth or composition due to natural aging, or disease progression 
may affect calculation of Raman matrix bands. In our studies, subtle alterations to the 
chemical composition of subchondral bone are evident at early ages. 
 
Because of the large degree of spectral overlap, we concluded that we could not use 
Raman bands from collagen to differentiate cartilage from subchondral bone. We propose 
that a Raman spectrum of normal intact cartilage would be a more suitable pure 
component spectrum because there are spectral contributions from sulfated 
glycosaminoglycans which may be used to distinguish cartilage matrix from bone matrix. 
Normal cartilage specimens as a spectroscopic standard was proposed in a previous 
infrared study because it is more representative of the interactions that occur between 
collagen matrix molecules.[32] Sulfated glycosaminoglycans have a strong band at ~ 
1061 cm-1 that does not overlap with any of the major bands in bone collagen or the 
carbonate ν1 stretch at ~ 1070 cm
-1 of bone mineral. We envision a study of 
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cartilage/subchondral bone cross-section specimens using Raman spectroscopy. Raman 
spectra would be collected from each unmineralized cartilage zone, calcified cartilage, 
subchondral bone plate and the cancellous bone. Bands in Raman cartilage spectra from 
sulfated glycosaminoglycans could then be validated by staining the cross-section 
specimens for cartilage proteoglycan content using Safranin O.  
 
Finally, it is intriguing to conceptualize the application of Raman spectroscopy as a 
diagnostic modality. The carbonate-to-phosphate band area ratio is calculated using 
bands that are not obscured by collagen protein signal. Observation of the strong 
phosphate ν1 band at 958 cm
-1 and the carbonate band at ~1070 cm-1 in spectra that have 
not been baseline corrected indicates that calculation of this ratio would be possible in 
specimens with a thicker articular cartilage layer. Fiber-optic technology is frequently 
used through arthroscopes to evaluate knee, hip, shoulder and ankle joints in the clinical 
setting. Silica fiber optic Raman probes have been used to evaluate coronary artery 
calcifications in a clinical experimental setting[33], as well as in animal studies to 
diagnose cellular dysplasia in cancer models.[34] The non-destructive nature and 
sensitivity of Raman spectra to subtle tissue changes are attractive features in developing 
clinically relevant platforms such as a fiber-optic insert within an arthroscope. 
Potentially, Raman spectroscopy could be utilized through a combined arthroscopic 
imaging/Raman spectroscopic fiber optic system to diagnose early OA, or follow the 
response of damaged cartilage or subchondral bone to therapeutic intervention. We 
explore prototype designs of a fiber-optic arthroscope system for Raman spectroscopy in 
















Figure 3.2:  Mineral-to-matrix ratio is a spectroscopic marker of 














Figure 3.3:  Carbonate-to-phosphate ratio is a spectroscopic marker of carbonate 
substitution into the apatite crystal lattice in femoral condyles from Del1 (+/-) 




















Figure 3.4:  Histopathology analysis was performed on femur stifle joints from 
wild-type and Del1 (+/-) transgenic mice. Modified Mankin scoring was used to 















850 νCC hydroxyproline Collagen Matrix 
876 νCC hydroxyproline Collagen Matrix 
945 disordered apatite Apatite Mineral 
958 ν1 PO4
3-
 Apatite Mineral 
1001 Phenylalanine Collagen Matrix 
1070 ν2 CO3
2-
 Apatite Mineral 
1240 Amide III (random coil) Collagen Matrix 
1270 Amide III (α-helix) Collagen Matrix 
1450 CH2 wag Collagen Matrix 
1667 Amide I Collagen Matrix 
 





Bone Parameter Wild-Type Del1 (+/-) 
Transgenic 
Bone Mineral Content 
(mg) 
0.74±0.5 0.26 ±0.07 
Bone Mineral Density 
(mg/cc) 
116.11 ±45.6 39.22 ±11.5 
Bone Volume Fraction 0.09 ± 0.08 0.003 ±0.002 
Bone Volume/Tissue 
Volume 
0.1 ± 0.08 0.003 ±0.002 
Bone Surface/Tissue 
Volume 
52.91 ± 6.11 94.15 ±30.79 
Trabecular Thickness 0.038 ±0.004 0.022 ±0.006 
Trabecular Number 2.43 ± 1.89 0.12 ±0.07 
Trabecular Spacing 0.78 ± 0.70 13.83 ±14.23 
 
Table 3.2:  Bone quality parameters obtained from microcomputed tomography 
of older (23-28 months) Del1 (+/-) transgenic and wild-type mice. Average 






















Raman Band Area Ratio Carbonate-to-
phosphate 
Mineral-to-matrix 
Pr>F, age 1.24x10-5 7.83x10-5 
Pr>F, transgenic status 0.005 0.003 
Interaction? Yes No 
 
 
Table 3.3:  ANOVA tests reveal that the mineral-to-matrix ratio (MTMR) 
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Chapter 4  
 Correlating Changes in Collagen Secondary 
Structure with Aging and Defective Type II 
Collagen by Raman Spectroscopy 
Introduction 
Diagnosis and monitoring of collagen defects poses a challenge, especially for 
sub-clinical patients, since several inter-related biochemical, environmental and genetic 
factors may lead to collagen damage. Genetic and acquired abnormalities in types I, II, 
and IX collagen cause a range of skeletal diseases, such as early-onset osteoarthritis, 
Stickler’s syndrome and osteogenesis imperfecta (OI). Type II collagen is a major 
component of articular cartilage and the vitreous humor of the eye. Known mutations of 
the type II collagen gene (COL2A1) in humans cause disorders, such as Stickler 
syndrome, that affects both the eye and skeletal systems.[1-3] 
 
In addition to symptoms affecting bone or cartilage, patients with collagen diseases 
exhibit a range of ocular disorders including a discoloration of the sclera and an increased 
risk for detached retina, glaucoma and myopia.[4-6] Other genetic and acquired collagen 
disorders causing various eye pathologies are under investigation.[7] Moreover, eye 
collagen can be damaged as a result of natural aging, or age-related diseases such as 
macular degeneration affect the eye, likely causing changes in collagen structure.[8, 9]  
Autoimmune and inflammatory disease can affect the eye, likely causing changes in 
collagen structure. Scleritis, for example, is a chronic destructive inflammation of the 
sclera which can lead to cataracts, glaucoma, and blindness. It is usually associated with 
systemic inflammatory disorders such as rheumatoid arthritis, Wegener’s granulomatosis, 
polyarteritis nodosa, sarcoidosis, inflammatory bowel disease, or systemic infections such 
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as syphilis or tuberculosis. The sclera is an avascular tissue made of dense fibrils of 
collagen, primarily types I and III, with smaller amounts of other collagen types, and 
interfibrillar leucine-rich proteoglycans and glycoproteins.[10] The episclera, which is 
superficial to the sclera, can also become inflamed, idiopathically or in association with 
inflammatory disorders such as rheumatoid arthritis, spondyloarthropathies or vasculitis. 
Sjogren’s syndrome, an inflammatory disorder causing decreased tear production, can 
occur on its own or in association with other inflammatory disorders such as systemic 
lupus erythematosis or rheumatoid arthritis. Sjogren’s syndrome can lead to damage and 
inflammation of the cornea. Anterior uveitis, also known as iritis or iridocyclitis, can be 
associated with juvenile rheumatoid arthritis or ankylosing spondylitis, both diseases of 
chronic arthritis. These inflammatory disorders of the eye often require prompt treatment, 
and can be difficult to diagnose.  
 
In addition to being a model for early-onset OA, the Del1 (+/-) transgenic mouse can be 
systematically examined for ultrastructure changes in ocular tissue because of the role of 
type II collagen in the development of eye tissue and the limited availability of eye tissue 
from human patients of arthro-ophthalmopathies. Type II collagen polypeptide chains in 
the Del1 (+/-) transgenic mouse are truncated by 15 amino acids, which is a result of a 
150 base pair deletion mutation in the COL2A1.[11] Because abnormal type II collagen 
is also expressed in vitreous, cornea and sclera, Del1 (+/-) transgenic mice exhibit ocular 
damage including early-onset liquefaction of the vitreous humor and reduction in vitreous 
fibrils.[12]  
 
The effects of defective type II collagen formation are evident in musculoskeletal tissue 
from Del1 (+/-) transgenic mice.[13-15] Our previous study demonstrated that defective 
type II collagen in Del1 (+/-) transgenic mice leads to formation of subchondral bone 
with an apatite mineral with more carbonate substitution into the crystal lattice.[16] 
Subchondral bone in Del1 (+/-) transgenic mice is also less mineralized. The material 
properties of subchondral bone in Del1 (+/-) transgenic mice were altered on a chemical 
level, even though histopathology analysis did not provide an indication of gross 
morphological changes to the joint. We hypothesized that we would observe chemical 
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changes in ocular tissue excised from Del1 (+/-) mice and these changes would be 
primarily observed as alterations in the collagen secondary structure.  
 
Raman spectroscopy has been used to examine a variety of biological tissues.[17, 18] A 
Raman spectroscopy microprobe for alterations in protein structure is especially useful to 
distinguish normal and pathological tissues since subtle molecular changes often cause 
detectable vibrational changes. Properties of the Raman microprobe that make it an 
attractive method for direct analysis of biological tissues include high spatial resolution 
(0.25-0.5 µm for a 532 nm system, 0.5 -1.0 µm for a 785 nm system) and limited spectral 
interference from water. Since Raman spectra are recorded in the visible or near-infrared 
region, the optics are compatible with current clinical arthroscopy tools. Vibrational 
spectroscopy methods are used to characterize surface components of tissues or identify 
damage to tissues. FT-IR fiber optic probe and imaging methods have been used to 
investigate the contents of mineralized soft tissues.[19, 20] FT-IR studies have shown 
spectra to indicate collagen damage with prolonged exposure of articular cartilage to 
collagenase.[21] Raman studies of collagen fibers have identified fiber damage due to 
mechanical stress.[22]  
 
Raman spectroscopy is an attractive tool to study ocular tissue because of the 
non-invasive and non-destructive nature of the technique and the accessibility of the eye. 
A single-channel resonance-enhanced Raman instrument quantifies macular pigments 
in-vivo in less than a minute, and has potential to track the progression of age-related 
macular degeneration.[23, 24] Identification of biological molecules and characterization 
of ocular surfaces by Raman spectroscopy have applications ranging from 
ophthalmologic disease diagnosis, monitoring effectiveness of treatments, to assessing 
compatibility of donated ocular tissue.[25, 26] Raman bands arising from spectra of the 
cornea and sclera are primarily due to contributions of type I collagen, and bands in the 





Eye tissue obtained during the study of wild-type and Del1 (+/-) transgenic mice 
subchondral bone on femoral condyles provided an opportunity for a preliminary study 
on the effects of defective type II collagen formation and aging on unmineralized ocular 
tissue. We used Raman spectroscopy to examine the sclera of eye tissue from Del1 (+/-) 
transgenic and wild-type mice. We observed changes in the area ratio of amide III bands, 
and band position of the 1235 cm-1 band in Raman spectra taken from the Del1 (+/-) 
transgenic and aged wild-type mice, reflecting an increase in the relative abundance in 
random coil secondary structure in eye collagen.  
Materials and Methods 
Animal Models 
Breeding pairs of Del1 (+/-) transgenic mice were provided by Drs. E.I. Vuorio and 
A.-M. Säämänen at the University of Turku, Finland.  Del1 (+/-) and wild-type mice were 
housed together under the same conditions. Del1 (+/-) transgenic and wild-type 
littermates mice were kept 1-5 per cage, allowed to ambulate ad lib and were given water 
and standard chow ad lib. Mice were sacrificed using anesthesia overdose, and the eye 
globe was enucleated en masse. Eye tissue from three mouse specimens, one 12-14 
month old wild-type, one 12-14 month old Del1 (+/-) transgenic, and one 20 month old 
wild-type, were examined. Both eyes from each specimen were analyzed. Specimens 54 
and 55 were 12-14 month Del1 (+/-) transgenic and wild-type mice. Specimen 13 was a 
20 month old wild-type mouse. Eyes excised from mice at the time of sacrifice were 
stored in an ethanol solution at 4°C until time of Raman analysis. The diameter of the eye 
globes examined ranged from 2-4 mm.   
 
Experimental Apparatus 
Prior to spectroscopic examination, an eye was removed from the ethanol storage 
solution and lightly touched with a clean lab tissue to remove excess ethanol. The eye 
was allowed to equilibrate in pH 7.4 phosphate buffered saline (PBS) for 10 minutes. The 
eye mount was constructed in-house. The cap was removed from an unused, disposable 
1.5 mL polypropylene micro-centrifuge tube (Fisher Scientific, Pittsburgh, PA), secured 
onto a microscope slide and filled with pH 7.4 phosphate buffered saline (PBS). A fresh 
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cap was used for each eye globe to minimize cross-contamination, and was cleaned by a 
PBS rinse prior to use. The eye was then placed into the PBS-filled mount. The globe 
remained in PBS solution throughout the Raman experiments.  
 
The Raman microprobe was constructed in-house and has been described in detail 
earlier.[28] Briefly, the Raman microprobe was equipped with a 785 nm Invictus 
line-focused laser (Kaiser Optical Systems, Ann Arbor MI). The laser was directed to an 
Olympus microscope, equipped with a 5X/0.25 NA objective. A 5X/0.25 NA objective 
and a 0.3 neutral density filter (laser intensity at objective ~105 mW) was used to avoid 
specimen burning and keep the entire specimen in focus, despite the small radius of 
curvature of the eye. Scattered light was collected by the objective and directed to a 
HoloSpec f/1.8i spectrometer that was equipped with a 25 µm slit for a spectral resolution 
of 4 cm-1 (Kaiser Optical Systems, Ann Arbor MI).The Raman signal was integrated for 
10 minutes on a 1024X256 deep-depleted charged-coupled device (CCD) detector 
(Model DU420-BR-DD, Andor Technologies, Belfast, Ireland) optimized for collection 
of signal in the near-infrared. Specimens were analyzed with no coverslip over the 
mount. The volume of PBS in the mount was continually monitored and refreshed as 
needed. The outer edges of the sclera were examined. Raman transects, 254 point spectra 
taken at ~0.5 µm intervals along a line, were taken along these outer sclera edges. Spectra 
from transects with excessive fluorescence interference or specimen movement were 
discarded.  
 
Analysis of Raman data  
Depending on the specimen, spectra from five to twelve Raman transects were used to 
calculate a band area ratio. Andor MCD software was used as the data collection 
software. After data collection, transects were pre-processed in Matlab© using locally 
written or available scripts to remove curvature and spikes, and to remove the dark signal 
from the spectra. Band target entropy minimization (BTEM) was performed on select 
transects to confirm the presence of bands in the amide III envelope using locally written 
scripts in Matlab©.[29] To minimize the effect of sample heterogeneity on band area 
calculations, a single normalized spectrum (representative of the entire transect) was 
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exported to GRAMS/AI© after the initial processing in Matlab©. Background signal from 
Raman spectra was removed using the baseline correction application, and bands in 
amide III envelope were fit using the curvefit application in GRAMS/AI© software. An 
example of the peak fitting routine, as applied to the amide III (1220-1280 cm-1) and 
amide I (1640-1700 cm-1) envelopes, is presented in Figure 4.1. Peak areas were recorded 
if the best-fit curve showed an R2 greater than 0.990 and had no negative peaks.  
Statistical Analysis 
Band areas from spectra corresponding to a single specimen were grouped together to 
calculate a single average value for each band area. Ratios were calculated from averaged 
band areas. Student t-tests (two-sample, assuming unequal variances) were performed on 
the area and position of bands in the amide III envelope to determine statistical 
significance (p<0.05). Amide III band area ratio and band position comparisons were 
made between a) 12-14 month transgenic and wild-type mice, b) 12-14 month wild-type 
and 20 month wild-type mice, and c) 12-14 month transgenic and 20 month wild-type 
mice.    
 
Chemicals 
Phosphate buffered saline solution (0.01 M, pH 7.4) was prepared by dissolving a single 
tablet of phosphate buffered saline (Sigma-Aldrich, St. Louis, MO, part P-4417) in 
purified water according to the manufacturer’s directions. 
Results  
A Raman spectrum of eye tissue is presented in Figure 4.1. A “blank” spectrum of the 
eye mount filled with PBS (spectrum not shown) confirmed that the spectral features of 
ocular tissue arose from the eye tissue, with minimal spectral interference from the 
mount. Minor spectral contributions, which are attributed to the phosphate 
buffer/polypropylene cap, were observed throughout these studies. An unusual, but 
consistent, finding was an enhanced band intensity of the amide III envelope. The amide 
III envelope is ~ 3 times more intense than the ring breathing mode at ~ 1002 cm-1. 
Moreover, the localized maxima within the amide III envelope are less well-defined as 
compared to both Raman spectra of eye tissue found in the literature and in spectra taken 
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of solid types I and II collagen in our laboratory (data not shown). We hypothesize that 
an unidentified fluorescence impurity, presumably from an eye pigment such as melanin, 
is overlapping with Raman scatter. The source of the fluorescence is not completely 
elucidated and, to date, we are unable to completely resolve the fluorescence background 
from the Raman signal using in-house data reduction routines. Band target entropy 
minimization (BTEM) and singular value decomposition (SVD) analysis of selected 
transects confirm the presence of a fluorescence impurity. As seen in Figure 4.2, applying 
singular value decomposition to Raman data reveal factors from eye collagen (Figure 
4.2.b) and a fluorescence impurity (Figure 4.2.a). Without the interfering signal from the 
fluorescence impurity, the eye tissue Raman spectrum is more consistent in both shape 
and intensity with literature spectra of sclera collagen. However, it was not possible to 
apply SVD and BTEM to all transects because these routines require over-sampled data 
sets.  
 
To verify the reliability of the curve-fitting routine, bands in the amide I envelope 
(1640-1720cm-1) were also fit using the curve-fit application in GRAMS/AI©. The 
relative intensity and band width of the amide I envelope was not affected by the 
fluorescence impurity that gave rise to the unusual band shape and intensity in the amide 
III envelope. The amide I band area ratio (area 1685 cm-1 band: area 1667 cm-1 band) was 
compared to the amide III ratio for each of the specimens. Due to the lower quantum 
efficiency of the CCD in the 1600-1720cm-1 region, it was not possible to obtain band 
area ratios in the amide I envelope for all of the transects. At least three transects from 
each specimen were used to calculate the amide I band area ratio.  
 
Analysis of fitted bands in the amide III envelope was used to estimate the relative 
content of random coil secondary structure in ocular collagen. The amide III envelope 
reflects both ordered protein secondary structure such as α-helix or β-sheet, and 
disordered secondary structure, such as random coil. The amide III envelope is observed 
as a broad feature in the Raman spectra of proteins and tissues. Two maxima are typically 
observed within the envelope. The wavenumber maximum at a lower Raman shift (range: 
1230-1240 cm-1) is indicative of random coil content in the protein’s secondary structure, 
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and the maximum at a higher Raman shift (range: 1260-1270 cm-1) is indicative of 
α-helix content in the protein secondary structure.[30] For eye tissue, the maxima were 
1235 cm-1 and 1265 cm-1 and we define the amide III ratio as the ratio of the 1235 cm-1 
and 1265 cm-1 band areas. Increases in the amide III ratio indicate an increase in the 
disorder of the collagen fiber. Band assignments are provided in Table 4.1 and are based 
on previous assignments of ocular tissue from the literature.[26, 31] Local maxima in the 
amide III envelope are less defined in ocular tissue than in articular cartilage likely due to 
several types of collagen structure in the ocular tissue.[32] Figure 4.3 is a comparison of 
Raman spectra of subchondral bone and eye cartilage taken from the same specimen. 
Contributions from phosphate and carbonate mineral components showed strong bands at 
959 cm-1 and 1070 cm-1 in spectra from subchondral bone, and these bands were not 
observed in Raman spectra taken from eye tissue.  
Discussion 
Raman spectra of eye tissue from the Del1 (+/-) transgenic mouse showed an increase in 
the relative abundance of disordered secondary structure in the collagen fiber that was 
also observed in the aged wild-type mouse. As shown in Table 4.2, spectra taken from 
12-14 month old transgenic and 20 month old wild-type mice have a higher amide III 
band area ratio. Increases in the amide III band area ratio reflect more disordered 
collagen secondary structure in ocular tissue. In the analysis of ocular tissue, there was an 
observable difference of amide III band area ratios corresponding to the 12-14 month 
transgenic and age-matched wild-type mice (specimen ID 54 and 55, respectively). The 
amide III band area ratio of transects taken from the 20 month wild-type mouse is 
comparable to that of the 12-14 month transgenic mouse, indicating that collagen damage 
caused by the COL2A1 transgene at age 12-14 months may be comparable to 20 months 
of the normal aging as seen in the older wild-type mouse. The amide III band area ratio of 
the aging wild-type mice (12-14 month old versus 20 month old) shows an increase in the 
amide III band area ratios, indicating that increase to the disorder of the secondary 
structure of collagen in older wild-type mice occurs as a natural result of aging and the 
low turnover rate of ocular collagen. An increase in disorder of collagen secondary 
structure as a function of age in wild-type mice is expected. A slight increase in the 
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amide III band area ratio was also observed in Raman analysis of femurs from aging 
wild-type mice.  
 
In addition to a higher amide III band area ratio, the average peak position of fitted bands 
in the amide III envelope provides another indication of collagen damage in the 12-14 
month Del1 (+/-) transgenic and 20 month wild-type specimens. We observed a shift to a 
higher wavenumber for the 1235 cm-1 peak for the 20 month wild-type and transgenic 
mouse and is thus dependent on both the age and transgenic status of the mouse. Spectra 
from the 12-14 month transgenic and 20 month wild-type mouse have an average peak 
position of 1234 cm-1 (±2) and 1236 cm-1 (±2) respectively, while spectra from the 12-14 
month wild-type mouse have an average peak position of 1231 cm-1 (± 1). The band 
position seen in both the 12-14 month transgenic and 20 month wild-type is statistically 
different (p<0.05) from the 12-14 month wild-type mouse.  
 
Raman spectroscopy of proteins has shown that changes in the secondary structure, due 
to environmental, mechanical, or chemical stresses, will be reflected in the amide III and 
amide I envelopes. These alterations may be observed as changes in band position, band 
area ratio, or band intensity ratio. Eye collagen is not subject to mechanical loading that 
occurs in musculoskeletal tissue. We conclude that the observed shifts in amide III band 
position resulted from chemical modifications. Our results suggest that the COL2A1 gene 
altered collagen cross-linking which led to an increase in the relative abundance of 
disordered collagen secondary structure. Shifts in the fitted amide III bands in spectra 
from 20 month wild-type and 12-14 month Del1 (+/-) transgenic mice to higher 
wavenumbers, relative to the 12-14 month wild-type, may be interpreted as increased 
compression of amide groups along the collagen backbone.   
 
Because we observed a fluorescence impurity that overlapped with Raman signal in the 
amide III envelope, the amide I band area ratio was used to confirm the reliability of the 
curve-fit routine for amide III bands. We compared the value of the amide I and amide III 
band area ratios of transects taken from eye tissue with transects taken from articular 
cartilage from mice of comparable ages (12, 13, and 20 months) and transgenic status. 
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The value of the amide III band ratio relative to the amide I band area ratio was expected 
to remain consistent, regardless of the type of tissue examined. In transects taken from 
both eye tissue and articular cartilage, the amide III band area ratio was ~ 2 times larger 
than the amide I band area ratio, indicating reliable band-fit for both the amide I and 
amide III envelopes.    
Conclusions 
The initial results of applying Raman spectroscopy to the study of ocular tissue from 
Del1 (+/-) and aging wild-type mice are promising. There is a statistically significant 
difference in the amide III band ratios between the 12-14 month transgenic and wild-type 
mice. The transgenic mouse showed a higher collagen disorder, as expected, compared to 
its age-matched wild-type littermate. Moreover, the increased collagen disorder in the 20 
month wild-type mouse indicates that Raman can also identify changes to collagen that 
are a result of normal aging. Truncation of the collagen fiber caused by the transgene or 
loss of collagen fiber elasticity from normal aging could be causes of the spectroscopic 
changes that are observed in both the amide III band area ratio and band position 
associated with disordered collagen in the amide III region. These data support and 
extend our earlier observations that Raman spectroscopy is able to identify increased 
collagen disorder in both transgenic mice and older wild-type mice. Raman bands in the 
amide III envelope can be used to identify and possibly quantify disorder in the 
secondary structure of the collagen protein in eye tissue. Despite the spectral interference 
in the amide III envelope from a fluorescence impurity, the curve-fit routine in 
GRAMS/AI© provides reliable calculation of band areas within the amide III envelope. A 
detailed study of transgenic and wild-type mice at several defined time points is 
necessary to fully evaluate the effect of the transgene and aging. Because it is 
non-invasively accessible, eye tissue may serve as a good site for study of collagen 












Figure 4.1:  Raman spectrum of eye tissue and curve-fit of amide III envelope. A baseline 
corrected Raman spectrum on the left shows subtle bands more clearly. Panels on the 





Figure 4.2:  Singular value decomposition (SVD) analysis of a Raman transect taken 
from eye tissue of a 12-14 month Del1 (+/-) transgenic mouse. The same transect that is 
represented in Figure 4.1 was also analyzed by SVD. There were two main non-noise 
factors. The fluorescence impurity (a) factor clearly overlaps with the amide III envelope. 
The eye tissue factor (b) is consistent with Raman literature spectra of eye sclera and dry 









Figure 4.3:  A comparison of a spectrum from subchondral bone versus ocular tissue. 
Raman spectra were taken from the (a) eye and (b) femur of the 20 month wild type 








642, 757, 827, 
853, 877 
757: ν (C-C-O), 853: ν (C-C-H) 
aromatic, 877: ν (C-C)  
Aromatic protein residues 
1003 ν (C-C) aromatic ring Aromatic ring breathing 
1220-1280 1235: δ (NH2) random coil 
1265: δ (NH2) alpha-helix 
Amide III  
1450 δ (C-H)  Protein CH2, CH3 scissor 
1650 O-H bend Amide I, H2O 
1667 ￿ (C=O) alpha-helix Amide I 
1685 ν (C=O)  Amide I 
 
Table 4.1:  Assignments for observed Raman bands of ocular tissue based on 
















Mouse transgenic status 










Wild-type, 12-14 months 1231 ± 1 1265 ± 4 0.552  
 
Wild-type, 20 months 1234 ± 2 1265 ± 3 0.965   
 
Del1 (+/-) transgenic, 
12-14 months 
1236 ± 2 1264 ± 2 0.881  
 
 
Table 4.2:  Comparison of band positions in amide III envelope and amide III band 
area ratios for all specimens. The ± value represents the 95% confidence limit. 
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Chapter 5  
Arthroscopic Raman Spectroscopy 
Introduction 
Arthroscopy is a minimally invasive surgical technique that is commonly used to treat or 
repair joint tissues. Arthroscopic techniques are commonly used in the diagnosis and 
treatment osteoarthritic joints.[1, 2] Features such as roughened cartilage, focal lesions on 
the cartilage surface (1-3 mm) or osteophytes can be readily visualized through an 
arthroscope, and the instrument can be used to guide arthroscopic surgery. An 
arthroscope is a probe with a long narrow rod-shaped portion ending in an optical port at 
the tip. The rod portion is typically 2-3 mm diameter, so that the arthroscope can be 
inserted into a joint space through a small incision. A video camera is attached to the 
proximal end of the arthroscope and enables visualization of the joint in situ. The primary 
benefit of arthroscopic surgery is the small incision, which reduces infection risk and 
patient recovery time.  
 
The surgical terms used in the next two paragraphs are defined below.  
Lavage: Lavage is a process in which the joint is rinsed with a buffered solution 
and has been shown to reduce short-term joint pain because inflammatory proteins 
are irrigated out of the joint. 
Shaving: Shaving of fibrillated cartilage surfaces or smoothing cartilage near 
focal lesions, using a mechanical cutting instrument, reduces friction in joints 
affected by osteoarthritis. 
Debridément: Debridément is a more intensive form of shaving, where 
osteophytes are removed in addition to damaged cartilage. Debridément can provide 




Laser reshaping: Using a high intensity excimer laser to reshape cartilage is an 
alternative to a mechanical cutter. Laser reshaping of cartilage provides better 
spatial resolution and is less destructive than a mechanical cutter.  
 
Several methods are used in arthroscopic surgery for treating osteoarthritis. Cartilage 
reshaping and lavage techniques provide short-term pain relief, especially for patients 
with mild or moderate osteoarthritis. The long-term efficacy of these techniques is still a 
topic of research, primarily because they do not repair damaged cartilage. Equally 
important, lavage and cartilage reshaping may potentially induce chondrocytes necrosis 
or remove healthy chondrocytes in addition to damaged cartilage.  
 
During therapeutic arthroscopic procedures it is critical that healthy and damaged tissue 
be identified. Current methods rely primarily on visual inspection of joint surfaces to 
identify damaged cartilage and osteophytes. Visual inspection does not provide complete 
identification of the tissue health. As a result, healthy cartilage is sometimes removed and 
lesions can only be identified in the superficial cartilage zone. Improved discrimination 
between healthy and diseased cartilage, and identification of subsurface focal lesions 
during arthroscopic joint surgery would improve treatment efficacy because healthy areas 
could be preserved and damaged sites would be better identified and treated. For this 
reason, there is interest in both clinical and basic science research to couple arthroscopy 
with techniques that can rapidly identify damaged cartilage tissue or microfracture sites 
and identification of appropriate shaving, debridément or laser shaping .[2] 
 
Spectroscopy and hyperspectral imaging of cartilage and subchondral bone during 
arthroscopy can provide contrast to show molecular signatures of damage, even if it is 
invisible to the eye. Alterations to the molecular structure of cartilage extracellular matrix 
and subchondral bone are among the earliest signs of osteoarthritic lesion formation.[3-5] 
In cartilage the primary molecular alterations include loss of proteoglycan content and 
disorganization of type II collagen fibrils.[5-8] In addition, there is a decrease in 
mineralization of subchondral bone which also becomes stiffer as a result of increased 
carbonate ion substitution into the apatite crystal lattice.[4, 9-12] Decreases in 
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proteoglycan content or increased type II collagen birefringence have been observed in 
examination of cartilage by Fourier-transform infrared (IR) spectroscopy and optical 
coherence tomography (OCT).[3, 13-15]  
 
Spectroscopic techniques can be adapted for use with fiber-optic probes, rendering them 
compatible with the small dimensions of an arthroscopic instrument. Fiber-optic FT-IR 
and OCT techniques have been used to examine articular cartilage. Use of a fiber-optic 
probe for examination of cartilage by FT-IR was demonstrated in 2004 by West et al.[16] 
This study showed proof-of-concept for collection of cartilage spectra in an infrared 
fiber-optic probe. A meter-long fiber-optic bundle was coupled to an attenuated total 
reflectance crystal and the probe was put in direct contact with articular cartilage. 
Spectral results from the FT-IR fiber-optic probe were validated against FT-IR 
microscopy of the cartilage specimens and Collins visual grading of cartilage damage.  
Both the fiber-optic probe and microscope measurements detected subtle but significant 
differences in established infrared markers of collagen damage between mildly and 
severely degraded cartilages.  In another study, fiber-optic polarized OCT was adapted 
for arthroscopy.[17] OCT measurements on full-depth (~ 2mm) porcine articular 
cartilage before and after surgical incision revealed incision-induced alterations to type II 
collagen orientation.  
 
We report the adaptation of Raman spectroscopy for arthroscopic measurements. Two 
configurations were explored. In the first configuration, a commercially-available 
arthroscope was coupled to a fiber-optic Raman spectroscopy detector. In the second 
configuration, a fiber-optic probe was tested where excitation and collection fiber-optics 
were coupled through a stainless steel tube with arthroscope dimensions. The second 
probe configuration was used to collect Raman signal of cadaveric human joint tissue at 
the proximal radius. Tissue optical scattering and absorption determine the optically 
sampled tissue volume, and thus the Raman spectra collected from cartilage and 
subsurface tissue. The effects of optical properties on arthroscopic tissue measurements 
are discussed.   
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Materials and Methods 
Raman Spectroscopy Microscope 
A Nikon E600 epi-fluorescence microscope (Nikon Inc., Melville, NY, USA) was 
modified for NIR Raman spectroscopy in-house. Microscope images were collected in 
epi-illumination mode with 4x/0.20NA, 10x/0.50NA, and 20x/0.75NA S Fluor objectives 
(Nikon Inc., Melville, NY, USA). A 785 nm Kaiser Invictus laser was line focused 
(Kaiser Optical Systems Inc., Ann Arbor, MI, USA) onto the specimen using a 
20x/0.75NA S Fluor objective. A neutral density filter of 0.3 reduced the laser intensity at 
the objective to ~ 10 mW. Raman-scattered light was collected through the same 
20x/0.75 NA S Fluor objective and dispersed through a spectrograph (HoloSpec f/1.8, 
Kaiser Optical Systems Inc., Ann Arbor, MI, USA).  Raman signal was collected for 10 
minutes on a deep-depletion, back-thinned 1024x128 charge-coupled device (CCD) 
detector (DU401-BR-DD, Andor Technologies, Belfast, Ireland). Raman transects 
consisted of 126 Raman spectra arranged at equidistant points along a line through the 
specimen.  
 
Raman Fiber-optic Probes 
Two arthroscopic-compatible Raman fiber-optic probe configurations were tested. In the 
first configuration a commercially-available arthroscope was coupled to a fiber-optic 
probe, as shown in Figure 5.1. A 785 nm laser beam (Invictus, Kaiser Optical Systems, 
Inc., Ann Arbor, MI, USA) was focused into a 62.5 µm core fiber-optic. The beam was 
collimated and focused into the center optical channel of an arthroscope (Stryker, San 
Jose, CA, USA). The laser intensity at the end of the arthroscope was 10-15 mW, and the 
beam size was less than 1 mm. Raman scatter was collected above the side channel of the 
arthroscope using a fiber-optic probe with 50 collection fibers, arranged in a circle, and 
fitted with a 75 mm diverging lens (PhAT probe, Kaiser Optical Systems, Inc., Ann 
Arbor, MI, USA).  Raman scatter collected by the PhAT probe was dispersed through a 
spectrograph (HoloSpec, Kaiser Optical Systems, Inc., Ann Arbor, MI, USA) and imaged 
onto a 1024x256 back-thinned deep-depletion charge-coupled device (CCD) detector 
(Andor Technologies, Belfast, N. Ireland). Raman spectra from a bovine bone specimen 




In the second configuration, Raman fiber-optics were coupled through a stainless steel 
tube with outer diameter of 2 mm (smaller outer diameter than the commercial 
arthroscope probe). An 830 nm laser (Invictus, Kaiser Optical Systems, Inc., Ann Arbor, 
MI, USA) was focused onto an excitation bundle of 15 optical fibers each with a 200 µm 
core and each enclosed in a Tefzel jacket (FiberTech Optica, Inc., Kitchener, Canada). 
The excitation bundle was bifurcated into 15 individual branches, each consisting of one 
coated fiber with a steel hypodermic tubing termination. Two excitation fibers were 
separated from the rest of the bundle to be used in the arthroscope and the other 13 fibers 
were covered. The two excitation fiber provided approximately 100mW of excitation 
laser power. The collection bundle was similar in design to the excitation bundle, with 50 
individual fibers of 100 µm core diameter and Tefzel jacketing. On one end of the bundle 
the fibers were arranged linearly for coupling to the spectrograph, and on the other end 
the individual fibers were enclosed in hypodermic tubing and the ends polished. Ten 
collection fibers were placed around the 2 excitation fibers and fed into the stainless steel 
tube so that they were flush with the end of the tube. Raman scatter was dispersed 
through a spectrograph and collected onto a 1024x256 CCD detector (RamanRxn1, 
Kaiser Optical Systems, Ann Arbor, MI, USA).  
 
Raman Data Preprocessing 
Raman data were preprocessed in Matlab (v7, The Math Works, Natick MA, USA) using 
software routines developed in-house. Spectra from a neon discharge source were used to 
calibrate the wavelength axis, spectra from a quartz-halogen source were used to correct 
for variations in CCD response and standardized using a NIST-traceable intensity 
calibration. Dark spectra were used to correct for detector noise. Data were imported into 
Matlab using software developed in-house where they were corrected for cosmic ray 
spikes, dark current and variations in the CCD camera efficiency. Corrections for slit 
image curvature and tilt of the CCD relative to the spectrograph were handled using 
software routines developed in-house.[18] For the fiber-optic probes, multiple (10) 
accumulations of short acquisition spectra were collected. A mean image was calculated 
from the multiple accumulations, however to remove spurious signals from cosmic rays, 
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some pixels were excluded from this mean. To determine which pixels to exclude, the 10 
pixels from every x-y point in the 10 accumulation images were examined. A median and 
standard deviation was calculated, and only pixel intensities within 3 times the standard 
deviation of the median value were used in calculating the mean image. From the cosmic 
ray corrected mean image, spectra associated with each individual collection fiber-optic 
were calculated. The spatial distribution of intensity from each collection fiber on the 
detector was mapped with broadband illumination and the normalized broadband profiles 
for the collection fibers were used to calculate the contributions from each individual 
fiber to the measured spectral image. Silica contributions to the measured spectra are 
significant with the long and unfiltered fiber-optics. Silica contributions were measured 
by reflecting the excitation laser from a roughened aluminum surface, and removed from 
the measured data using a derivative subtraction of the measured silica spectra. 
 
Raman Data Processing 
Mean spectra for each transect were calculated and baseline corrected in Matlab. 
Baseline-corrected mean spectra were imported into GRAMS/AI software 
(ThermoGalactic Salem NH, USA). Raman bands in baseline-corrected spectra were 
fitted to mixed Lorentzian/Gaussian peaks to obtain band width, height and area 
parameters.  The resulting fit was accepted if the R2>0.99 and no negative bands were 
generated. The bands generated by the curvefit application were identified as carbonated 
apatite mineral and type I collagen in subchondral bone spectra or carbonated apatite 
mineral and lipids in cancellous bone spectra. Table 5.1 shows band assignments for 
cancellous bone based on literature reports.[19-21] Band assignments for subchondral 
bone are presented in Table 3.1, and band assignments for articular cartilage extracellular 
matrix molecules are presented in Table 1.2. Raman band intensity ratios were used as 
markers of bone mineralization, mineral to matrix ratio (MTMR, 958 cm-1/(850 cm-1+876 
cm-1)), and extent of carbonate substitution into the apatite lattice 
(carbonate-to-phosphate, 1070 cm-1/958 cm-1) or protein secondary structure (amide III, 
1245 cm-1/1268 cm-1). 
 
Human Proximal Radius Tissue Specimen 
90 
 
A human arm specimen was acquired from the University of Michigan anatomical 
donations program.  An approximately 1 cm section of human proximal radius, including 
the articular cartilage, was removed from a cadaveric arm specimen, for use in another 
experiment. Immediately after dissection, the proximal radius specimen was stored in 
phosphate buffered saline (PBS) at 4°C until examination. The specimen was examined 
within 3 days of dissection. Prior to examination by Raman spectroscopy, the specimen 
was placed onto a gauze pad, moistened with fresh PBS, and positioned on top of a 
gold-coated glass slide (EMF Corporation, Ithaca, NY, USA). Cortical bone in the 
subchondral bone plate was first examined on the Raman microscope under an intact 
layer of cartilage. Articular cartilage was then removed with a fresh scalpel and spectra 
were collected from the exposed subchondral bone. After turning the specimen over, 
cancellous bone underlying the subchondral bone plate was examined. Articular surface 
with intact cartilage and cancellous bone were examined using the fiber-optic 
arthroscope.  
Results 
As a proof-of-concept for coupling Raman measurements through an arthroscope, we 
examined bovine cortical bone and human ex vivo tissue from the proximal radius. In the 
first experiment, bovine bone was examined to determine whether it was feasible to 
measure bone Raman signal through an arthroscope. The Raman spectrum of bovine 
cortical bone collected in this way is shown in Figure 5.2. In this spectrum the phosphate 
ν1 at 958 cm
-1 and carbonate ν2 at 1068 cm
-1 were easily observed. In order to detect bone 
signal at an appreciable signal to noise level, a single accumulation of 10 minutes was 
adequate. 
 
In the second experiment, tissue excised from a human proximal radius was examined 
directly with a prototype arthroscope to determine the feasibility of measuring cartilage, 
subchondral bone, and cancellous bone spectra. Raman spectra collected through the 
fiber-optic probe are shown in Figure 5.3. For validation of the fiber-optic measurements, 
the same tissue regions were examined using a Raman microscope. Spectra collected on 
the Raman microscope are shown in Figure 5.4. Raman spectra collected from articular 
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surface (with the cartilage intact) were predominately type II collagen protein and 
sulfated glycosaminoglycan bands with minor spectral contributions from the underlying 
subchondral bone. Spectra collected from the articular surface after removal of the 
cartilage layer revealed mineral bands at 959 cm-1 and 1073 cm-1 in addition to collagen 
matrix bands. Raman spectra from cancellous bone contain bands from both the 
carbonated apatite mineral and lipids. Bands at 1300 cm-1 and 1744 cm-1 are unique to 
lipids and were attributed to marrow lipids because they were not observed in cartilage or 
subchondral bone spectra. 
 
Band intensity ratios calculated from proximal radius spectra collected from the 
fiber-optic arthroscope were compared against ratios calculated from proximal radius 
spectra collected from the Raman microscope. Mineral to matrix and carbonate to 
phosphate band intensity ratios calculated from these measurements are listed in Table 
5.2.  
Discussion 
Arthroscopic surgery is widely used to remove damaged cartilage from patients with 
osteoarthritic joints. Enhanced contrast from Raman spectroscopy has the potential to 
improve identification of damaged cartilage and guide surgical intervention towards 
better outcomes. Raman measurements coupled through an arthroscope have been 
demonstrated using a human cadervic proximal radius specimen. These initial results are 
promising because we were able to observe Raman bands unique to subchondral bone 
and cancellous bone. Raman band intensity ratios calculated from spectra collected from 
the fiber-optic arthroscope compare favorably with microscope measurements of the 
same tissue.  
 
Differences in the spectra collected with the microscope and fiber-optic probe arise 
because of the optical volumes sampled. The Raman microscope operates in a quasi-
confocal geometry to maximize signal collection. In spectra taken with the Raman 
microscope of the articular surface, we found only minor spectral contributions from 
subchondral bone when the cartilage layer was intact. This result was expected, given 
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that the scattering efficiency of bone is higher than cartilage. Spectra collected from the 
articular surface of the proximal radius using the fiber-optic probe contained strong 
spectral contributions from subchondral bone and lipid. Lipid signal was not detected in 
microscopy of the articular surface.  Although lipids are present in fresh tissue, lipids are 
not present on the articular surface in large quantities. However, we expected to observe 
contributions from lipids in the fiber-optic measurements of the articular surface because 
the fiber-optic system samples a larger spatial volume, and hence also returns signal from 
the underlying lipid-containing marrow space. Strong lipid contributions were also found 
in spectra of cancellous bone measured with both the microscope and fiber-optic probe.  
 
The joint is a complex optical system consisting of the three primary cartilage layers 
(superficial, intermediate, deep), calcified cartilage, subchondral bone and cancellous 
bone. Each layer has unique optical scattering and absorption properties which affect 
collection of Raman signal from articular surfaces. Optical scattering (µs), absorption (µa) 
coefficients and anisotropy of cartilage and bone are listed in Table 5.3. Scattering is the 
dominant optical property of cartilage.[22-25] Scattering is highly forward directed in 
cartilage, with an anisotropy of 0.94. The forward scattering of light in cartilage leads to 
penetration of light to great depths. The penetration depth of light through articular 
cartilage increases with wavelength. At 850 nm, approximately 37% of the light 
penetrates to 3.4 mm and approximately 13% of light penetrates to 6.8 mm.[24]  Thus, 
the fiber-optic Raman arthroscope excitation light is expected to penetrate to the 
subchondral bone layer and, to a lesser extent, to cancellous bone. Because cartilage is a 
forward scattering medium and has a relatively weak Raman signal, the cartilage 
spectrum measured with a fiber-optic probe is expected to contain appreciable 
contributions from the underlying tissue layers.  
Conclusions 
In this study, Raman spectra were collected from the articular surface and cancellous 
bone of a human proximal radius specimen using a novel arthroscopic Raman 
spectroscopy instrument. These ex vivo experiments demonstrate proof-of-concept that a 
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fiber-optic Raman spectroscopy instrument has potential for providing markers of 
contrast for cartilage or bone damage based on the molecular composition.  
 
Optical examination techniques during arthroscopic surgery present unique challenges 
and opportunities. Because joints are avascular no blood interferes with the spectroscopic 
measurements in joint cavities. However, constrained probe volumes and the optical 
properties of the tissue layers provide additional challenges for Raman measurements. 
Furthermore, the relative Raman scattering efficiency of cartilage relative to subchondral 
bone needs to be further studied. 
 
Our data indicate that the probe configuration can easily detect subsurface spectra, but 
will require optimization in order to maximize Raman spectra from the cartilage layer. 
We propose two improvements for future Raman arthroscopy. The first suggested 
improvement is to use a lower wavelength excitation laser because the penetration depth 
would decrease to about 2 mm (37% of total excitation), although tissue auto 
fluorescence will also be more pronounced at lower wavelengths. A second suggested 
improvement would be to utilize an optical method for reducing the spatial collection 
volume as a way to improve collection of Raman scatter from the cartilage layers and 
















Figure 5.2:  Raman spectrum of bovine bone collected from an arthroscope 







Figure 5.3:  Raman spectra of proximal radius at a) articular surface with intact 







Figure 5.4:  Raman spectra of proximal radius head at a) articular surface with 
intact cartilage, b) articular surface with cartilage removed and c) cancellous bone 




Raman Shift (cm-1) Assignment Component  
958 ν1 PO4
3-
 Apatite Mineral 
1001 Phenylalanine Collagen Matrix 
1062 ν C-C skeleton, trans  Lipid 
1070 ν2 CO3
2-
 Apatite Mineral 
1079 ν C-C skeleton, random Lipid 
1268 =CH deformation Lipid 
1300  CH2 deformation Lipid 
1439 CH2 deformation Lipid 
1450 CH2 deformation Protein, Lipid 
1654 ν (C=C) Lipid 
1745 ν (C=O) Lipid 
 
Table 5.1:  Band assignments for major bands found in Raman spectra 
cancellous bone. Carbonated apatite mineral and lipids were the major 








Ratio, Specimen Microscope Arthroscope  % 
difference 
CO3:PO4, subchondral bone 0.24 0.25 4 
MTMR, subchondral bone 2.2 3.3 50 
Amide III, subchondral bone 0.79 0.52 34 
CO3:PO4, cancellous bone 0.21 0.28 29 
MTMR, cancellous bone 6.9 3.7 46 
Amide III, cancellous bone 0.47 0.41 13 
 
Table 5.2:  Raman band intensity ratios calculated from spectra of subchondral 
and cancellous bone on a Raman microscope (λ=785 nm) and fiber-optic 












Specimen  λ (nm) µs (1/cm) µa (1/cm) g 
Cartilage, rabbit 632.8 214 ± 0.2 0.33 ± 0.05 N/A 
Articular cartilage, 
equine 
850 6*  1* 0.8 
Cartilage, human 633 246 ±16 1.0 ±0.1 0.95±0.01 
Cortical bone, 
porcine 
950 350±7 0.4±0.02 0.945±0.013 
 
Table 5.3:  Optical absorption and scattering coefficients of cartilage and 
bone in the visible or near-infrared wavelengths. Kubelka-Monk absorption 
and scattering coefficients were estimated for horse articular cartilage and 
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Chapter 6  
Dynamics of Biofluid Drop Deposition 
Introduction 
Drop deposition of fluids, in which a small-volume drop of fluid is placed onto a flat 
substrate and allowed to dry, is a well characterized phenomenon that is used to model 
fluid dynamics, polymer film drying, and conformation of macromolecules.[1-3] Drop 
deposition has the dual advantages of preconcentration and a coarse separation. In its 
simplest model, a pinned contact line forms at the edge of the drop, capillary flow 
transports solute toward the contact line as solvent evaporates and a ring-shaped deposit 
is formed.[4, 5] A recent study showed that suppression of Marangoni flow, induced by 
temperature gradients within the drop, is equally important to drop formation. [2] 
Additional studies showed that fluid properties, solute-substrate interaction, 
intermolecular forces, and drying conditions affect drop shape and drop surface 
properties.[6-8] The resulting dried drop can be either ring-shaped, with the components 
coarsely separated, or a uniform deposition.   
 
Drop deposition has been used to examine low abundance biofluids, such as tears or joint 
fluid, and has been shown to be useful as a potential diagnosis of eye infection or 
osteoarthritis.[9-11] Because the biofluid drop is typically deposited onto a flat surface, 
and is stable over many weeks, the same biofluid drop can be examined using many 
techniques, such as optical microscopy, atomic force microscopy, MALDI-MS, or Raman 
spectroscopy. These multiple levels of information, such as drop thickness, visual drop 
features and chemical composition can then be used to provide a robust description of the 
physiochemical and viscoelastic properties of a biofluid. A combined drop 
deposition/Raman spectroscopy (DDRS) technique improved Raman detection limits 
because fluorescence impurities are localized in the drop center and the molecule of 
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interest is concentrated at the drop edges.[12, 13] DDRS, also called drop coating 
deposition Raman spectroscopy, has been shown to be an excellent technique for 
examining protein samples at low concentrations.[14-16] DDRS or drop deposition 
coupled with surface-enhanced Raman spectroscopy were used to profile drop thickness 
and demonstrated the relationship between a fluids viscoelastic properties and its 
deposition behavior.[17, 18]  
 
Depending on the experiment, either a uniform dot or a ring-shaped deposition may be 
produced during drop deposition. Drop deposition can be optimized by controlling fluid 
preparation, environmental conditions, and substrate. Fluid preparation steps, including 
filtration or centrifugation, were used to remove tissue or cellular debris.[13] 
Incorporation of multiple centrifugal filters provided an additional dimension of 
mass-specific information in an examination of tear fluid by DDRS.[19] Environmental 
factors, such as drying conditions, can also be optimized because principles and 
experimental techniques for crystallization can also be applied to drop deposition. Choice 
of substrate for drop deposition is a simple factor to control, and it has a profound effect 
on drop formation.  
 
In this study, we examined the effects of substrate surface chemistry, and fluid viscosity, 
and the interaction of these effects, on formation of plasma drops. Plasma was chosen as 
a model biofluid because plasma biomarkers and/or viscosity have been widely studied as 
a potential markers for obesity and cardiovascular diseases.[20, 21] Plasma was deposited 
onto four commercially-available substrates that spanned a broad range of surface 
hydrophobicity: fused silica, gold-coated glass, calcium fluoride (CaF2) and 
Teflon-coated stainless steel (SpectRIM). Microscope images and Raman spectra 
collected from the dried drops were used to examine drop appearance and chemical 
composition. We found that substrate surface and fluid viscosity affected the final 
deposition pattern. Raman spectra of dried plasma drops showed a moderate effect of 
dilution on the amide I envelope intensity, but we found no significant differences in 
spectra collected from drops dried on different substrates.  
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Materials and Methods 
Design of Experiments 
Two main factors were examined: substrate surface chemistry and fluid viscosity.  The 
substrate surface factor has four levels (SpectRIM, CaF2, fused silica, gold-coated glass) 
and viscosity has three levels (high, medium, low). Interactions of the two factors were 
considered at all levels. The outcome measures were microscope image features, such as 
thin-films or cracks, and Raman band intensity ratios.  
 
Materials 
Freeze-dried human plasma was obtained through commercial sources, reconstituted 
using purified water, and used without additional preparation (Sigma, St. Louis, MO, 
USA). Benzoic acid (Sigma-Aldrich, St. Louis, MO, USA), and iodobenzene (98%, 
Acros Organics, Geel, Belgium) were used as received. A 1 mg/ml benzoic acid solution 
was prepared using purified water. SpectRIM (Tienta Sciences, Indianapolis, IN, USA), 
gold-coated glass (EMF Corporation, Ithaca, NY, USA), CaF2 (International Crystal 
Laboratories, Garfield, NJ, USA), and fused silica slides were used as received.  
 
Capillary Viscometry 
A size 75 Cannon-Ubbeholde semi-micro ultra-low charge capillary viscometer, 
approximate viscometric constant: 0.008 (cSt/s), was used to measure viscosity of plasma 
dilutions. Viscosity was measured for plasma at the following dilutions: 1.0, 0.5 and 0.25 
(volume fraction). Plasma dilutions were vacuum-loaded into the capillary viscometer 
and allowed to equilibrate in a 25°C water bath for 5 minutes prior to viscosity 
measurements. The standard deviation was less than 0.1 for the replicate measurements. 
Kinematic (η, cSt), relative (ηrel) and specific (ηsp) viscosity was calculated using 
Equations 1-3, where ∆t is the efflux time (s), k is the viscometric constant (cSt/s) and η0 
is the kinematic viscosity of water.  





    (Equation 2) 




Static Contact Angle Measurements 
A photograph was collected of a drop immediately following deposition using a digital 
camera. The image was imported into MATLAB (v 7.0, The Math Works, Natick, MA, 
USA) to magnify visualization of the drop. The magnified photo was printed and the 
contact angle was measured using the Young equation, as seen in Equation 4. Surface 
wetting was estimated from the contact angle, where low contact angle indicated good 
wetting and a high contact angle indicated poor wetting. Contact angle measurements of 
benzoic acid and iodobenzene were also collected on each of the substrates as references 
to encompass a range of fluid lipophilicity values.  
CLVSLSV θγγγ cos0 −−=    (Equation 4) 
Where γSV is the surface energy, γSL is the surface tension, γLV is the liquid surface free 
energy and θC is the contact angle.  
 
Drop Deposition/Raman Spectroscopy 
Fluids (v=2 µl) were deposited onto substrates using an Eagle micropipette (World 
Precision Instruments, Sarasota, FL, USA). Drops were allowed to dry at room 
temperature overnight. Microscopy images and Raman spectra were collected from dried 
drops. A Nikon E600 epi-fluorescence microscope (Nikon Inc., Melville, NY, USA) was 
modified for NIR Raman spectroscopy in-house. Microscope images were collected in 
epi-illumination mode with 2x/0.06NA Plan UW, 4x/0.20NA, 10x/0.50NA, and 
20x/0.75NA S Fluor objectives (Nikon Inc., Melville, NY, USA). A 785 nm Kaiser 
Invictus laser was line focused (Kaiser Optical Systems Inc., Ann Arbor, MI, USA) onto 
dried drops using a 20x/0.75NA S Fluor objective. Laser intensity at the objective was ~ 
100 mW. Raman-scattered light was collected through the same 20x/0.75 NA S Fluor 
objective and dispersed through a spectrograph (HoloSpec f/1.8, Kaiser Optical Systems 
Inc., Ann Arbor, MI, USA).  Raman signal was collected for 3 minutes on a deep-
depletion, back-thinned 1024x128 charge-coupled device (CCD) detector (DU401-BR-
DD, Andor Technologies, Belfast, Ireland). Raman transects consisted of 126 Raman 
spectra arranged at equidistant points along a line through the specimen. Five transects 
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were collected starting at 25 µm from the drop edge, spaced 20 µm apart, toward the drop 
center. Raman spectra were collected at the drop edge at least 25 µm from the drop edge 
because, in some cases, we observed protein dessication at the very edge of the drop. 
Raman spectra were not collected from drops dried onto CaF2 because the CaF2 surface 
produced a large background signal that prohibited detection of plasma Raman signal. 
 
Raman Data Analysis 
Data were imported into MATLAB software and corrected for curvature, dark current, 
and variations in the CCD quantum efficiency using in-house routines that were recently 
optimized.[22] Raman spectra collected from drops deposited on fused silica were not 
corrected for the fused silica background signal. Raman spectra were not corrected for 
water background signal. The mean spectrum was calculated for each transect and 
baseline corrected using a baseline fitting routine modified from Lieber.[23] Baseline 
corrected spectra of plasma were intensity-normalized to the phenylalanine ring breathing 
band intensity at ~1002 cm-1. Table 6.3 shows the Raman band assignments.  Pixel 
intensities corresponding the bands listed in Table 6.3 were calculated from the mean 
spectrum of each transect. Band intensity ratios corresponding to protein primary and 
secondary structure were calculated.[24, 25] 
Results  
Figure 6.1.a depicts the simultaneous concentration of biofluid (filled dots) at the drop 
edges and a coarse separation of biofluid from small salts or impurities (non-filled dots). 
Figure 6.1.b is a representation of Sommer’s drop formation model, adapted for biofluid 
drop formation. There are two primary flows, capillary flow (FC) and Marangoni flow 
(FM), and two primary interactions, substrate-fluid interaction (IS) and intermolecular 
interactions (IMM). Table 6.1 shows how viscosity and contact angle measurements were 
interpreted as indications of the fundamental flows and interactions that guide drop 
deposition. Higher contact angle indicated poor substrate-fluid interaction and a higher 
Marangoni flow. Higher viscosity values indicated a greater degree of intermolecular 




Table 6.2 shows the contact angles of plasma on four commercially-available substrates. 
At any given plasma concentration, the contact angle was the highest for plasma drops on 
the SpectRIM substrate and the lowest on fused silica. Contact angle of plasma solutions 
were similar when deposited onto CaF2 or gold-coated glass. The contact angle increased 
with decreasing plasma concentration when deposited on CaF2, gold-coated glass and 
fused silica. Plasma contact angles decreased with plasma concentration when deposited 
onto SpectRIM substrates. Solutions of benzoic acid (log P=1.87) and iodobenzene (log 
P=3.25) were deposited onto all four substrates as lipophilicity standards.[26] 
 
Figure 6.2 shows the effects of fluid viscosity and substrate on the deposition pattern of 
plasma on SpectRIM (1st row), CaF2 (2
nd row), gold-coated glass (3rd row) and fused 
silica (4th row). We observed that the deposition behavior of plasma was similar when 
deposited on fused silica, gold-coated glass and CaF2.  Plasma solutions deposited onto 
SpectRIM substrates dried in a different pattern and were characterized by large full-
depth cracks in the dried drop. Figure 6.3 shows Raman spectra of plasma (0.5 v/v) 
deposited onto a) fused silica, b) SpectRIM, and c) gold-coated glass. CaF2 was reported 
as a background-free substrate for drop deposition of tear fluid.[10] However, we found 
that the CaF2 surface produced a large background signal that prohibited detection of 
plasma Raman signal. It is possible that the higher laser intensity in our study produced a 
non-linear effect in the CaF2 crystal lattice giving rise to higher order bands in the 800-
1700 cm-1 spectral region. The effect of water on Raman spectra of dried plasma drops 
was examined. Figure 6.4.a compares Raman spectra from plasma dried on gold-coated 
glass at three plasma concentrations. Figure 6.4.b shows that the normalized intensity of 
the amide I maximum at ~ 1655 cm-1 increases with decreasing plasma concentration.  
Table 6.4 shows Raman band intensity ratios corresponding to markers of protein 
primary and secondary structure for plasma dilutions deposited onto gold-coated glass.   
Discussion 
Microscope images revealed that the substrate used for drop deposition had an effect on 
the drop size and deposition pattern of dried plasma drops. As shown in Figure 6.2, the 
size and shape of the resulting dried drop varied because of the different substrate wetting 
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properties. Plasma dried in a symmetric circular drop when deposited onto CaF2 or gold-
coated glass, but dried as an asymmetric circle when deposited onto fused silica. Because 
of the moderate wetting properties of CaF2, gold-coated glass and fused silica, IS was 
sufficiently low to allow ring formation and we observed a separation of plasma 
components. On these substrates, plasma dried as a smooth film-like ring at the drop edge 
with a crystalline deposit in the drop center when placed onto fused silica, CaF2 and gold-
coated glass.  
 
An unexpected finding was that undiluted plasma formed a uniform dot when deposited 
onto SpectRIM substrates. We observed a large contact angle (θC>80°) of plasma drops 
on the SpectRIM substrate, which indicated incomplete surface wetting and a more 
pronounced Marangoni effect. We also observed that plasma drops shrunk during 
evaporation on SpectRIM. From these observations, we inferred that plasma did not form 
a pinned contact line on the SpectRIM substrate. Because the contact line was not pinned 
and Marangoni flow may not have been adequately suppressed, we concluded that 
plasma did not form a ring on SpectRIM substrate and our model of biofluid drop 
formation does not adequately describe biofluid deposition onto highly hydrophobic 
surfaces. It is more likely that plasma undergoes a piling-to-bucking transition, as 
described by Tadashi et al, during the evaporation process. Piling-to-bucking is 
commonly observed when polymer solutions are deposited onto highly hydrophobic 
surfaces.[1] Higher magnification microscope images revealed that plasma dried on 
SpectRIM substrates as a uniform deposition in the shape of a concave dot, which 
support a bucking-to-piling model. Raman spectra collected across the surface of uniform 
dot further supported this hypothesis.  
 
The observation that undiluted plasma formed a uniform dot on SpectRIM substrates was 
unexpected because previous reports had shown ring formation of low concentration 
(µM-mM) protein solutions.[12, 13] However, the protein concentration in plasma is 
100x greater than protein solutions where ring formation was reported. Higher protein 
concentrations and the presence of biopolymers such as glycoproteins, lipids, or 
polysaccharides in plasma resulted in a higher fluid viscosity. Because of the inverse 
110 
 
relationship between viscosity and capillary flow, higher fluid viscosity, coupled with 
poor wetting on the SpectRIM substrate, resulted in formation of a uniform dot for 
plasma instead of a ring for protein solutions. Formation of a uniform dot can be 
advantageous for some analytical approaches because segregation of components is 
undesirable. For example, a uniform dot is the preferred deposition pattern for liquid 
MALDI-MS samples because matrix is not segregated from the analyte, enabling more 
efficient analyte ionization.  We observed partial ring formation in dried drops of diluted 
plasma because there was a slightly lower contact angle and the fluid was less viscous. 
These two factors enabled ring formation of diluted plasma on SpectRIM substrates.  
 
Raman spectroscopy of dried drops provided an indication about the effects of dilution or 
ring formation on protein secondary structure and hydration. 5 transects were collected 
across approximately a 100 µm section of the dried outer ring, at least 25 µm interior to 
the ring edge. Spectra collected from dried plasma drops were dominated by albumin 
contributions. Within a single drop, the measured area was chemically homogeneous, and 
the standard deviation of mean spectra corresponding to the 5 transects was less than 
0.02. High magnification (80x) Raman spectra collected within a deposited ring of 
aqueous protein mixtures indicated chemical heterogeneity.[27] Although the chemical 
composition of plasma is primarily albumin, it is chemically heterogeneous. It is possible 
that, at higher magnifications, we would also observe Raman bands that could be 
attributed to individual plasma proteins. In another approach, tryptic digestion of albumin 
or preparative chromatography can be used to prepare plasma prior to drop deposition. 
These preparative steps may enable detection of low abundance plasma proteins.  
 
We observed minor effects of substrate surface on Raman spectra collected from dried 
plasma drops, and the differences primarily arose because fused silica background signal 
overlapped with a few of the measured band intensities. The effects of substrate surface 
are presented in Figure 6.3 that shows representative spectra of undiluted plasma after 
drying on a) fused silica, b) SpectRIM and c) gold-coated glass. A large background 
signal from the fused silica is evident in the top spectrum of Figure 6.3.a. Filik and Stone 
reported similar findings.[27] The normalized intensity of the amide I envelope at ~ 1655 
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cm-1 is slightly higher in Raman spectra collected from plasma deposited onto fused 
silica. Most ratios were not significantly affected by substrate surface at any single 
plasma dilution. 
 
There were moderate concentration effects when plasma dilutions were deposited onto a 
single substrate, most notably in the amide I envelope maximum. The maximum of the 
amide I envelope at ~ 1655cm-1 increased in spectra collected from dried drops of diluted 
plasma. Figure 6.4.a illustrates this effect on plasma deposited onto gold-coated glass. 
Undiluted plasma (bottom spectrum) has the lowest normalized Amide I intensity while 
the 0.25 v/v plasma (top spectrum) has the highest normalized Amide I intensity. Figure 
6.4.a also shows that the bands at ~1603 cm-1 and 1617 cm-1, corresponding to Phe and 
Tyr amino acids in albumin, are less resolved in spectra collected from diluted plasma 
drops. Figure 6.4.b shows the trend of increasing Amide I envelope intensity was 
independent of the substrate surface. Linear trendlines were calculated for fused silica: y 
= -0.2406x + 0.9701 (R2=0.90), for SpectRIM: y = -0.2405x + 0.8768 (R2=0.96), for 
gold-coated glass y = -0.2804x + 0.9133 (R2=0.99).  
 
Dilution had a minimal effect on the secondary structure of plasma proteins, as measured 
the intensity ratio of amide I bands at 1655 cm-1 and 1670 cm-1. We conclude that water 
used to dilute plasma samples affected the Raman measurements in two ways. The first is 
an increased efficiency in the Raman scatter of more dilute solutions. Dried drops of 
highly concentrated solutions have more light scattering centers which decreases 
collection efficiency because the excitation laser is spread out over a wider surface area. 
A higher plasma concentration may also result in a higher index of refraction. The second 
factor is the presence of additional free water. Raman O-H stretching bands from water 
bound to plasma proteins, arise in the amide I envelope at 1630-1645 cm-1, and free water 
at ~ 1650 cm-1.[28]   
Conclusions 
Drop deposition is a simple, yet powerful, technique to prepare biofluids for a variety of 
analytical tools. Multiple levels of information can be obtained from a single drop and the 
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technique can be modified for robotic liquid handling. The resulting dried drop can be 
either a ring-shaped deposit or a uniform dot. Once the proper conditions are identified, it 
is simple to produce either type of deposition pattern. Because the evaporation process is 
a simplified crystallization process, drying conditions can be controlled to ensure that the 
desired type of deposit is obtained. A condition that can be easily modified is the choice 
of substrate. There are several commercially-available substrates suitable for DDRS that 
have surface chemistries amenable to drop or uniform dot formation.  
 
Simple physical measurements, such as contact angle and viscosity, incorporated into a 
drop deposition study can aid in interpreting the dried drop and provide insight into the 
complex drop deposition process. By measuring the contact angle plasma deposited onto 
a substrate, we obtained a relative measure of temperature gradients within the drop. 
Viscosity measurements provided an indication about the relative capillary flow and 
intermolecular interactions. Together, these measurements can help predict formation of a 
uniform dot or ring-shaped deposit, and provide additional information about the biofluid 
physical properties. We demonstrated that either a ring-shaped or uniform dot deposit can 
be obtained for plasma by using a different substrate. Microscopy images of dried plasma 
drops were used to determine the type of deposit and identify visual features such as 
thin-film accumulations or cracks within the drop.  
 
Raman spectra collected from dried plasma drops suggest that the chemistry of the 
protein-rich outer edge in the dried drop was consistent when dried on different 
substrates. Dilution of plasma affected both the optical properties and the amount of free 
water in the dried drop. We concluded that the choice of substrate affects the final 
deposition pattern and the efficiency of the coarse separation. However, the important 








Figure 6.1:  Drop deposition provides simultaneous coarse separation and 
preconcentration, as shown in Figure 6.1.a. Biofluid (closed circles) is 
concentrated in a ring at the outer edge of the drop while salts (open circles) 
are deposited in the drop center. Figure 6.1.b shows the primary flows and 
interactions that guide biofluid drop formation. Capillary flow, FC is 
responsible for fluid motion toward the pinned contact lines at the drop edge, 
upward Marangoni flow, FM, arises from a temperature gradient within the 
drying drop. Substrate and fluid interactions, IS, and intermolecular 






Figure 6.2:  Low magnification microscope images of dried plasma drops shows 









Figure 6.3:  Raman spectrum of 0.5 v/v dried plasma drops after deposition on fused 
silica (top spectrum), SpectRIM (middle spectrum), and gold coated glass (bottom 
spectrum) in the 700-1700 cm-1 spectral region. Spectra in Figure 6.3.a are offset for 








Figure 6.4:  Raman spectrum of dried drops of 0.25 v/v (top spectrum), 0.5 v/v (middle 
spectrum), and undiluted (bottom spectrum), plasma after deposition on gold-coated glass 
in the amide I envelope at 1550-1750 cm-1. Figure 6.4.b. shows the trend of increasing 
normalized amide I intensity with plasma dilution. The trendlines shown in Figure 6.4.b 









Interaction/Flow Physical Measurement Interpretation 
Fluid-Substrate interaction (IS) Contact angle (θC) IS∝1/θC 
Intermolecular interactions (IMM) Specific viscosity (ηsp) IMM∝ηsp 
Capillary Flow (FC) ηsp FC∝1/ηsp 
Marangoni Flow (FM) θC FM∝θC 
 
Table 6.1:  The relationship between measured physical properties and fundamental 
phenomenon that guide the drop deposition process. Contact angle is proportional to 
Marangoni flow (FM in Figure 6.1) and inversely proportional to fluid-substrate 
interactions (IS). A higher contact angle indicated reduced IS and higher effects from 
FM. Viscosity is proportional to intermolecular interactions (IIM) and inversely 







 SpectRIM CaF2 Gold-coated 
glass 
Fused silica 
Plasma 88 57 53 29 
0.5 v/v Plasma 87 61 59 34 
0.25 v/v Plasma 85 71 62 39 
Benzoic acid (aq) 86 84 44 43 
Iodobenzene 82 60 < 10 49 
 
Table 6.2:  Contact angle of a drop was measured immediately after deposition 





Raman Shift (cm-1) Band Assignment Component 
828 Tyr Protein  
852 Tyr Protein 
938 α-helix Protein 
1002 Aromatic ring breathing Protein 
1080 C-N, C-C stretch Protein 
1310 C-H/CH2 bend  Protein 
1340 C-H/CH2 bend Protein 
1446 CH2/CH3 deformation Organic content 
1655 Amide I, α-helix Protein 
1670 Amide I, random coil Protein 
 











Band Intensity Ratio Undiluted 
Plasma 
0.5 v/v Plasma 0.25 v/v Plasma 
1655 cm-1:1670 cm-1 
(Amide I) 0.912 0.933 0.930 
1080 cm-1: 1002 cm-1 0.133 0.140 0.144 
852 cm-1: 828 cm-1 1.149 1.162 1.201 
1340 cm-1: 1310 cm-1 0.995 0.965 0.977 
1655 cm-1: 1002 cm-1 0.632 0.777 0.841 
1448 cm-1: 1002 cm-1 0.616 0.652 0.683 
 
Table 6.4:  Raman band intensities of undiluted plasma, 0.5 v/v and 0.25 v/v plasma 
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Chapter 7  
Raman Spectroscopy of Synovial Fluid as a Tool 
for Diagnosing Osteoarthritis 
Introduction 
Osteoarthritis (OA) is considered a disease of the whole joint as a result of biological, 
chemical and viscoelastic changes to the cartilage, synovium, subchondral bone, and 
synovial fluid.[1, 2] Synovial fluid research is important not only to understand the role 
of synovial fluid (SF) in OA pathophysiology but also to identify biomarkers that may 
have significant diagnostic value. SF is primarily composed of water, proteins, 
proteoglycans, glycosaminoglycans (GAGs), lipids, small inorganic salts, and metabolites 
such as amino acids or sugars. Moreover, individual SF components may often perform 
multiple functions. For example, hyaluronic acid (HA), an unsulfated GAG, maintains 
the complex viscoelastic properties of SF and regulates the biological activity of 
advanced glycation end-products, cytokines, and enzymes associated with OA.[3-5] 
Normal joint function is dependent on the status of SF composition, especially 
considering the large interaction between the individual SF components. Therefore, 
measurements that reflect the entire SF chemical, biological or viscoelastic profile may 
prove to be a robust approach to the clinical diagnosis of OA.  
 
Analysis of SF is an attractive target for the early detection of OA damage because it 
allows for collection of multiple levels of information from the clinic and the laboratory. 
SF aspirates are obtained using a sterile needle and thus allows the rheumatologist to 
perform an preliminary visual inspection for features such as color, clarity, string test, 
and the mucin clot test.[6, 7] Although these visual tests have been used by 
rheumatologists for the past 50 years, they provide limited quantitative data. To obtain 
more quantitative result, viscosity measurements on SF aspirates can be performed. This 
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approach has been used to establish the deleterious effects of OA and age on SF 
viscosity. [8] More recently, the measurement of mechanical properties of SF, such as 
lubricity, suggest an untapped potential for SF-based diagnostics of OA.[9]  
 
Besides changes in viscosity, SF in arthritic joints may undergo biochemical and 
chemical changes, such as alterations in protein composition and proteomic profile. [10, 
11] Chemical changes affect many types of SF molecules. The complexity of this disease 
is reflected in the lack of a consensus regarding OA biomarkers in SF, serum or urine. 
Two approaches have been presented in the literature. The first approach is to look for a 
single molecular marker, and recent studies have shown that cartilage oligomeric matrix 
protein (COMP) is a promising marker. [10, 12-16] Arthritic SF may contain higher 
levels of cartilage fragments, low molecular weight HA molecules, and basic calcium 
phosphate crystals.[17-19] Another approach is to examine the entire chemical profile 
and proteomic analysis, using 2-D electrophoresis or mass spectrometry, has been 
demonstrated for SF.[20] A recent SF proteomic analysis had found changes in abundant 
proteins in SF from arthritic joints, but these changes in protein profile were not 
dependent on the stage of OA.[11] Biochemical and chemical changes that occur in SF 
associated with OA progression have been examined using immunoassay, 
chromatography, or mass spectrometry and the results are typically compared with 
clinical measures of severity including conventional radiographs, magnetic resonance 
imaging, or arthroscopy.[21-23] 
 
Molecular spectroscopy techniques, such as near-infrared (NIR), Raman and infrared 
spectroscopy, are used to analyze biomedical specimens such as cells, tissues or fluids 
because of their specificity, ease-of-use, and non-destructive nature.[24, 25]. Vibrational 
spectroscopy has been used to examine joint tissues, and spectra identified early chemical 
alterations in animal and human arthritic cartilage or subchondral bone.[26-30] NIR and 
Fourier-transform infrared (FTIR) spectroscopy have both been used to analyze the 
chemical composition of SF from osteoarthritis, rheumatoid arthritis, or 
spondyloarthropathy patients.[31-34] NIR or FTIR spectra of dried SF films allowed 
automated identification of arthritis with a classification rate greater than 95%. Individual 
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components in SF could not be identified using NIR or FTIR spectra. However, the 
overall chemical composition did correlate with spectral patterns. These early studies 
provided evidence that vibrational spectra of SF could be used to discriminate between 
different types of arthritis. A fuzzy C-means cluster/adaptive wavelet analysis of IR 
spectra from SF films yielded good agreement with clinical diagnosis for OA and 
rheumatoid arthritis (Kappa,κ=0.6).[34] 
 
Drop deposition, also known as the “coffee ring” effect, is a simple technique in which a 
fluid drop dries on a solid substrate.[35] Drop deposition differs from film preparation 
because a rough separation of components occurs and the solution state conformation is 
preserved during the drop drying process. Because drops are typically deposited on a flat 
solid substrate, the dried drops can be examined using one or more microscopy or 
spectroscopy tools. Drop deposition of biofluids is a potential biomedical diagnostic, 
owing to its simplicity, small volume requirements, and broad applicability.[36, 37] 
Recently, Raman spectroscopy has been used in conjunction with drop deposition to 
examine protein mixtures and biofluids.[38, 39] A combined drop deposition/Raman 
technique for tears and synovial fluid showed subtle differences in the chemical 
composition at various locations in a drop. [40, 41] Raman signal of poorly scattering 
components can be improved because impurities that fluoresce, and otherwise dominate 
the Raman spectra, are segregated in the drop center during the drying process.[42] 
Multiple studies that compared solution and dried drop Raman spectra of proteins found 
that solution-state conformation of proteins is preserved during the deposition 
process.[43, 44] Raman band intensities were used to estimate the relative thickness of 
dried albumin or HA drops.[44, 45] 
 
In this study, drop deposition/Raman spectroscopy (DDRS) was used as a method to 
assess knee OA severity and was compared with conventional radiographs. DDRS of SF 
does not require specimen pretreatment or extensive preparation. The purpose of this 
study was to identify Raman spectroscopic markers in SF associated with knee OA. 
Raman band intensity ratios used to describe protein content and structure correlated with 
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Kellgren/Lawrence (K/L) radiographic scoring of OA damage. These results are the first 
indications that DDRS may have value for rapid staging of knee OA. 
Materials and Methods 
Clinical Protocol 
All aspects of the clinical protocol were reviewed and approved by the University of 
Michigan Medical School Institutional Review Board (IRBMED). A total of 40 patients 
with clinical symptoms of chronic knee pain, and who were also scheduled for elective 
surgical treatment were enrolled in the study. Pre-operative conventional postero-antero 
radiographs of the symptomatic knee were reviewed by a musculoskeletal radiologist. 
Radiographs were read using the Osteoarthritis Research Society International atlas for 
identification of definite osteophytes [46] and OA was defined as the presence of a 
definite osteophyte in any of three views in accordance with American College of 
Rheumatology criteria for knee OA [47]. Overall radiographic severity of OA was 
assessed using Kellgren/Lawrence (K/L) criteria on the postero-antero view only [48]. 
Patients were classified into two groups by K/L score. Even though all of the patients 
presented clinical evidence of OA (knee effusion and pain), x-rays of the affected knee 
joint had found that 17 patients had a low K/L score (K/L=0-1) and were placed in the 
negative for radiological OA (-/ROA) group. Patients with a K/L score above 2 (K/L=2-
4) were placed in the positive for radiological OA (+/ROA) group. These grouping are 
congruent with other arthritis studies that use a K/L score.[12, 15, 49, 50]  
 
22 patients in the study underwent total knee arthroplasty, 1 patient underwent 
hemiarthroplasty and 17 patients underwent therapeutic arthroscopy. Patient 
demographics are shown in Table 1. At the time of surgery, SF was obtained from the 
knee by needle aspiration using a size 18 gauge needle and immediately placed into glass 
specimen tubes. (SCAT-1, Haematologic Technologies Inc., Essex Junction, VT, USA). 
SCAT-1 tubes contained 25 µM Phe-Pro-Arg-chloromethylkeytone as an anti-coagulant, 
200 KIU/ml aprotinin as an enzyme inhibitor and 4.5 mM EDTA buffer.  Additives in 
SCAT-1 tubes were examined using Raman spectroscopy to verify that their Raman 
spectrum does not overlap with SF Raman bands. Macroscopic debris in SF was removed 
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by low speed centrifugation and specimens were aliquoted then snap frozen and stored at 
-80°C until use.  
 
Power Analysis 
A total of N=40 subjects and a normal distribution of K/L scores with 20 subjects in the 
-/ROA (K/L=0-1) group and 20 subjects in the +/ROA (K/L=2-4) group was assumed for 
a priori power calculations. A two-sample t-test of means with a 95% confidence limit 
yielded a power of 87% (N=40) to detect moderate differences between -/ROA and 
+/ROA groups. Raman data from three SF specimens were removed from the -/ROA 
group when comparing Raman band intensity ratios because these specimens had severe 
contamination from hemoglobin or anti-coagulant from the storage vial. Raman data of 
synovial fluid from 37 patients were used in comparing Raman band intensity ratios 
between -/ROA (n=14) and +/ROA (n=23) groups. For N=37, the power was 84%. The 
power for a comparison of all five K/L groups (0-4) was 62% using an ANOVA, one-
way, fixed effect f-test. The a priori power tests indicated adequate power for 
comparison of differences between -/ROA and +/ROA groups.  
 
Drop Deposition of Synovial Fluid 
Synovial fluid from all 40 patients was examined using the DDRS protocol. SF 
specimens were examined without extensive preparation. Two small volume (2-10 µl) 
drops of synovial fluid were deposited onto a fused silica slide using an Eagle pipette 
(World Precision Instruments, Sarasota, FL, USA). Drops were allowed to dry overnight, 
semi-covered, at room temperature then examined the following day using light 
microscopy and Raman spectroscopy. Light microscope images were taken for both SF 
drops, and Raman spectra were collected from one SF drop.  
 
Microscopy/Raman Spectroscopy 
A Nikon E600 epi-fluorescence microscope (Nikon Inc., Melville, NY, USA) was 
modified for NIR Raman spectroscopy in-house. Microscope images were collected in 
epi-illumination and transmission illumination modes with 2x/0.06NA, 4x/0.20NA, 
10x/0.50NA, and 20x/0.75NA S Fluor objectives (Nikon Inc., Melville, NY, USA). A 
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785 nm Kaiser Invictus laser was line focused (Kaiser Optical Systems Inc., Ann Arbor, 
MI, USA) onto dried drops using a 20x/0.75NA S Fluor objective. Raman-scattered light 
was collected through the same 20x/0.75 NA S Fluor objective and dispersed through a 
spectrograph (HoloSpec f/1.8, Kaiser Optical Systems Inc., Ann Arbor, MI, USA). 
Raman signal was collected for 10 minutes on a charge-coupled device (CCD) detector 
optimized for near-infrared wavelengths (DU401-BR-DD, Andor Technologies, Belfast, 
N. Ireland). Raman transects consisted of 126 Raman spectra arranged at equidistant 
points along a line through the specimen. 6-12 transects were collected at various 
locations across the surface of each of the dried drops. A total of 418 Raman transects 
(52,668 spectra) were collected in this study.  
 
Data Analysis 
Raman data was collected and processed without prior knowledge of the radiography 
results. Data were imported into MATLAB software (v 7.0, The Math Works, Natick 
MA) and corrected for curvature, dark current, and variations in the CCD quantum 
efficiency. A mean spectrum was calculated from each transect after correction for the 
fused silica background. The mean spectrum was imported into GRAMS/AI 
(ThermoGalactic, Salem, NH, USA) and baseline corrected using a user-defined multi-
point baseline fitting routine. Baseline corrected spectra were intensity-normalized to the 
phenylalanine ring breathing band intensity at ~1002 cm-1 because it was the best 
resolved band and is not sensitive to local chemical environments. Raman bands in 
baseline corrected spectra were fitted with mixed Gaussian/Lorentzian functions. Curve 
fitting results were accepted when the residuals were minimized (R2 > 0.99) and no 
negative bands were generated. Bands generated in the 600-1750 cm-1 spectral region 
were identified as primarily from proteins. Band positions were reproducible to ± 2 cm-1. 
Raman band data (area, intensity, width) were imported to Excel and band intensity ratios 
were calculated. Intensity band ratios at 1080 cm-1/1002 cm-1, 1080 cm-1/1125 cm-1, 1235 
cm-1/1260 cm-1 (amide III), 1655 cm-1/1448 cm-1 and 1670 cm-1/1655 cm-1 (amide I) were 
used to evaluate protein content and structure. Raman spectra collected from drop edges 
were analyzed separately from Raman spectra collected from the drop center. After 
Raman data was analyzed for the entire patient cohort, radiograph scores were provided. 
129 
 
Band intensity ratios from 37 patients were plotted according to the patient’s K/L score 
and compared in two ways:  1) -/ROA group vs. +/ROA group and 2) according to K/L 
scores 0-4.  Raman data corresponding to patients with a K/L score of 3 and 4 were 
grouped together because there were only 2 patients in the K/L=4 group.   
 
A nonparametric Wilcoxon rank sum analysis was used to test for significance in 
differences between -/ROA and +/ROA groups. The null hypothesis, that Raman band 
intensity ratios come from distributions with equal mean values, was rejected if p<0.05. 
Differences in Raman data corresponding with the individual K/L scores 
(K/L=0,1,2,3&4) were tested for significance using Kruskal-Wallis test for the major 
factor and multiple comparison was performed using the Kruskal-Wallis criterion to test 
for significance between mean ranks of groups. 
 
In another test, MATLAB was used to preprocess all spectra from drop edges, perform 
baseline and background corrections, and generate a mean spectrum for each patient 
using only the spectra collected from SF drop edges. The mean spectra were input into an 
unsupervised K-means cluster analysis. Raman peaks were not fitted with 
Gaussian/Lorentzian functions for k-means clustering. Classification was based on pixel 
intensities corresponding to the 1080 cm-1/1002 cm-1 and amide I ratios and we input two 
groups to correspond to the -/ROA and +/ROA groups. 
Results 
Light Microscopy of Dried SF Drops 
All of the SF drops dried as a heterogeneous deposit. Drop deposition provided a coarse 
separation as shown by the low magnification microscope images in Figure 7.1. In Figure 
1a, the dried drop contains two distinct regions. The outer edge gave a glassy appearance 
and the drop center contained fern shaped crystalline deposits. There are other 
distinguishable features, including cracks radiating from the drop center and interference 
patterns along the edges of some radial cracks. Most of the drops dried in the same 
general pattern and was independent of the SF volume aspirated from the patient and K/L 
score. We did observe some variety in the SF deposition pattern, as seen in Figure 7.1. 
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Approximately 1/3 of the drops (n=11) did not dry in the deposition pattern seen in Panel 
a. Alternative deposition patterns either lacked cracks near the drop edges (Panel b), were 
glassy throughout the drop (Panel c), or contained no fern shaped crystal deposits (Panel 
d). Analysis of microscope images for presence of radial cracks at the drop edge and fern-
shaped crystals indicated a moderate correlation between OA severity and the presence of 
these drop features at low magnification (R2=0.30). Detailed visual features are apparent 
upon higher magnification (10x) and these features may correlate more strongly with 
fluid viscosity or arthritis damage. Figure 7.2 shows representative images of synovial 
fluid drops at the drop edge (panels a and b) and in the drop center (panels c and d). 
Automated image analysis algorithms, similar to ones used for automated cell phenotype 
scoring, may also be able to find a stronger correlative trend between the visual features 
observed in SF drops and radiographic scoring.[51] 
 
Separation of Synovial Fluid Components by Drop Deposition 
Figure 7.3 shows a Raman spectrum collected from the drop edge (Spectrum a) and the 
drop center (Spectrum b) of one dried SF drop. Raman spectra collected from the drop 
edges are typical of proteins, as seen in spectrum A Figure 7.3. Raman transects collected 
in the drop center of 26 SF specimens contained additional bands at ~920 cm-1 and 1410 
cm-1 and are highlighted in Figure 7.3.b. The 920 cm-1 and 1410 cm-1 bands were initially 
attributed to α-helical secondary structure and ionized carboxyl groups in SF proteins, 
and we hypothesized that more-soluble SF protein species had precipitated in the drop 
center.[41] Upon further examination, this initial hypothesis was determined to be null 
because it is inconsistent with principles of drop deposition and crystallization. During 
drop deposition, more soluble components precipitate in the drop center. These deposits 
found in the center of dried drops are usually crystalline because the more soluble 
material is often a small molecule with ionic side groups. Because the small molecules 
have a relatively longer time to precipitate, long-range ordered interactions can occur and 
the resulting precipitate is usually crystalline.  
 
Assignment of the 920 cm-1 and the 1410 cm-1 bands provide conflicting interpretations 
as to the nature of the deposits found in the center of dried SF drops. The Raman band at 
131 
 
920 cm-1, assigned to α-helix secondary structure, supports the hypothesis of smaller 
(<1000 Da) SF protein or peptide deposits in the center. However, the band at 1410 cm-1, 
assigned to ionized carboxyl groups, contradicts the possibility of long-range ordered 
interactions because the anions would repel each other.  
 
Another possibility was contamination of SF with specimen vial additives. An empty 
SCAT-1 specimen vial was examined by Raman spectroscopy and the contents were 
found to contain strong bands at ~920 cm-1 and 1410 cm-1, which were identified as 
bands arising from PPACK. We concluded that PPACK had partially dissolved in SF. 
PPACK contamination of SF likely affected whole-fluid analyses such as viscosity. 
However, PPACK contamination of SF did not affect identification of chemical changes 
in SF using DDRS because of the coarse separation. Even with the PPACK 
contamination, DDRS was able to identify spectroscopic markers that can be associated 
with OA damage. The extent of PPACK contamination was measured by the intensities 
of the most prominent PPACK bands at ~920 cm-1 and 1410 cm-1 and the intensities did 
not depend on K/L score or SF volume. Principal components analysis of spectra 
collected from the drop center readily separated PPACK signal from SF signal and it is 
possible that potentially diagnostic information can be extracted from data collected from 
the center of dried SF drops.  
 
Drop Deposition/Raman Spectroscopy of Dried SF Drops  
Raman spectra of the dried SF drops also identified two primary regions within the drop, 
which supported our findings from the light microscopy studies. Spectra collected from 
the drop edges were comprised primarily of protein Raman bands, shown in Figure 7.3, 
which provided sufficient data for evaluating the physiochemical composition of human 
SF. Although Raman bands from glycosaminoglycans (GAGs) and lipids can overlap 
with some protein bands, they are relatively weak Raman scatterers and thus do not 
contribute significantly to the overall SF spectra. However, interaction of proteins with 
GAGs and lipids may still influence protein spectral features such as band position, 
width, height, or area. Previous studies of DDRS to examine solutions of proteins or 
biofluids found drop deposition spectra of proteins were similar to solution state or solid 
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state spectra.[41, 43, 44] As expected, SF volume increased with OA damage, but the 
differences in SF volume were not statistically significant.  
 
To interpret and eventually quantify changes to SF composition, bands were identified 
and assigned. Table 7.2 shows band assignments made for SF spectra, based from 
previous Raman studies of proteins and GAG’s. [52-56] The most promising ratios were 
the 1080 cm-1/1002 cm-1 (p=8.1x10-8) and amide I band intensity (p=5.6x10-5) ratios.  
Differences between -/ROA and +/ROA groups were significant for the 
1080cm-1/1002cm-1. Figure 7.4 shows the 1080 cm-1/1002 cm-1 and amide I band 
intensity ratio sorted by ± ROA group (panels a and b) and by K/L score (panels c and d). 
The 1080 cm-1/1002 cm-1 (Panel a) intensity ratio increased in the +/ROA group and is 
evidence that the chemical environment of the protein backbone is altered with OA 
damage. The ratio of band intensities in the amide I envelope provide a marker of the 
relative abundance of disordered random coil secondary structure and ordered α-helix 
secondary structure. Higher amide I ratio observed in SF from patients in the +/ROA 
group indicate more disorder in protein secondary structure and provide further evidence 
of altered electrostatic interactions. Panels c and d of Figure 7.4 show that the mean ratio 
values begin to overlap in adjacent K/L score groups, but there is a moderate correlation 
of the ratios with K/L score (R2=0.31 for amide I and R2=0.35 for 1080 cm-1/1002 cm-1 
ratio). Kruskal-Wallis comparison showed significant differences in the mean rank 
between K/L groups 0-1, 0-2, 0-3 and 1-3 for the 1080 cm-1/1002 cm-1 intensity ratio and 
between K/L groups 0-3, 1-3 and 2-3 for the Amide I ratio.    
 
Preliminary application of automated data analysis techniques shows a good separation of 
data in the -/ROA and +/ROA groups. Figure 7.5 shows k-means clustering of pixel 
intensities corresponding to the 1080 cm-1/1002 cm-1 and amide I ratios. The data indicate 
that simple pixel intensity ratios could be a good input for a k-means cluster analysis. 
Table 7.3 presents the sensitivity and selectivity of the cluster analysis. Based on the a 
priori power analysis, we chose to cluster the data into two groups because there was a 
higher power of analysis (84%). A mean spectrum for each SF specimen was calculated 
(N=37) and an unsupervised K-means cluster analysis was performed on the entire 
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spectrum. The sensitivity (74%) and selectivity (71%) of the analysis is satisfactory for 
an unsupervised classification. We observed a high degree of misclassification when 
creating clusters based on bands that span a wide spectral range. Additional approaches, 
including principal components analysis, limiting the spectral window, or wavelet 
analysis, may improve sensitivity and classification rate. Using a support vector machine 
or principal components analysis with cluster analysis, or leave-one-out validation, are 
additional possible software approaches to improve classification rate.      
Discussion 
DDRS is compatible with standard clinical practice of SF collection. Small peptides used 
to preserve SF do not complicate Raman identification of chemical changes in SF 
because of the coarse separation provided by drop deposition. A peptide used as an 
anti-coagulant in the collection vials, PPACK, was localized in the drop center. Raman 
spectra collected from drop center had spectral contributions from dissolved SCAT-1 vial 
additives, as shown in Figure 7.3. In 2 SF specimens with the lowest aspiration volume 
(<0.5 ml), we observed extensive PPACK contamination so DDRS data from these two 
patients were removed from the final data set. The extent of PPACK contamination was 
measured by the intensities of its most prominent bands at ~920 cm-1 and 1410 cm-1, 
which did not correlate with K/L score or SF volume.  
 
Raman spectra collected from the edge of SF drops provided the most diagnostic 
information and showed significant differences between -/ROA (K/L=0-1) and +/ROA 
(K/L=2-4) groups. Comparison of Raman band intensity ratios from -/ROA and +/ROA 
groups show regions corresponding to protein backbone and amide linkages in the Raman 
spectra were sensitive to OA damage. Calculation of band intensity ratios from fitting 
peaks to SF spectra and cluster analysis indicate that the chemical environment is altered 
in SF collected from patients with radiological evidence of OA. Ratios of bands in the 
1010-1150 cm-1 spectral region provided evidence for changes in the chemical 
environment of SF protein backbone. Raman spectra are sensitive to different protein 
amide linkages in secondary structures such as α-helix, β-sheet and random coil.[53] 
Increases in the amide I ratio is evidence of decreased relative amount in ordered protein 
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secondary structure such as an α-helix. The trend toward reduced α-helical structure in 
SF proteins also indicates disruption in SF macromolecular interactions.  
 
There are several possible mechanisms for an altered chemical environment in SF 
including: lower pH of diseased SF disrupts normal hydrogen bonding and partially 
denatures SF proteins, altered HA-protein interactions because HA depolymerizes in 
diseased SF, and/or more degraded type II collagen fragments in diseased SF.[8, 14] A 
recent proteomic analysis of SF found that cystatin A, an inhibitor of cysteine proteases, 
is elevated in healthy SF.[11]  It is possible that, in diseased SF, cysteine proteases are 
more active and may disrupt normal SF electrostatic interactions.  
Conclusions 
The lack of a robust diagnostic of knee OA in its early stages, especially before structural 
alterations become apparent by conventional radiographs, continues to hinder research 
progress in both the etiologic and therapeutic arenas. The application of vibrational 
spectroscopy to examine chemical changes in SF may have diagnostic or prognostic 
value. In this study we employed a novel drop deposition/Raman spectroscopy protocol 
(DDRS) to examine SF from forty patients with clinical and radiographic evidence of 
knee OA. Analysis of light microscope images of dried drops revealed a coarse 
separation of the SF components, while measured Raman spectra provided information 
on protein secondary structure and content. We hypothesized that changes to the protein 
secondary structure could be used as general marker of chemical changes in SF and that 
these changes can be associated with radiographic scoring of knee damage. Raman data 
confirm our hypothesis and indicate a mechanism in which normal electrostatic 
interactions are disrupted in SF from damaged joints.  
 
Raman spectra collected from dried synovial fluid drops were compared to x ray images 
collected from the affected knee joint. X ray scoring of radiological features using the 
K/L system provided an objective measurement of joint tissue damage because all of the 
patients exhibited clinical symptoms of OA such as effusion or pain. Comparison of SF 
Raman band intensity ratios from -/ROA and +/ROA groups support our hypothesis. We 
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observed significant differences between Raman spectra of SF in -/ROA and +/ROA 
groups and showed trends toward a measurement that moderately correlates to individual 
K/L scores. The DDRS method can provide a “yes/no” classification of OA damage 
based on calculation of band intensity ratios or use of cluster analysis. Raman band 
intensity ratios indicate a possible trend toward correlation of the amide I or 1080 
cm-1/1002 cm-1 ratio with K/L score. We expect that expanded clinical studies will 
provide further discrimination between -/ROA and +/ROA groups, and possibly between 
adjacent K/L scores. Furthermore, it is also possible that DDRS of SF has value as a 







Figure 7.1:  Microscope images of human synovial fluid (SF) dried 






Figure 7.2:  Higher magnification microscope images of SF drops reveal 
visual features such as accumulation of thin films and full-thickness 
cracking or shallow radial cracking (Panels a and b). Fern-shaped 






Figure 7.3:  Raman spectra collected from the drop edge (a) and the drop center (b) 







Figure 7.4:  Comparison of two band intensity ratios for -/ROA (K/L=0-1) and +/ROA 
(K/L=2-4) groups found significant differences (p<0.01) in the +/ROA group. Error bars 
show the 95% confidence interval. The 1080 cm-1/1002 cm-1 (Panel a) and amide I (Panel 
b) band intensity ratios indicated alterations to protein chemical structure. When these 
ratios are sorted by K/L score (1080 cm-1/1002 cm-1 , Panel c and amide I, Panel d) these 
differences begin to diminish but moderate correlative trends (0.31 and 0.35, 







Figure 7.5:  In another analysis, unsupervised K-means cluster analysis was 
performed on data collected from the edges of dried SF drops. Closed circles 
represent correct classification, closed triangles represent false negative and closed 








# Male # Female 
0 44 19-66 7 1 
1 53 31-72 7 2 
2 59 43-78 5 3 
3&4 59 42-69 10 5 
 







Raman Shift (cm-1) Band Assignment Component 
895 C-C stretch Protein  
938 C-C stretch, α-helix Protein 
1002 Ring breathing Protein 
1080 C-N, C-C stretch Protein 
1125 C-C, C-OH, C-N stretch 
C-O-C glycosidic linkage 
Protein 
Protein 
1235 Amide III, random coil Protein 
1260 Amide III, α-helix Protein 
1340 CH2/CH3 wag Protein 
1446 CH2/CH3 deformation Organic content 
1655 Amide I, α-helix Protein 
1670 Amide I, random coil Protein 
1687 Amide I, β-sheet Protein 
 
Table 7.2:  Raman band assignments of SF drops were based on literature reports of 














 -/ROA +/ROA 
K/L=0-1 10 4 
K/L=2-4 6 17 
Sensitivity: 74% 
Selectivity: 71% 
Positive Predictive Value: 81% 
Negative Predictive Value: 63% 
 
Table 7.3:  Results from unsupervised K-means cluster analysis of mean 
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Chapter 8  
Surface-Enhanced Raman Spectroscopy 
Detection of Hyaluronic Acid: A Potential 
Biomarker for Osteoarthritis 
Introduction 
Osteoarthritis (OA), the progressive degeneration of synovial joints affects more than 20 
million adults in the United States and is expected to rise to 70 million by 2030. 
Symptomatic knee OA is one of the most prevalent form of arthritis and affects 6 % of 
adults 30 years or older.[1] Current methods of detecting OA often rely upon physical 
examination and radiographic evaluation with follow-up times of about two years to 
establish the level of disease progression.[1, 2] Chemical, biological and viscoelastic 
properties of synovial fluid often precede or accompany radiographic evidence of joint 
damage. These synovial fluid markers may provide the first indications of early-stage OA 
progression. Additionally, synovial fluid markers may be used to monitor the efficacy of 
therapeutic interventions.  
 
Evaluating chemical structure of sulfated or unsulfated glycosaminoglycans (GAGs) in 
synovial fluid or cartilage has received considerable attention in recent years as a 
potential biomarker of early-stage OA.[3-5] Inflammation of the synovial membrane 
leads to the enhanced secretion of pathological synovial fluid. An expression of altered 
synovial fluid is a lower abundance and lower molecular weight of the unsulfated GAG 
hyaluronic acid (HA) compared to normal synovial fluids.[4, 6] These changes are 
undesirable as HA is primarily responsible for the viscoelastic properties of synovial fluid 
and aids in the lubrication and protection of articular cartilage from mechanical injury. 
The loss of HA concentration is caused by infiltration of the plasma fluid and proteins 
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into the synovial fluid, whereas the molecular size reduction is caused by abnormal 
metabolic processes occurring within the inflamed synovial structures.[4, 7, 8]  
 
The depolymerization of hyaluronic acid into low molecular weight fragments results in 
decreased viscoelasticity of synovial fluid. Current techniques for measuring hyaluronic 
acid, such as chromatography, rheology or dynamic light scattering require large sample 
volumes and extensive sample preparation. We hypothesized that Raman spectroscopy 
could be used to examine hyaluronic acid in solution and in synovial fluid. Raman 
spectra of the HA polymer could be obtained using low volume and minimal sample 
preparation and the measured spectrum could correlate to the entanglement properties of 
HA.  
 
Raman spectroscopy is a powerful tool for examining subtle changes in chemical 
structure or composition. The field of biomedical Raman spectroscopy has grown 
substantially in the past 10 years, as many applications using Raman to examine cells, 
tissues, and biofluids have been reported.[9-12] Surface-enhanced Raman spectroscopy 
has also been used to examine biological specimens such as biofilms, bacteria, or 
cancerous tissue.[13-17] Despite the large enhancement of Raman signal, the potential of 
SERS has not yet been fully realized because of the experimental difficulties in achieving 
reproducible signal enhancements.[18, 19] Recently, commercially available SERS 
substrates produced by semiconductor nanofabrication techniques have overcome the 
limitation in reproducibility of enhancement on substrate surfaces.[20, 21] These 
substrates are based on silicon photonic crystals, which are etched with void architectures 
and coated with a layer of gold producing a SERS-active surface.  
 
Drop deposition is a seemingly simple phenomenon that has recently gained considerable 
attention in the biomedical and pharmaceutical fields as a way to rapidly measure 
protein-protein interactions or generate single-crystals for a polymorph crystal screen. 
The formation of a dried drop onto a solid surface is influenced primarily by capillary 
flow, and can be affected by variables such as substrate material, analyte concentration, 
and speed of evaporation.[22-24] Because most drop deposition studies are performed on 
150 
 
flat substrates, such as silicon, mica or Teflon©, light microscopy is frequently used to 
follow solvent evaporation and examine the morphology of the resulting drop. The 
dimensions of the substrates are typically compatible with other microscope-based 
analytical tools such as cross-polarized light microscopy, fluorescence or 
microspectroscopy. Ben-Amotz et al recently demonstrated the use of normal Raman 
spectroscopy to detect proteins from dried drops at concentrations as low as 1 µM in the 
presence of a buffer.[25]  
 
Because the ring formation can function simultaneously as both a low resolution 
separation and a preconcentration method, it can help overcome the well-known 
limitations of fluorescence interference and high sample concentration requirements that 
are inherent in normal Raman spectroscopy. However, normal Raman spectroscopic 
detection of rings may not be feasible for weakly scattering biomolecules, such as HA. 
Drying HA drops using the drop deposition technique on gold-coated SERS substrates 
can overcome this problem. Both the preconcentration effect of a ring shaped deposition 
and the surface-enhancement offers an additional improvement in the Raman signal 
intensity of weakly scattering HA biomolecules. 
 
We explored the feasibility of using these gold-coated SERS substrates for the rapid and 
reproducible detection of HA at clinically useful levels in biofluids such as synovial fluid 
or plasma. We hypothesized that surface-enhanced Raman spectroscopy (SERS) can be 
used for evaluating the chemical structure of HA as a biomarker for pathological synovial 
fluid secretions. In our study, we deposited a small volume of liquid containing HA onto 
a SERS substrate and allowed the drop to dry naturally under ambient conditions. We 
tested the technique on aqueous HA solutions and synthetic models of synovial fluid 
before applying it to human synovial fluid specimens.  
Materials and Methods 
Raman Spectroscopy 
Raman spectra were collected with a Raman microprobe, optimized for collection of 
near-infrared signal, described elsewhere.[26] The system consists of a 400 mW 785 nm 
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laser (Invictus, Kaiser Optical Systems, Inc., Ann Arbor, MI) and an epi-illumination 
microscope (BH-2, Olympus, Center Valley, PA). Laser light was coupled with a 1.0 
neutral density filter, Powell lens (StockerYale, Salem, NH), and lined-focused through a 
20X/0.75 NA Fluor objective (Carl Zeiss, Inc., Thornwood, NY). A laser power output of 
~8 mW was achieved at the objective. Raman scatter was collected using an f/1.8 axial 
transmissive spectrograph (HoloSpec, Kaiser Optical Systems, Inc., Ann Arbor, MI) and 
detected using a back-thinned deep depletion CCD camera (Andor Technologies, Belfast, 
Ireland). Raman spectra were acquired for 60-120 seconds. Wavenumber calibration, 
correction for variation in CCD response, dark current and image curvature were 
performed in Matlab 6.1 (The Math Works, Natick, MA) using built-in and 
locally-written scripts. Data preprocessing in Grams/AI 7.01 software (ThermoGalactic, 
Waltham, MA) consisted of user-input, multi-point baseline correction and (if applicable) 
correction for contributions from the substrate. Low magnification light microscope 
images of dried drops were collected using either a 5X/0.25 NA Fluor (Carl Zeiss, Inc., 
Thornwood, NY) or a 10X/0.50 Fluor (Carl Zeiss, Inc., Thornwood, NY) objective.  
 
Materials  
Rooster comb hyaluronic acid (HA, ~2000 kDa), bovine serum albumin (BSA), 
γ-globulins, and human plasma (ca., 72 % albumin and 15 % γ-globulin) were obtained 
from Sigma-Aldrich (St. Louis, MO) and used as received. All other used reagents and 
solvents were of analytical grade.  
 
Preparation of Standard Solutions  
Aqueous HA standards (4-0.25 mg/mL) were prepared by dilution of a 6-8 mg/mL HA 
stock solution in water. Artificial synovial fluid standards (ASF) containing human 
plasma was prepared by mixing 25 µL HA standards (4-0.25 mg/mL) in 25 µL solutions 
containing 11.5 µL deionized water and 13.5 µL human plasma, giving final HA, 
albumin, and globulin concentrations of approximately 2.0-0.125, 11.8, and 3.8 mg/mL, 
respectively. A human plasma solution (27% v/v in deionized water) was prepared as an 
experimental control at the same albumin and γ-globulin concentrations. All solutions 




Precipitation of hyaluronic acid from artificial synovial fluid 
Precipitation of proteins was tested in artificial synovial fluid. Plasma, as a control fluid, 
was also tested. A 50 µL aliquot of ASF or plasma were transferred to 500 µL centrifuge 
tubes, followed by an equivalent volume of 10 % trichloroacetic acid (TCA) solution. 
The centrifuge tubes were vortexed for 30 seconds, incubated at -4 °C overnight, and 
centrifuged at 9,500 rpm for 10 min. The clear supernatant layer was extracted and stored 
at -4 °C.  
 
Another approach was to isolate HA from a mixture of proteins and HA. We used the 
method of Kvam et al., to purify HA from synovial fluid using additions of chloroform 
and phenol-saturated buffer.[27] An aqueous mixture of HA (2 mg/mL), bovine serum 
albumin (11.8 mg/mL) and γ-globulin was dissolved in pH 7.4 PBS and stirred at room 
temperature for 1-2 hours. HA-protein mixtures can be either diluted 1:3 (%v/v) with pH 
7.4 PBS or remain undiluted and then the HA was extracted using the following steps. A) 
The sample was extracted in a 1:1 (%v/v) mixture of phenol-saturated buffer, and 
centrifuged for 3 minutes at 5000 rpm. B) The upper phase was extracted with 2:1:1 
(%v/v/v) phenol-saturated buffer: chloroform and centrifuged for 2 minutes at 5000 rpm. 
C) The aqueous phase was then extracted with 1:1 (%v/v) chloroform and centrifuged for 
2 minutes at 5000 rpm. A 0.2 µL aliquot of the final HA solution was deposited onto a 
Klarite substrate within 1 hour of the final preparation step. Extraction protocols were 
tested against with two controls a) proteins-only solution that has also been run through 
the same phenol-chloroform extraction procedure and b) mixture of HA and proteins that 
was untreated. 
 
SERS analysis protocols 
For all fluids examined, 0.2-0.3 µL of each solution were deposited onto Klarite™ SERS 
Substrates (Mesophotonics Ltd, Hampshire, UK) and left to air dry at room temperature 
for 30 min. Raman spectra of the ring-like deposits were acquired with 60 or 120 second 
integration times and ~8 mW laser power. Normal Raman spectra of a 0.5 mg/mL HA 
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deposits dried on bare gold and fused silica slides were acquired for 120 seconds. The 
resulting Raman spectra were examined for characteristic HA bands between 800 and 
1700 cm-1.  
Results  
Raman bands of HA are shown in Table 1.2. assignments were based on literature reports 
of the spectra of aqueous and solid HA.[28, 29] The major bands of HA are found at 899, 
945, 1050, 1130 and 1410 cm-1 and were used to identify HA in artificial synovial fluid 
(ASF) preparations. Noise in the measured Raman spectra limited the reproducibility of 
band positions to ± 2 cm-1.  
 
The effect of substrate surface and HA concentration on drop shape was studied on fused 
silica, bare gold, and a SERS substrate. A consistent observation throughout these studies 
was the asymmetric ring shape when drops dried on the SERS substrate. As seen in 
Figure 8.1.a, the drop shape is similar to an octagon. A similar drop shape was observed 
when aqueous HA solutions at various concentrations (0.25-6 mg/ml) are deposited onto 
the SERS substrate. In addition to the non-spherical shape of the drop, asymmetric 
concentric rings at the drop edge (Figure 8.1.b) were observed when highly concentrated 
aqueous HA solutions were deposited on the SERS substrate. In Chapter 9 we discuss 
how concentration affects deposition patterns and SERS spectra of HA.  
 
Figure 8.2 shows spectra of a 0.5 mg/ml aqueous HA solution evaporated onto fused 
silica (a), bare gold (b), and a gold-coated SERS substrate (c). It is clear from Figure 8.2 
that normal (unenhanced) Raman spectroscopy is not possible at low concentrations of 
HA in solution, even using signal integration times as long as 120 seconds. Raman bands 
from HA are clearly observed on the SERS substrate, even with an integration time of 60 
seconds. The positions of surface-enhanced Raman bands of HA are in good agreement 
with literature values for bands of the normal Raman spectrum of the molecule.  
 
Several methods were evaluated for reduction of spectral interference from proteins. We 
examined filtration, drop deposition, and ultracentrifugation methods to separate protein 
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from HA using protocols from the published literature.[30, 31] We concluded that these 
techniques do not adequately reduce the protein signal, which provides evidence for our 
hypothesis that hyaluronic acid binds non-specifically with synovial fluid proteins such 
as albumin or γ-globulin. By contrast, albumin and γ-globulin were almost completely 
removed from ASF using either the TCA or phenol/chloroform treatment. As shown in 
Figure 8.3, the intense phenylalanine ring breathing band at ~1000 cm-1 is reduced to 
intensities similar to or lower than the intensities of the most intense and characteristic 
HA bands.  
Discussion 
The use of a SERS substrate enables rapid collection of HA spectra at clinically relevant 
concentrations. Even at higher concentrations, attempts to collect unenhanced Raman 
spectra were unsuccessful.  We did not observe HA bands when aqueous solutions at 6 
mg/ml, 3 mg/ml or 0.5 mg/ml were deposited on fused silica or bare gold, even at 
integration times of 120 seconds. Previously reported detection limits for HA solutions 
by normal Raman spectroscopy are in the 40-50 mg/ml range. The limit of detection is 
reduced by at least two orders of magnitude. The current detection limit of about 0.5 
mg/mL is within synovial fluid HA levels (0.25-3 mg/mL) observed in osteoarthritis 
patients.[27] By contrast, serum HA levels that are correlated with future (approximately 
2 years) joint space narrowing are much lower (30.2 ± 19.6 ng/mL).[32] To reach such 
levels a more efficient illumination scheme or an evaporation protocol that produces 
smaller ring diameters will be need to be examined. The relatively high HA detection 
limit observed in our studies may be a consequence of using the drop evaporation 
technique. As HA concentration is reduced the ring of precipitated HA becomes 
narrower. Because the drop edge is illuminated by our line-focused laser and most of the 
deposited HA is not interrogated, the detection limit is relatively high. 
 
We observed that the initial HA concentration and surface geometry of the substrate 
affected the pattern of the dried HA drop. Previous studies have demonstrated that 
concentric ring formation is concentration-dependent.[22] We hypothesize that the 
presence of concentric rings is related to entanglement of the HA polymer chains because 
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the concentric rings are not prominent at concentrations below 2 mg/ml. The presence of 
these concentric rings does not prevent the collection of HA Raman spectra, and may 
provide additional information about the size distribution of the polysaccharide. 
Deposition of polygonal rather than circular rings appears to be a result of the geometry 
of the SERS substrate. Circular rings were observed when 0.2µl drops of the same HA 
solutions were deposited on fused silica slides or the bare gold portions of SERS 
substrates.  
 
Several techniques were used to separate HA from proteins. Microscopy images and 
SERS spectra of dried ASF drops showed that drop deposition alone is inadequate for 
separation of HA from the proteins present in synovial fluid. Light microscope images of 
the deposits from untreated artificial synovial fluid showed a few concentric rings at the 
edges of the drops. SERS spectra showed that protein preferentially adsorbed onto the 
SERS surface. Small molecule impurities were still segregated in the drop center. We 
observed similar protein bands in SERS spectra of dried canine synovial fluid and canine 
plasma drops (data not shown). These experiments in artificial synovial fluid indicated 
non-specific binding of HA to albumin.[33] Even at higher starting HA concentrations (2 
mg/ml) in untreated artificial synovial fluid, Raman spectra taken anywhere in the deposit 
are dominated by protein bands that obscure any HA signal.  
 
Chemical pretreatment of ASF was necessary to reduce protein signal in dried ASF 
drops. Trichloroacetic acid (TCA) protein precipitation followed by ultracentrifugation 
was successful in reducing the protein concentration in ASF. However, we were not able 
to clearly identify HA in spectra collected from dried drops of ASF treated with TCA. 
Although microscope images and Raman spectroscopy showed TCA had primarily 
localized in the center of the dried drop, Raman spectra showed that some TCA co-
precipitated with HA in the drop edges. Moreover, we observed overlap of TCA bands 
with characteristic HA bands at 899 and 945 cm-1. As shown in Figure 8.3.a, ASF after 
TCA treatment contained primarily bands from TCA with possible contributions from 
HA. A broad TCA band is observed between 830-860 cm-1 and other bands are found at 




Our results indicated that the phenol/chloroform protocol is better suited for isolation of 
HA than the TCA protocol.  Raman spectra of HA with good signal-to-noise were 
demonstrated for HA at clinically relevant HA concentrations (final HA concentration 
~0.66-2 mg/mL). We observed non-overlapping phenol solvent bands in SERS spectra 
taken from dried drops of the final HA isolation. A simple spectral subtraction of phenol 
solvent revealed HA bands. As shown in Figure 8.3.b, HA bands can be easily observed 
at 899, 1040, and 1117 cm-1 after treatment with phenol/chloroform. Protein signal was 
completely eliminated. Preliminary application of the phenol-chloroform treatment to 
synthetic synovial fluid indicates that dilution of untreated synovial fluid with phosphate 
buffer is also necessary in order to reduce fluid viscosity.  
 
The phenol-chloroform method was used to isolate HA from human synovial fluid 
specimens. Prior to HA extraction by phenol/chloroform, synovial fluid specimens were 
diluted with phosphate buffered saline (pH 7.4). HA-protein interactions were reduced by 
addition of pronase E and protease K to diluted synovial fluid (stirred with synovial fluid 
specimens for 15 minutes at room temperature). Samples were then passed through a 
teflon filter to remove synovial fluid lipids. HA was then extracted using additions of 
phenol/chloroform. SERS spectra were collected from aliquots kept after the filtration 
step and the final product. Similar to Kvam’s study, we found residual phenol solvent in 
the final product. [27] SERS spectra indicated that HA was present synovial fluid after 
the filtration step as shown in Figure 8.4.a, but the extraction steps removed most traces 
of HA as shown in Figure 8.4.b. We suspect that the enzymatic pretreatment did not 
adequately reduce HA-protein interactions and that HA was extracted with proteins 
during the phenol/chloroform additions.  
 
Conclusions 
The results demonstrate the potential of surface-enhanced Raman spectroscopy for 
hyaluronic acid detection in biofluids at clinically relevant concentrations. Removal of 
most proteins is necessary for successful measurement of HA in artificial models of 
biofluids. Simple filtration and chemical segregation by drop deposition were insufficient 
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for reducing protein SERS signal. Two chemical extraction techniques were tested. 
Precipitation of proteins by TCA or extraction of HA by phenol/chloroform successfully 
reduced protein signal in an artificial model of synovial fluid. Incorporation of an 
enzymatic digestion step prior to HA extraction was necessary in human synovial fluid 
specimens because HA is the foci for proteoglycan aggregation and can also bind to 
many synovial fluid proteins.[34]  
 
One limitation of the drop deposition protocol used in these experiments is that it leaves 
HA deposited in a ring that is difficult to interrogate efficiently with a line-shaped laser 
or point source. Optical and optomechanical systems for illuminating the entire drop 
simultaneously, or deposition onto chemically modified surfaces to manipulate the dried 







Figure 8.1:  Microscope image of a droplet of 4 mg/ml aqueous solution of HA deposited 






Figure 8.2:  Identification of 0.5 mg/ml aqueous HA solution deposited onto (a) fused 






Figure 8.3:  SERS spectra of artificial synovial fluid containing 0.5 mg/mL HA 










Figure 8.4: SERS spectra of human synovial fluid after the a) enzymatic 
digestion/filtration step and the b) subsequent phenol/chloroform extraction step of the 
Kvam method for extracting HA from synovial fluid. Bands attributed to HA at 894, 947 
and 1125 cm-1 (bolded) were observed in synovial fluid after the enzymatic 
digestion/filtration step indicating partial reduction in non-specific HA-protein binding. 
However, the enzymatic digestion appeared to be incomplete because we did not observe 
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Chapter 9  
Effect of Conformation and Drop Properties on 
Surface-Enhanced Raman Spectroscopy of Dried 
Biopolymer Drops 
Introduction 
Drop deposition of biofluids is an analytical method that is garnering attention in 
biomedicine because it is a rapid, specific and simple method to obtain physical chemical 
information that may have diagnostic value. Drop deposition, also known as the “coffee 
ring” phenomenon, is based on the observation that a drop of solution will form a 
ring-like shape as the water evaporates.[1-3] The evaporation process is influenced by 
drop composition and viscosity, evaporation conditions, and the surface chemistry of the 
substrate.[4-6] The resulting drop is rich in information; the shape of the resulting droplet 
and distribution of chemical components may be used to identify impurities, quantify 
biomarkers, direct crystallization of small molecules, or gauge chemical affinity to an 
enzyme. Drop deposition is performed on a flat solid surface, such as mica, fused silica or 
coated stainless steel. This format is compatible with analyses using a variety of optical 
microscopy or spectroscopic methods.[7-9] Surface-enhanced Raman spectroscopy 
(SERS) is an attractive analytical method to couple with drop deposition because Raman 
signal is enhanced 102-106 fold and detailed chemical information is obtained from SERS 
spectra.[10-12].  
 
Thickness of polymer films and polymer conformations play important roles in SERS 
band intensities.[13-16] We hypothesized that drop thickness and polymer conformation 
would affect SERS band intensities of biopolymer drops similar to the effects observed in 
thin films. Microscope images of dried drops were used to estimate relative drop 
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thickness. Dark areas in microscope images were areas where light was destructively 












1λ=∆  for k=1,3,5 etc  (Equation 1) 
where t is the change in drop thickness, λ is the wavelength, n1 is the index of refraction 
for air (n1=1) and n2 is the index of refraction of the drop (n2~1.4).[15]  
 
Most biofluids contain biopolymers, such as high molecular weight proteins 
(nucleoproteins, glycoproteins) or glycosaminoglycans. Hyaluronic acid (HA) is an 
unsulfated glycosaminoglycan. Although HA can be found throughout the body, it is 
most concentrated in vitreous humor and synovial fluid.[17] HA is biologically active in 
wound healing, treating inflammatory joint diseases, and may act as a signaling 
molecule.[18-21] Hyaluronic acid is also used in the preparation of injectable gels for use 
as a tissue engineering scaffold or a drug delivery system.[22, 23] The chemical structure 
of HA, shown in Figure 9.1, is comprised of repeating D-glucuronic acid and N-acetyl-
D-glucosamine units. Because the carboxyl groups on D-glucuronic acid are ionized at 
physiological pH, HA is considered to be a polyelectrolyte polymer and its solution 
properties can be described using scaling theory.   
 
Intermolecular interactions between HA chains and electrostatic interactions with solvent 
are extensive and are dominated by carboxyl functional groups on D-glucuronic acid 
monomers. These interactions are reflected in the sensitivity of HA viscosity to pH, salt, 
molecules such as sucrose or proteins, and solution temperature.[24-27] For accurate 
entanglement measurements, viscosity measurements of polyelectrolytes, such as HA, are 
measured in salt solutions to shield electrostatic repulsion of ionized carboxyl groups. 
Equations 2-4 were used to calculate the relative, specific, and reduced viscosity of HA:  
0η
η
η =rel   (Equation 2) 







η =   (Equation 4) 
Where η0 is the solvent viscosity, η denotes viscosity (ηred units of ml/mg, ηrel and ηsp are 
dimensionless). Intrinsic viscosity, [η] units of ml/mg, is extrapolated from a plot of ηred 
vs. HA concentration using the 2-term Huggins equation[28]:  
ckred
2][][ ηηη +=   (Equation 5) 
In a solution with added counterion, the rheology of a polyelectrolyte is similar to that of 
a neutral polymer in good solvent.[29] Scaling theory of polyelectrolyte solutions 
describes the behavior of polyelectrolytes in a no-salt solution and in a salt solution 
where electrostatic repulsion is shielded by counterions. Scaling theory describes three 
concentration domains of polyelectrolyte chains: dilute, semidilute and concentrated. 
Changes in intermolecular attraction of the polymer with relation to other coils and the 
solvent characterize each concentration domain. For dilute HA solutions, specific 
viscosity scales approximately linearly with concentration, reflecting little inter-chain 
attraction. The scaling theory is especially useful in the semidilute region, where there are 
large changes associated with concentration.[30] In the semidilute regime there are two 
intervals, semidilute unentangled and semidilute entangled. In salt solutions, scaling 
theory predicts that the specific viscosity of polyelectrolytes is dependent on 
concentration in the following proportions:  
ηsp≈c
5/4 (semidilute unentangled)  (Equation 6) 
ηsp≈c
15/4 (semidilute entangled) (Equation 7) 
Previous examinations of hyaluronic acid solution properties in 0.1 M NaCl and 
phosphate buffered saline showed a concentration dependence of specific viscosity within 
predictions of scaling theory.[27] In this study we used viscometry measurements to 
verify inter-chain attraction between HA molecules, and incorporated the viscosity data 
into our model of drop formation.  
 
Raman spectroscopy has been used to examine the structure and conformation of 
hyaluronic acid and other glycosaminoglycans (GAG’s) in solution. HA bands at 899 
cm-1, 949 cm-1 and 1130 cm-1 are established markers of HA conformation.[31] Raman 
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spectra of a 4% HA solution (~40 mg/ml) did not change in the pH range of 6-8, where 
significant changes in HA viscosity and birefringence were observed, indicating the 
presence of inter-chain long-range interactions.[32, 33] We demonstrated that SERS 
could detect HA drops at clinically relevant concentrations (0.125-3 mg/ml) that were 
undetected when spotted onto fused silica or non-enhancing gold surfaces. [34, 35] Early 
experiments indicated that both drop shape and SERS spectra taken of the droplet were 
dependent upon HA concentration. [34]  
 
Biopolymers affect bulk biofluid properties, such as viscosity, which are known to 
influence drop deposition. We incorporated scaling theory principles of polyelectrolyte 
solution behavior into a drop deposition model developed to describe ring formation of 
suspended particles.[5] As seen in Figure 9.2, there are four primary flows or interactions 
that are responsible for the fluid dynamics of drop deposition: capillary flow (FC), 
Marangoni flow (FM), intermolecular interactions (IIM) and substrate-drop interaction (IS). 
For suspended particles, IIM is minimal and a simple prediction of ring formation can be 
made: when IS>FC then there is a uniform deposition and when IS<FC then there is ring 
formation. Biopolymers strongly interact with other polymer molecules, ions and water in 
solution. Thus the effects of intermolecular interaction on drop formation were 
considered in the model of polymer drop formation.  
 
Our previous studies, described in Chapter 8, showed preliminary evidence on the effect 
of HA concentration on drop formation. The presence of concentric rings and a non-
linear SERS response with HA concentration was initially attributed to the entanglement 
properties of HA. In that study, we examined HA from rooster comb with an average 
molecular weight of ~2x106 Da with unknown polydispersity and potential chain 
aggregation from minor protein contaminants.[24]  
 
In this study, we measured the entanglement of well-characterized HA. Because the 
solution properties of HA is highly dependent on its molecular weight, we examined HA 
from bacterial sources with low polydispersity. [24, 25, 28] Salt solutions of high 
molecular weight HA (MW>1x106 Da) was expected to exhibit entanglement behavior at 
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~ 1 mg/ml, while solutions of low molecular weight HA (MW<5x105 Da) was not 
expected to exhibit entanglement at any concentration.  
 
Viscosity measurements were used to incorporate the effect of intermolecular interactions 
on drop formation. HA entanglement behavior was modeled using scaling theory 
principles. We found combined effects of drop thickness and shape, and polymer 
conformation on SERS spectra of high molecular weight hyaluronic acid drops dried onto 
a SERS-active surface. Protein impurities that are known to induce aggregation of HA 
chains can be easily detected by SERS in binary protein-HA solutions. The ring breathing 
band at ~1001 cm-1 was used as a marker for synovial fluid protein content because there 
are no HA bands at that Raman shift. We found SERS band intensities of hyaluronic acid 
dried drops were affected by drop properties and HA conformation.  
Materials and Methods 
Raman spectroscopy 
A Nikon E600 epi-illumination microscope was modified for Raman spectroscopy 
(Nikon, Melville, NY, USA).  A Kaiser Invictus line-focused laser operating at 785 nm 
was used as an excitation source (Kaiser Optical Systems, Ann Arbor, MI, USA). The 
laser line was focused onto the sample using a 20X/0.75 Nikon S Fluar objective. A 0.3 
neutral density filter was used to attenuate the laser intensity to 8-11 mW. Raman signal 
was collected for 3-5 minutes. Raman scattered light was collected by the 20X/0.75 S 
Fluor microscope objective, directed to a spectrograph (Kaiser HoloSpec f/1.8), and 
focused onto a 1024x128 near-infrared optimized CCD camera (Andor Technologies, 
Belfast, Ireland). Because of noise in the system and the spectral resolution of 4 cm-1, 
band positions were reproducible to ± 1-2 cm-1. The holographic grating used in the 
spectrometer provided a spectral window of 400-1800 cm-1. A non-confocal geometry 
was used to maximize collection efficiency. White-light microscope images were 
collected using 2X/0.06NA Plan UW, 4X/0.02NA Plan Apo and 10X/0.45NA S Fluor 
microscope objectives (Nikon, Melville, NY, USA). Gold coated Klarite SERS substrates 
(D3 Technologies Ltd, Southamptom, UK) were used as received. No laser-induced 




HA solution preparation and drop deposition 
Sodium hyaluronate manufactured from bacterial fermentation using Strep. A. bacteria 
were used without further purification (1.4x106 Da for high MW, and 2.3x105 Da for low 
MW) (Lifecore Inc., Chaska, MN, USA). Solvents and reagents were analytical grade. 
The molecular weight of the 1.4x106 Da hyaluronic acid was verified as 1.5 x 106 in 0.1 
M NaCl using the Mark-Houwink relationship [η]=KMa, where [η]=2.52 ml/mg a=0.79 
and K=0.0336 ml/g at 25° in 0.1 M NaCl.[27]  Stock solutions of 6 mg/ml or 10 mg/ml 
were prepared by dissolving sodium hyaluronate in purified water. Stock solutions were 
stirred overnight in ambient laboratory conditions to ensure complete solubilization. 
Serial dilutions were prepared volumetrically from the stock solutions. Dilutions were 
prepared at concentrations of 0.125, 0.25, 0.5, 1, 1.5, 2, 3, 4, and 5 mg/ml and stored at 
0°C until examination. Additional HA solutions were prepared in 0.1 M or 0.2 M NaCl 
using the protocol described above to examine HA entanglement behavior in a salt 
solution. HA solutions were evaluated using a capillary viscometer and the drop 
deposition/SERS protocol. For the drop deposition procedure, a 0.2-2 µl Eagle pipette 
(World Precision Instruments, Sarasota, FL, USA) was used to deposit 0.2 µl of HA 
solutions onto the substrate. Drops were dried in ambient laboratory conditions overnight 
prior to collecting spectra. Approximately 8 drops were deposited onto a SERS substrate 
in random order to reduce any effects of inter-chip variability. For ring-shaped drops, 
transects were collected within the ring. For uniform depositions, transects were collected 
at various locations in the drop.  
 
Capillary viscometry 
Cannon-Ubbeholde semi-micro ultra-low charge capillary viscometers were used to 
measure viscosity of HA solutions in concentrations ranging from 0.125-4 mg/ml. Three 
capillary viscometers were used: 1) size 50, approximate viscometric constant: 0.004 
centiStokes/sec (cSt/s); 2) size 75, approximate viscometric constant: 0.008 (cSt/s); and 
3) size 200, approximate viscometric constant: 0.1 cSt/s). The efflux time for deionized 
water, 0.1M NaCl, and 0.2 M NaCl in the size 75 viscometer was 151s, 153s, and 161s 
respectively. The overlap concentration (c*, in mg/ml) and entanglement concentration 
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(ce, in mg/ml) was calculated from a log-log plot of specific viscosity versus HA 
concentration, shown in Figures 9.3 and 9.4. 
 
SERS data analysis 
Raman transects were imported to Matlab (v 6.1, The Math Works, Natick, MA). Spectra 
were corrected for curvature, dark current and variations in the CCD quantum efficiency. 
Corrected spectra were imported to GRAMS/AI© (ThermoGalactic). In GRAMS/AI©, 
background signal from the SERS substrate (if applicable) was subtracted and a baseline 
correction was performed using a user-defined, multi-point polynomial. Baseline 
corrected spectra were intensity normalized to the 1130 cm-1 band. HA peaks were fit to 
mixed Lorentzian/Gaussian bands using the GRAMS/AI© curvefit routine. The resulting 
curve-fit was accepted if the R2 was > 0.999 and the calculation did not produce any 
negative subtraction artifacts.  
 
Estimation of drop profile  
White-light microscope images were collected on the Raman microscope using 
2X/0.06NA Plan UW, 4X/0.02NA Plan Apo and 10X/0.45NA S Fluor microscope 
objectives (Nikon, Melville, NY, USA). Images were imported into Matlab where the 
position of the drop edge, drop center, and the middle of each interference band was 
estimated. The pixel positions were plotted in Excel and converted to microns using a 25 




A summary of viscosity measurements is presented in Table 9.1. Values for intrinsic 
viscosity [η], and the Huggins’ constant ‘k’, for low and high MW HA in 0.1 M NaCl 
and 0.2 M NaCl solutions are included. For high and low MW HA, intrinsic viscosity was 
within reported ranges, and decreased with increasing salt concentration.[26] Figure 9.3 
shows specific viscosity measurements of low molecular weight HA in water (Figure 
9.3.a) and 0.1 M NaCl (Figure 9.3.b). Figure 9.4 shows the dependence of specific 
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viscosity on high molecular weight HA concentration in water (Figure 9.4.a) or in salt 
solution (Figure 9.4.b).  
 
Microscope images of dried droplets 
Figure 9.5 shows white-light images of 5 mg/ml (Figure 9.5.a) and 0.25 mg/ml (Figure 
9.5.b) HA in H2O drop dried on the SERS substrate. Ring deposition versus uniform 
deposition was dependent on HA concentration. Figure 9.5.a shows a uniform deposition 
with concentric rings around the droplet edge, Figure 9.5.b shows a ring deposition and 
no concentric rings. Concentric rings around the droplet edge are evident in microscope 
images of concentrated (>1 mg/ml) HA solutions are dried on the SERS substrate. The 
position and number of concentric rings relative to the drop edge provides an indication 
of thickness. More concentric rings indicate a thicker HA deposition.  Figure 9.6 shows 
the estimated drop thickness when dark rings are modeled as thin film interference 
patterns. At low HA concentrations (0.125-1 mg/ml), concentric rings were not observed 
and the shape of the drop changed from a ring (Figure 9.6.a) to a uniform deposition 
(Figure 9.6.b). The uniform deposition shape is maintained but the thickness of the 
deposition increases when more concentrated (>1 mg/ml) HA solutions are deposited 
onto the SERS surface (Figure 9.6.c).  
 
SERS of HA dried droplets  
Assignment of the major bands of HA were based on previous Raman reports of HA and 
are listed in Table 9.2.[31, 33] The bands at 899 cm-1, 945 cm-1, 1130 cm-1 and 1410 cm-1 
were used to examine HA conformation in previous vibrational spectroscopic studies of 
glycosaminoglycans.[31, 33, 36, 37] Figure 9.7 shows a representative spectrum of high 
molecular weight HA at 1.5 mg/ml in water and 1.5 mg/ml in 0.2 M NaCl, after 
deposition onto the SERS substrate. HA does have a band in the amide I region (1590-
1700 cm-1), but it is weak and broad in Raman spectra. Thus, we focused our analysis on 
the 800-1500 cm-1 region. HA Raman spectra in water and salt solution are similar to a 
spectrum of solid state HA. These observations are consistent with Raman spectra of 




Figure 9.8 shows the effect of HA conformation, drop type, and drop thickness on SERS 
band intensities at 899 cm-1 and 945 cm-1. Figure 9.8.a shows the effect of outward 
convective flow and substrate-HA attraction on SERS band intensities of HA in H2O. 
Viscosity measurements indicate that a constant inter-chain interaction of HA in H2O in 
the concentration range 0.125-2 mg/ml. Figure 9.8.b shows band intensities for HA in salt 
solution, and variable inter-chain interaction was considered in addition to outward 
convective flow and substrate-HA attraction.  
Discussion 
Viscosity measurements 
Viscosity of high MW and low MW HA was measured using capillary viscometry. 
Specific viscosity of low MW scaled linearly with HA concentration from 0.125-4 
mg/ml, as shown in Figure 9.3. Low MW HA was not examined using the drop 
deposition/SERS method because viscometry measurements indicated no significant 
inter-chain attraction (ηsp~c
0.98). Thus, we focused on high MW HA. High MW HA was 
examined using the drop deposition/SERS method because viscosity measurements 
indicated significant inter-chain attraction in water and a variable attraction in salt. 
Specific viscosity of HA in H2O scaled with concentration to a power of 1.6 
(ηsp=50.5c
1.6) as seen in Figure 9.4. This power relationship was constant from 0.125-1.5 
mg/ml and indicated that HA chains strongly interact in water, even at low 
concentrations. We observed a large increase in specific viscosity with concentration of 
HA in H2O, which is reflected in a large value of the slope (50.5).  
 
As shown in Figure 9.4, there are three distinct specific viscosity regions for the high 
MW HA salt solutions. These regions have a different scaling of specific viscosity with 
concentration, and correspond to dilute, semidilute unentangled and semidilute entangled 
regimes. At low HA concentrations specific viscosity scaled approximately linearly 
(ηsp~c
1.1), indicating the dilute regime where HA chains did not interact and were not 
overlapped. The overlap concentration (c*) marked the end of the dilute regime and was 
where HA chains began to interact. As shown in Table 9.1, the overlap concentration was 
0.74-0.76 mg/ml for high MW HA in 0.2 M and 0.1 M NaCl. At higher HA 
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concentrations specific viscosity scaled to a higher power (ηsp~c
2.2), indicating 
overlapping HA chains. The entanglement concentration (ce) marked the onset of the 
semidilute entangled regime and was found to be 1.9-2.8 mg/ml in 0.1 M and 0.2 M 
NaCl. Specific viscosity scaled with concentration to a higher extent (ηsp~c
3.6) above 
chain entanglement, indicating significant inter-chain HA attraction.  
 
Modeling HA drop formation 
Previous models of drop formation of suspended particles on a solid flat surface assume 
four main forces on a particle during solvent evaporation.[5] Briefly, a uniform 
deposition is expected when the substrate-HA attraction (IS in Figure 9.2) is greater than 
the outward capillary flow (FC in Figure 9.2) toward the contact point of the droplet and a 
ring-shaped deposition is expected when the FC>IS. However, this model assumed 
negligible intermolecular attraction (IIM in Figure 9.2). Our model of drop formation 
included the effect of intermolecular attraction because viscosity measurements indicated 
significant intermolecular attraction for high MW HA in H2O and in salt solution.  
 
We considered only IS and FC in the model of HA in H2O drops. Scaling of specific 
viscosity of HA in H2O (ηsp~50.5c
1.6) indicated constant intermolecular interactions, and 
we assumed a constant IIM. Specific viscosity increased significantly with HA 
concentration, as indicated by the large constant (ηsp~50.5c
1.6). We also assumed constant 
IS. From 0.125-0.5 mg/ml we observed ring deposition, indicating FC>IS. At these 
concentrations HA dried as a ring-shaped deposition, as shown in Figure 9.5.a. At 
concentrations above 1 mg/ml, specific viscosity increased to the point where outward 
convective flow became weaker than substrate-HA attraction. At these higher 
concentrations HA drops dried with uniform deposition, shown in Figure 9.5.b.  
 
Dark lines found in dried drops were examined using principles of destructive 
interference by thin films. Relative drop thickness and drop profiles were estimated using 
this technique. Figure 9.6 shows the profiles and relative thickness of HA in water at 0.25 
mg/ml, 1 mg/ml and 5 mg/ml. Relative thickness of the drop is ~150 nm at 0.25 and 1 
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mg/ml, and ~1.4 µm at 5 mg/ml. Estimation of relative drop thickness provided a basis to 
compare the collection efficiency and efficiency of surface plasmon interaction with HA. 
SERS spectra of polymer thin films are affected by film thickness and polymer 
conformation. [13, 14, 16] SERS bands are more intense at thinner films, owing to a 
greater interaction of surface plasmons with the film. We propose that, in polymer drops, 
SERS band intensities are also subject to the effects of drop thickness and polymer 
conformation. 
 
In addition to increased collection efficiency at low HA concentrations (because of a 
thinner deposition) there was a preconcentration effect with ring deposition versus 
uniform deposition. There was also a greater apparent concentration in the ring versus a 
uniform deposition. We used our estimates of ring profiles from interference patterns to 
calculate a concentration density (mg/ml/µm2) and identified a 4-fold increase in 
concentration density in the 0.25 mg/ml ring compared to the 1 mg/ml uniform 
deposition. There was, as expected, a 5-fold increase in concentration density of the 5 
mg/ml uniform deposition compared to the 1 mg/ml uniform deposition. Effects of ring 
versus uniform deposition and preconcentration were observed in SERS spectra from 
aqueous HA dried drops, especially in the band intensity at 945 cm-1.  
 
Viscosity measurements of HA in salt solutions indicated variable intermolecular 
attraction. Intermolecular attraction (F4), outward convective flow (F2), and substrate-HA 
attraction (F1) were considered in the model of HA in salt drops. Ring formations and 
concentric ring formations were observed in dried drops of HA in salt solution. However, 
sodium chloride crystals precipitated throughout the dried drops and prohibited 
estimation of drop properties using interference patterns. We expect that future studies to 
verify our method of estimating drop properties using interference patterns, such as the 
use of atomic force microscopy, will account for the presence of salt crystals and allow 
drop profiles to be obtained.[38] 
 
SERS of HA dried drops 
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Since most synovial fluid proteins have at least one phenylalanine ring, the ring breathing 
mode at ~1001 cm-1 was used as a marker for protein content. There was no detectable 
protein signal, as indicated by no band at ~1001 cm-1. We focused our analyses on the 
“fingerprint” region (400-1800 cm-1) because it is a more direct measurement of HA 
conformation. In this spectral range, HA is weakly scattering in solution and previous 
vibrational spectroscopy studies of HA in thin films or solutions have been limited to 
high (>10 mg/ml or 1% w/v) HA concentrations.[31, 33, 39-41] SERS spectra of aqueous 
HA (Figure 9.8.a) and HA in salt solution (Figure 9.8.b) dried onto the SERS surface 
showed little variation. The C1-H deformation band occurs at ~ 899 cm
-1 when the C1 
hydrogen is axial and at ~ 845 cm-1 when the C1 hydrogen is equatorial. Symmetric 
C-O-C linkage vibration occurs at ~945 cm-1 for GAG’s with β-type or α-type linkages. 
The 899 cm-1 and 945 cm-1 SERS bands were examined because they are the most 
insightful to HA conformation and were the best resolved bands in SERS spectra of HA.  
SERS band intensities at 899 cm-1 and 945 cm-1 were affected by efficiency of the SERS 
enhancement processes, HA concentration and HA conformation. Drop profiles from 
microscope images were used to estimate the relative concentration density of HA in a 
drop or uniform deposition. Viscosity measurements were used to verify HA 
conformation and model the effect of intermolecular attraction on drop formation. SERS 
intensities of the 899 cm-1 and 945 cm-1 bands were examined in the context of drop 
properties and HA conformation. The 945 cm-1 SERS band appeared to be more sensitive 
to these effects than the 899 cm-1 SERS band.  As seen in Figure 9.8, there are differences 
in SERS band intensities when aqueous HA (Figure 9.8.a) or HA in salt solution (Figure 
9.8.b) is deposited onto a SERS substrate.  
 
Dried drops of aqueous HA solutions formed a ring at low HA concentrations and a 
uniform deposition at higher HA concentrations. Localization of HA into a ring had a 
preconcentration effect, and resulted in more intense SERS bands (Figure 9.8.a). At 
higher HA concentrations (>0.5 mg/ml, uniform deposition), the 945 cm-1 SERS intensity 
slightly increased, indicating contributions from unenhanced Raman as the relative 




SERS band intensities at 899 cm-1 and 945 cm-1 varied with HA concentration when HA 
salt solutions were deposited onto the SERS substrate.  Changes in the 945 cm-1 SERS 
band intensity, shown in Figure 9.8.b, roughly correlated to transitions from a dilute to 
semidilute unentangled solution at 0.76 mg/ml and from a semidilute unentangled to a 
semidilute entangled solution at 1.9-2.8 mg/ml. The SERS 945 cm-1 intensity increased 
with HA concentration in the dilute regime (0.125-0.5 mg/ml). After 0.5 mg/ml, the 
SERS 945 cm-1 intensity decreased until ~ 2 mg/ml. At HA concentrations greater than 2 
mg/ml, the SERS 945 cm-1 intensity remained relatively constant.  SERS data indicate 
that, in salt solutions, the HA C-O-C backbone is stretched on the SERS surface at dilute 
concentrations, as reflected by a higher intensity of the SERS 945 cm-1 band. We 
observed a “dilution effect” in the SERS 945 cm-1 band intensity, where the band 
intensity decreased at concentrations above the overlap concentration. [13, 14]  The 
transition observed in the SERS 945 cm-1 band intensity correlated to the transition from 
an elongated chain at dilute concentrations to collapsed chains that are overlapping. A 
“dilution effect” was not observed for the SERS 899 cm-1 band intensity. As seen in 
Figure 9.8.b, the SERS 899 cm-1 intensity decreased from 0.125-1 mg/ml and remained 
constant thereafter. SERS data indicate that the 899 cm-1 band is sensitive to 
conformation changes when the HA chain is elongated at dilute concentrations while at 
concentrations higher than the overlap concentration there were no changes observed in 
the 899 cm-1 SERS intensity.    
Conclusions 
Biopolymers are ubiquitous in biofluids and in order to develop a more accurate model of 
biofluid drop formation, we needed to understand the effect of biopolymers in the context 
of drop formation and subsequent collection of SERS spectra from dried drops. We 
examined the effect of biopolymers on drop formation using hyaluronic acid (HA) as a 
model biopolymer. Surface-enhanced Raman spectroscopy (SERS) was used to examine 
chemical structure of HA solutions dried onto a SERS-active substrate as a ring 
deposition or as a uniform deposition. Viscosity measurements were used in previously 
established models of drop formation to account for intermolecular interaction of HA 
chains. Microscope images were used to estimate relative drop thickness and drop profile.  
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We found that the complex viscoelastic properties of HA affected drop formation and 
SERS spectra collected from drops. Two models of drop formation were developed for 
HA. In the first model, where aqueous HA is dried onto the SERS substrate, we found 
that solution viscosity was the dominant force in the type of deposition which was 
reflected in the SERS band intensity at 945 cm-1. In the second model, where HA in salt 
solutions were deposited onto the SERS substrate, we found that the viscoelastic 
properties of HA was the dominant force in the SERS band intensity at 945 cm-1.  
 
Combined data from viscosity measurements with microscope images provided a more 
accurate description of HA solution properties during drop formation. Future studies 
include using SERS combined with drop deposition of biofluids which will incorporate 








Figure 9.1:  The chemical structure of hyaluronic acid. Hyaluronic acid is a 
polysaccharide composed of two monosaccharides: D-glucuronic acid (Monomer G) and 






Figure 9.2:  There are four primary flows or interactions that influence biofluid 
drop formation. Capillary flow, FC, is responsible for fluid motion toward the 
pinned contact lines at the drop edge, upward Marangoni flow, FM, arises from a 
temperature gradient within the drying drop. Substrate and fluid interactions, IS, 






Figure 9.3:  Specific viscosity of low molecular weight (MW=2.3x105 Da) hyaluronic 






Figure 9.4:  Specific viscosity of high molecular weight (MW=1.4x106 Da) hyaluronic 






Figure 9.5:  Microscope images of aqueous HA dried drops at (a) high and (b) low HA 
concentrations. At high concentrations, concentric rings formed on the outer edge of the 
drop and the HA dried as a uniform deposition. At low concentrations, HA dried as a ring 
deposit and no concentric rings were observed. Destructive interference of light resulted 






Figure 9.6:  Relative drop thickness and drop profiles were calculated from the 
interference patterns. At low aqueous HA drops, a ring-shaped drop is formed (a). At ~ 
1mg/ml, the drop dried as a uniform deposition (b). Highly concentrated HA solutions 







Figure 9.7:  SERS spectrum of dried drops of high MW HA in solutions of: 






Figure 9.8:  SERS band intensities at 899 cm-1 and 945 cm-1 are dependent on HA 




 High MW HA (1.387 x106 Da) Low MW HA (2.344 x105 Da) 
Parameter 0.1 M NaCl 0.2 M NaCl  0.1 M NaCl 0.2 M NaCl  
[η] (ml/mg) 2.5 2.03 0.39 0.35 
c* (mg/ml) 0.76 0.74 N/A N/A 
c*[η] 1.9 1.5 N/A N/A 
k’ 0.44 0.59 0.44 0.62 
ce (mg/ml) 1.9 2.8 N/A N/A 
 
Table 9.1:  Intrinsic viscosity [η], overlap concentration (c*), entanglement concentration 
(ce), and the Huggins constant (k’) were calculated from viscosity measurements of high 












Raman Shift (cm-1) Band Assignment 
899 C1-H deformation, β-linkage 
945 Skeletal C-O-C linkage stretch 
~1045 C-O,C-C 
~1090 C-OH bend, acetyl group 
~1130 C4-OH bend and C4-H bend 
~1150 C-O, C-C, Oxygen bridge 
~1210 CH2 twist 
1330 CH bend, Amide III 
1370 COO- symmetric stretch 
CH3 deformation 
~1410 COO- symmetric stretch 
CH3 bend 
~1460 CH2 bend 
 
Table 9.2:  Raman bands for hyaluronic acid observed for solid HA, 
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Chapter 10  
Conclusions  
Osteoarthritis is a musculoskeletal disease that affects joints, leading to pain and loss of 
joint function. The asymptomatic nature of osteoarthritis is an obstacle to diagnosis, and 
the lack of an early-stage diagnostic tool prevents treatment. Current diagnostics rely on 
morphological changes to the joint, but these changes are typically found only when the 
disease is in the later stages. Joint health inherently relies upon a proper molecular 
composition of articular joint tissues and synovial fluid. The molecular composition 
determines not only the joint’s chemical environment, but also influences biological 
function and viscoelasticity. Morphological changes are apparent in standard 
osteoarthritis tests. Chemical, biological and mechanical properties of joints may be 
altered before morphological changes occur, allowing a window for earlier diagnosis of 
disease. 
 
Through a more complete understanding of the molecular composition of joint tissue, 
molecular targets for early diagnostics and treatment monitoring can be developed. In this 
dissertation we have examined the molecular properties of both healthy and diseased 
joints. In early-stage osteoarthritis, cartilage extracellular matrix molecules degenerate.  
Degeneration of extracellular matrix occurs either through depolymerization or 
alterations in hydrogen bonding that maintain secondary structure integrity. Components 
of extracellular matrix subject to degeneration include: type II collagen, aggregan, 
hyaluronic acid and chondroitin sulfate. Other changes in early-stage osteoarthritis 
include reduced mineral content in subchondral bone, increased synovial fluid volume, 
and a release of inflammatory cytokines from the synovium. These subtle chemical 
changes have been examined using a variety of chromatographic, histopathologic and 
mass spectrometric techniques. Such subtle chemical changes cannot be detected with 
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standard clinical imaging techniques. An alternative technique for measuring the subtle 
chemical changes in joint tissues is through vibrational spectroscopy. 
 
Raman spectroscopy of cartilage, subchondral bone and synovial fluid was the focus of 
the research presented in this dissertation. Direct examination of joint tissues using 
Raman spectroscopy was presented in Chapters 3 and 5. Chemical structure is measured 
through Raman spectroscopy, and was used in conjunction with micro-computed 
tomography and histopathology. The Raman measurements indicated that bone 
mineralization was altered in a mouse model of early-onset osteoarthritis. Such 
alterations in subchondral bone are not feasible for clinical measurements because all 
other methods for measuring bone chemistry involve destructive testing. Vibrational 
spectroscopic methods are minimally invasive, and are appropriate for use in clinical 
contexts. To demonstrate the feasibility of measuring the molecular properties of joint 
tissue with clinically-relevant tools, a fiber-optic Raman probe for arthroscopic 
measurements was developed. With further work, this method may provide molecular 
contrast between normal and healthy cartilage for improving the outcome of surgical 
interventions.  
 
In addition to the cartilage and subchondral bone, the composition of synovial fluid is a 
key factor in maintaining healthy joint function. The composition of synovial fluid from 
normal and diseased joints was examined in Chapters 6-9. A novel method called drop 
deposition/Raman spectroscopy was developed to measure the Raman spectra of synovial 
fluid. Using the principles of drop deposition allowed optimization of the synovial fluid 
and plasma deposition patterns. After drops were allowed to form dried deposits, the 
enriched deposits were examined using Raman microscopy. Drop deposition/Raman 
spectroscopy was used to examine synovial fluid from human patients exhibiting clinical 
signs of osteoarthritis. Synovial fluid is commonly drawn from patients with 
osteoarthritis during lavage procedures, and so this provided an opportunity to investigate 
the relationship between molecular composition and joint disease. We found that Raman 
spectroscopic markers of protein secondary structure were correlated with radiographic 
evidence of osteoarthritis. We also found that hyaluronic acid content plays an important 
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role in the drop deposition process. Hyaluronic acid is also a potential osteoarthritis 
biomarker, and was examined using drop deposition coupled to surface-enhanced Raman 
spectroscopy. Because of the common clinical practice of extracting synovial fluid and 
the utility for drop deposition/Raman spectroscopy analysis of synovial fluid 
composition, this method has potential as a screening tool for osteoarthritis. In particular, 
the drop deposition/Raman spectroscopy method would be amenable for high-throughput 
screening. 
 
Methods were developed in this dissertation for evaluating joint damage and disease. 
These methods provide a foundation for the analysis of joint tissue with Raman 
spectroscopy. The studies presented in this thesis examined known populations and we 
expect to apply the technologies developed toward examination of unknown or blinded 
populations. Improvements to instrumentation, data processing and standards should 
enable clinical applications of arthroscopic joint measurements. This might include the 
development of compact fiber-optic probes for better control over optical sampling 
volumes to optimize measurement of cartilage. Furthermore, current standards for in vitro 
modeling of cartilage are composed of mixtures of collagen and proteoglycan. These are 
not ideal models because interactions are not accounted for. Because current data 
processing and interpretation is based on these imperfect models, quantification of 
proteoglycan content and interpretation of the amide I envelope are also imperfect. To 
better understand the interactions between macromolecular cartilage components, healthy 
cartilage is the ideal model. Furthermore, spectral contributions from noncollageneous 
proteins and matrix vesicles can only be discovered through direct measurements of 
cartilage.  
 
One difficulty in using cartilage for studies of joint composition is that chondrocytes 
rapidly lose their phenotype in culturing conditions, so it is currently impossible to use 
cartilage for intervals longer than 4 weeks. The extracellular matrix is critical to 
maintaining chondrocytes phenotype, but interactions between chondrocytes and the 
extracellular matrix are not yet adequately understood. Drop deposition of prepared 




In summary, the techniques demonstrated in this dissertation have the potential to provide 
quantitative information about joint health, with particular emphasis on early-stage 
osteoarthritis detection. Results show promise toward minimally invasive measurements 
in joint tissue and extracted synovial fluid. Drop-deposition for preparing Raman samples 
pre-dates this research. However, the research presented here allows a more detailed 
understanding of how complex fluid properties and fluid-substrate interactions influence 
the final deposit, with a particular emphasis on commercially available substrates suitable 
for Raman spectroscopy. Through this enhanced understanding, optimization of drop 
deposition methodology for biofluid preparation has been simplified. Potential further 
applications of this research span from basic science research in understanding joint 
chemistry, to the development of new treatments through detailed molecular feedback, as 
a clinical early-stage screening tool, and for enhancing contrast in image-guided therapy 
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